var title_f12_32_12800="Endothelial dysfunction CHD I";
var content_f12_32_12800=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F52009&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F52009&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Coronary endothelial dysfunction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 335px; height: 342px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Baseline arteriogram in a patient with early atherosclerosis and endothelial dysfunction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Charles E Rackley, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_32_12800=[""].join("\n");
var outline_f12_32_12800=null;
var title_f12_32_12801="Contents: Reproductive endocrine female";
var content_f12_32_12801=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/56/1934\">",
"       Endocrinology and Diabetes",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Reproductive endocrine female",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Reproductive endocrine female",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Contraception",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/13/42201\">",
"           Contraception: Overview of issues specific to adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/54/33640\">",
"           Contraceptive vaginal ring",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/62/37859\">",
"           Effect of oral contraceptives and postmenopausal hormone therapy on blood pressure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/5/31833\">",
"           Emergency contraception",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/16/16646\">",
"           Menstrual function, menopause, and hormonal contraceptives in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/24/39306\">",
"           Overview of contraception",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/19/32058\">",
"           Overview of intrauterine contraception",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/5/18522\">",
"           Overview of the use of estrogen-progestin contraceptives",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/7/39034\">",
"           Risks and side effects associated with estrogen-progestin contraceptives",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Endometriosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/46/5863\">",
"           Diagnosis and management of ovarian endometriomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/8/11402\">",
"           Diagnosis and treatment of endometriosis in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/35/8761\">",
"           Gonadotropin releasing hormone agonists for long-term treatment of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/29/14810\">",
"           Overview of the treatment of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/15/38136\">",
"           Pathogenesis and treatment of infertility in women with endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/48/19210\">",
"           Pathogenesis, clinical features, and diagnosis of endometriosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Estrogen replacement therapy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/34/40486\">",
"           Continuous postmenopausal hormone therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/62/37859\">",
"           Effect of oral contraceptives and postmenopausal hormone therapy on blood pressure",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/63/41975\">",
"           Estrogen and cognitive function",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/38/41576\">",
"           Managing the side effects of tamoxifen",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/2/7210\">",
"           Mechanisms of action of selective estrogen receptor modulators",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/44/41672\">",
"           Molecular biology and physiology of estrogen action",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/36/29258\">",
"           Postmenopausal hormone therapy and cardiovascular risk",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/11/11449\">",
"           Postmenopausal hormone therapy and the risk of breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/26/17831\">",
"           Postmenopausal hormone therapy in the prevention and treatment of osteoporosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/23/32122\">",
"           Postmenopausal hormone therapy: Benefits and risks",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/53/16218\">",
"           Preparations for postmenopausal hormone therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/42/40615\">",
"           Treatment of menopausal symptoms with hormone therapy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Fertility",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/18/3367\">",
"           Causes of female infertility",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/41/35479\">",
"           Classification and treatment of ovarian hyperstimulation syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/10/11433\">",
"           Donor insemination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/7/38010\">",
"           Fertility preservation in patients undergoing gonadotoxic treatment or gonadal resection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/61/18392\">",
"           Fertility preserving options for women of advancing age",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/35/8761\">",
"           Gonadotropin releasing hormone agonists for long-term treatment of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/56/37770\">",
"           In vitro fertilization",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/11/15546\">",
"           Intracytoplasmic sperm injection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/31/26101\">",
"           Intrauterine adhesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/14/24807\">",
"           Oocyte donation for assisted reproduction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/13/11482\">",
"           Optimizing natural fertility in couples planning pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/56/17287\">",
"           Overview of infertility",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/10/13482\">",
"           Overview of ovulation induction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/29/14810\">",
"           Overview of the treatment of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/6/4201\">",
"           Ovulation induction with aromatase inhibitors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/25/9626\">",
"           Ovulation induction with clomiphene citrate",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/15/38136\">",
"           Pathogenesis and treatment of infertility in women with endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/17/16660\">",
"           Pathogenesis of ovarian hyperstimulation syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/48/19210\">",
"           Pathogenesis, clinical features, and diagnosis of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/42/36519\">",
"           Posthumous assisted reproduction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/7/22647\">",
"           Prevention of ovarian hyperstimulation syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/48/25351\">",
"           Procedure for intrauterine insemination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/18/9513\">",
"           Reproductive surgery for female infertility",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/6/16487\">",
"           Strategies for improving the efficacy of clomiphene induction of ovulation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/27/43449\">",
"           Strategies to control the rate of high order multiple gestation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/42/15015\">",
"           Surrogate pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/36/29256\">",
"           Techniques for preimplantation sex selection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/57/25496\">",
"           Unexplained infertility",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/59/39865\">",
"           Use of assisted reproduction in HIV and hepatitis infected couples",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hormone physiology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/2/7210\">",
"           Mechanisms of action of selective estrogen receptor modulators",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/44/41672\">",
"           Molecular biology and physiology of estrogen action",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/47/8952\">",
"           Pharmacology and mechanism of action of progesterone receptor modulators (PRMs)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/27/32181\">",
"           Physiology of gonadotropin-releasing hormone",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/16/25866\">",
"           Therapeutic use and adverse effects of progesterone receptor antagonists and selective progesterone receptor modulators",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hyperandrogenism and hirsutism",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/31/9721\">",
"           Evaluation of premenopausal women with hirsutism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/48/38662\">",
"           Ovarian hyperthecosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/28/24007\">",
"           Pathogenesis and causes of hirsutism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/37/35416\">",
"           Treatment of hirsutism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/16/32005\">",
"           Use of GnRH agonists in the treatment of hyperandrogenism and hirsutism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/17/27928\">",
"           Use of combination estrogen-progestin contraceptives in the treatment of hyperandrogenism and hirsutism",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypogonadism and ovarian failure",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/42/33449\">",
"           Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/2/36903\">",
"           Clinical manifestations and evaluation of spontaneous primary ovarian insufficiency (premature ovarian failure)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/7/2170\">",
"           Congenital gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/2/2089\">",
"           Etiology, diagnosis, and treatment of primary amenorrhea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/56/34697\">",
"           Etiology, diagnosis, and treatment of secondary amenorrhea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/63/14329\">",
"           Management of Turner syndrome (gonadal dysgenesis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/63/37880\">",
"           Management of spontaneous primary ovarian insufficiency (premature ovarian failure)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/22/15720\">",
"           Ovarian development and failure (menopause) in normal women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/26/1447\">",
"           Ovarian failure due to anticancer drugs and radiation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/40/7817\">",
"           Pathogenesis and causes of spontaneous primary ovarian insufficiency (premature ovarian failure)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/26/23976\">",
"           Pathogenesis, diagnosis, and treatment of autoimmune ovarian failure",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Menopause",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/45/20184\">",
"           Androgen production and therapy in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/45/44761\">",
"           Clinical manifestations and diagnosis of menopause",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/34/40486\">",
"           Continuous postmenopausal hormone therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/38/41576\">",
"           Managing the side effects of tamoxifen",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/53/25434\">",
"           Menopausal hot flashes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/16/16646\">",
"           Menstrual function, menopause, and hormonal contraceptives in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/53/16218\">",
"           Preparations for postmenopausal hormone therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/42/40615\">",
"           Treatment of menopausal symptoms with hormone therapy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Menstrual cycle",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/3/36919\">",
"           Amenorrhea and infertility associated with exercise",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/7/31866\">",
"           An overview of endometrial ablation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/41/20122\">",
"           Chronic menorrhagia or anovulatory uterine bleeding",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/52/39751\">",
"           Clinical manifestations and diagnosis of premenstrual syndrome and premenstrual dysphoric disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/16/28935\">",
"           Epidemiology and pathogenesis of premenstrual syndrome and premenstrual dysphoric disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/6/26724\">",
"           Evaluation of the menstrual cycle and timing of ovulation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/16/16646\">",
"           Menstrual function, menopause, and hormonal contraceptives in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/2/27685\">",
"           Physiology of the normal menstrual cycle",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/25/31125\">",
"           Primary dysmenorrhea in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/10/3241\">",
"           Treatment of premenstrual syndrome and premenstrual dysphoric disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/8/44166\">",
"           Ultrasound evaluation of the normal menstrual cycle",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Miscellaneous",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/15/24825\">",
"           Breast masses and other common breast problems",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/61/22489\">",
"           Clinical manifestations and diagnosis of gonadotroph and other clinically nonfunctioning pituitary adenomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/31/23034\">",
"           Clinical manifestations of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/5/19546\">",
"           Definition, etiology, and evaluation of precocious puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/57/22424\">",
"           Diagnosis and treatment of delayed puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/29/27096\">",
"           Diagnosis of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/16/41220\">",
"           Normal sexual differentiation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/29/14810\">",
"           Overview of the treatment of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/48/19210\">",
"           Pathogenesis, clinical features, and diagnosis of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/25/31125\">",
"           Primary dysmenorrhea in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/36/2630\">",
"           Transsexualism: Epidemiology, pathophysiology, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/41/8857\">",
"           Treatment of gonadotroph and other clinically nonfunctioning adenomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/52/31561\">",
"           Treatment of hyperprolactinemia due to lactotroph adenoma and other causes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/49/4889\">",
"           Treatment of precocious puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/25/8602\">",
"           Treatment of transsexualism",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pediatric issues",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/57/22424\">",
"           Diagnosis and treatment of delayed puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/25/31125\">",
"           Primary dysmenorrhea in adolescents",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Polycystic ovary syndrome",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/6/16490\">",
"           Clinical manifestations of polycystic ovary syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/36/39495\">",
"           Diagnosis of polycystic ovary syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/39/40568\">",
"           Epidemiology and pathogenesis of the polycystic ovary syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/0/24583\">",
"           Laparoscopic surgery for ovulation induction in polycystic ovary syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/27/16826\">",
"           Metformin for treatment of the polycystic ovary syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/0/12\">",
"           Steroid hormone metabolism in polycystic ovary syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/46/24297\">",
"           Treatment of polycystic ovary syndrome in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/49/1817\">",
"           Treatment of polycystic ovary syndrome in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pregnancy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/61/35798\">",
"           Androgen production and metabolism in normal pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/32/1543\">",
"           Angiotensin converting enzyme inhibitors and receptor blockers in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/2/18470\">",
"           Causes of gestational hyperandrogenism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/32/31236\">",
"           Diagnosis and management of gestational hyperandrogenism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/34/29226\">",
"           Management of asthma during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/7/13434\">",
"           Management of hypertension in pregnant and postpartum women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/34/41510\">",
"           Management of lactotroph adenoma (prolactinoma) during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/29/14810\">",
"           Overview of the treatment of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/61/34777\">",
"           Pathogenesis of preeclampsia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/45/19159\">",
"           Physiology and clinical course of asthma in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/20/27978\">",
"           Preeclampsia: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/45/39641\">",
"           Pregnancy in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/62/11241\">",
"           Pregnancy in women with underlying renal disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/40/41609\">",
"           Prevention of preeclampsia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Puberty",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/13/39130\">",
"           Clinical features and diagnosis of polycystic ovary syndrome in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/5/19546\">",
"           Definition, etiology, and evaluation of precocious puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/9/34970\">",
"           Definition, pathogenesis, and etiology of polycystic ovary syndrome in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/11/12473\">",
"           Diagnosis and management of congenital anomalies of the vagina",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/57/22424\">",
"           Diagnosis and treatment of delayed puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/25/1434\">",
"           Normal puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/62/21481\">",
"           Premature adrenarche",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/46/24297\">",
"           Treatment of polycystic ovary syndrome in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/49/4889\">",
"           Treatment of precocious puberty",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Sexual dysfunction",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/40/36484\">",
"           Reproductive and sexual dysfunction in uremic women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/15/8442\">",
"           Sexual activity in patients with heart disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/42/25258\">",
"           Sexual dysfunction in women: Epidemiology, risk factors, and evaluation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/10/34985\">",
"           Sexual dysfunction in women: Management",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-F0B776D0A6-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f12_32_12801=[""].join("\n");
var outline_f12_32_12801=null;
var title_f12_32_12802="Cutaneous fields head neck";
var content_f12_32_12802=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F70877&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F70877&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 521px\">",
"   <div class=\"ttl\">",
"    Cutaneous innervation of the head and neck",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 501px; height: 461px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The sensory distribution of the trigeminal nerve (cranial nerve V) and its three divisions (V1, V2, V3) are shown along with branches of the cervical spinal nerves that innervate cutaneous regions of the head and neck.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_32_12802=[""].join("\n");
var outline_f12_32_12802=null;
var title_f12_32_12803="Digital gangrene Raynauds I";
var content_f12_32_12803=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F67307%7ERHEUM%2F82451&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F67307%7ERHEUM%2F82451&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Digital gangrene in Raynaud's",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 260px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patient with severe Raynaud's phenomenon and systemic lupus erythematosus who developed digital gangrene in the winter. She was treated conservatively, and the gangrenous digits self-amputated six months later. In patients with lupus, similar lesions can be seen with antiphospholipid antibodies.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Peter H Schur, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Digital gangrene in Raynaud's",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple gangrenous lesions of the toes due to necrotizing arteriolitis in a patient with systemic lupus erythematosus and severe Raynaud's phenomenon.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Samuel Moschella, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_32_12803=[""].join("\n");
var outline_f12_32_12803=null;
var title_f12_32_12804="Magnesium hydroxide and mineral oil emulsion: Patient drug information";
var content_f12_32_12804=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Magnesium hydroxide and mineral oil emulsion: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/2/13350?source=see_link\">",
"     see \"Magnesium hydroxide and mineral oil emulsion: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F190953\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Phillips'&reg; M-O [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10020523\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10020525\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691793",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat hard stools (constipation).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10020524\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702434",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to magnesium hydroxide, mineral oil, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703861",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have trouble swallowing or are not able to stand or sit up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10020529\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696933",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use this drug for more than 1 week unless told to do so by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10020530\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10020532\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698608",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bleeding from rectum or rectal pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10020527\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695862",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take at bedtime. Do not lie down while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695887",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take on an empty stomach. Take 1 hour before or 2 hours after meals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10020528\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10020533\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10020534\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12072 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-200.215.4.194-6EBEB1F6CE-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_32_12804=[""].join("\n");
var outline_f12_32_12804=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190953\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020523\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020525\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020524\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020529\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020530\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020532\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020527\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020528\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020533\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020534\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?13/2/13350?source=related_link\">",
"      Magnesium hydroxide and mineral oil emulsion: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_32_12805="Heart failure PA I";
var content_f12_32_12805=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F61783&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F61783&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Heart failure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 359px; height: 315px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This chest radiograph of a 65-year-old male with dyspnea and orthopnea demonstrates mild pulmonary vascular congestion, septal lymphatic distention (white arrow), interstitial veiling, and enlarged hilar shadows (black arrow), indicative of left ventricular decompensation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_32_12805=[""].join("\n");
var outline_f12_32_12805=null;
var title_f12_32_12806="Aliskiren and hydrochlorothiazide: Patient drug information";
var content_f12_32_12806=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Aliskiren and hydrochlorothiazide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/51/3895?source=see_link\">",
"     see \"Aliskiren and hydrochlorothiazide: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F5661724\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Tekturna HCT&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F11574773\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Rasilez HCT&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10023811\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700281",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10023813\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692146",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It may be given to you for other reasons. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10023812\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to aliskiren, hydrochlorothiazide, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfa (sulfonamide) allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4231924",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking any of these drugs: Cyclosporine, dofetilide, or itraconazole.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703827",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have very bad kidney disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4231925",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes) or kidney disease and are taking certain drugs for high blood pressure or your heart. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701072",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are on a low-salt or salt-free diet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4194403",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This is not a list of all drugs or health problems that interact with this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4194405",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take this drug with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10023817\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2858939",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid driving and doing other tasks or actions that call for you to be alert until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4201327",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To lower the chance of feeling dizzy or passing out, rise slowly over a few minutes when sitting or lying down. Be careful climbing stairs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4231042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before you drink wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697207",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), this drug may sometimes raise blood sugar. Talk with your doctor about how to fine tune this.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4194396",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may affect certain lab tests. Be sure your doctor and lab workers know you take this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697100",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a salt substitute that has potassium, potassium-sparing diuretics, or potassium, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697627",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Watch for gout attacks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698650",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you have too much sweat, fluid loss, throwing up, or loose stools. This may lead to low blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697004",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are 65 or older, use this drug with care. You could have more side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10023818\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4186184",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       All drugs may cause side effects. However, many people have no side effects or only have minor side effects. Call your doctor if any of these side effects or any other side effects bother you:",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698017",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698663",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10023820\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4186185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these side effects:",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698137",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of high blood sugar like confusion, feeling sleepy, more thirst, more hungry, passing urine more often, flushing, fast breathing, or breath that smells like fruit.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4193750",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of fluid and electrolyte problems like mood changes, confusion, muscle pain or weakness, a heartbeat that does not feel normal, very bad dizziness or passing out, fast heartbeat, more thirst, seizures, feeling very tired or weak, not hungry, unable to pass urine or change in the amount of urine produced, dry mouth, dry eyes, or very bad upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4193665",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shortness of breath, a big weight gain, swelling in the arms or legs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4230804",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug can cause certain eye problems. If left untreated, this can lead to lasting eyesight loss. If eye problems happen, signs like change in eyesight or eye pain most often happen within hours to weeks of starting this drug. Call your doctor right away if you have these signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2699690",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects at",
"       <a href=\"file://www.fda.gov/medwatch\" target=\"_blank\">",
"        file://www.fda.gov/medwatch",
"       </a>",
"       .",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2699689",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may report side effects to Health Canada's Canada Vigilance Program at 1-866-234-2345.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10023815\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2696083",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use this drug as ordered by your doctor. Read and follow the dosing on the label closely.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Always take with food or always take on an empty stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695872",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause you to pass urine more often. To keep from having sleep problems, try to take before 6 pm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10023816\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10023821\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699399",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in the original container at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4194563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check with your pharmacist about how to throw out unused drugs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10023822\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11961 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-4554544F47-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_32_12806=[""].join("\n");
var outline_f12_32_12806=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5661724\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11574773\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023811\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023813\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023812\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023817\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023818\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023820\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023815\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023816\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023821\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023822\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?3/51/3895?source=related_link\">",
"      Aliskiren and hydrochlorothiazide: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_32_12807="Chest wall injuries in children";
var content_f12_32_12807=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Chest wall injuries in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/32/12807/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/32/12807/contributors\">",
"     Howard Kadish, MD, MBA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/32/12807/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/32/12807/contributors\">",
"     Richard G Bachur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/32/12807/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/32/12807/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/32/12807/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest wall injuries in children are significant primarily because they often occur as the result forceful mechanisms that also cause serious associated injuries. Because the thoracic cage of a child is more elastic and flexible than that of an adult, less of the force of impact is absorbed by the chest wall and proportionally more force is transmitted to intrathoracic organs. Intrathoracic injury (such as pulmonary contusion) often occurs without visible damage to the chest wall.",
"   </p>",
"   <p>",
"    This topic will review the epidemiology, injury types, evaluation, and management of chest wall injuries in children. Included in chest wall injuries are rib fractures, flail chest, and sternal and scapular fractures. Thoracic trauma, intrathoracic injuries, and pulmonary contusion in children, as well as thoracic trauma and rib fractures in adults, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/63/27640?source=see_link\">",
"     \"Initial evaluation and stabilization of children with thoracic trauma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/26/3495?source=see_link\">",
"     \"Intrathoracic injuries in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/38/29285?source=see_link\">",
"     \"Pulmonary contusion in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34426?source=see_link\">",
"     \"Initial evaluation and management of blunt thoracic trauma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/17/4376?source=see_link\">",
"     \"Initial evaluation and management of rib fractures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest wall injuries in children typically occur as the result of blunt thoracic trauma. Rib fractures constitute the vast majority of these injuries. In a prospective series describing 80 children with thoracic injuries following blunt torso trauma, 28 had rib fractures, and one had a fractured sternum [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Rib fractures'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In reports describing children with thoracic injuries evaluated in pediatric trauma centers, most patients were injured as passengers or pedestrians in motor vehicle crashes [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Among infants and young children, however, rib fractures occur most commonly as the result of inflicted injury [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/30/13802?source=see_link&amp;anchor=H19#H19\">",
"     \"Orthopedic aspects of child abuse\", section on 'Rib fractures'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Mortality for children with chest wall injuries is usually the result of associated injuries, particularly head injury. In several retrospective series describing children with thoracic trauma, 4 to 14 percent of deaths occurred because of thoracic injuries alone. Mortality rates for children with chest and head injuries ranged from 28 to 37 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/2,6,7\">",
"     2,6,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anatomic structures that comprise the chest wall include ribs, costal cartilages, sternum, clavicles, and intercostal muscles. Neurovascular bundles (comprised of an intercostal nerve, artery, and vein) run along the inferior margin of each rib and may be damaged when a rib is fractured. The pectoralis muscles contribute to the support of the anterior chest wall, while the scapula provides additional protection to the superior posterior chest. Functionally, the chest wall is an essential part of the mechanics of respiration and provides protection for intrathoracic organs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34426?source=see_link&amp;anchor=H3#H3\">",
"     \"Initial evaluation and management of blunt thoracic trauma in adults\", section on 'Anatomy and mechanism'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Anatomic differences in the chest walls of children, as compared with adults, influence mechanisms of injury.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased cartilage content and incomplete ossification of the ribs make the thoracic cage of a child more compliant than that of an adult [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/8\">",
"       8",
"      </a>",
"      ]. Consequently, significant force is usually required to produce chest wall injuries in children. This was illustrated in one observational series describing children admitted to a pediatric trauma center with thoracic trauma in which those with multiple rib fractures were more severely injured than those without rib fractures [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Because the chest wall of a child is more compliant, more kinetic energy can be transmitted to the intrathoracic structures without bony injury. For this reason, pulmonary contusion without rib fracture occurs more often in children than adults. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/38/29285?source=see_link&amp;anchor=H3#H3\">",
"       \"Pulmonary contusion in children\", section on 'Pathogenesis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     INJURY TYPES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Rib fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common chest wall injury among children is rib fracture. In observational series from pediatric trauma centers, rib fractures were identified in over 30 percent of children evaluated for blunt thoracic trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rib fracture may occur as the result of a direct blow to the rib or from compression of the chest in an anterior-posterior direction [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With a direct blow, the rib may fracture inward and puncture the pleural cavity, causing a pneumothorax. Hemothorax can develop when the fractured rib lacerates an intercostal artery, an internal mammary artery, or the lung parenchyma.",
"     </li>",
"     <li>",
"      Compression of the chest wall can cause the lateral portions of the ribs to fracture outward. Intrathoracic injury is seen less commonly with this mechanism.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Rib fractures may be characterized as upper zone (ribs 1 to 4), midzone (ribs 5 to 8), and lower zone (ribs 9 to 12) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     First rib fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because the upper ribs (one through three) are protected by the scapula, humerus, and clavicle (along with their muscular attachments), a significant amount of force is required to fracture these ribs. Consequently, sternal and scapular fractures as well as serious injuries such as pulmonary contusion and injury to intrathoracic vessels or cervical spine are associated with fractures of the first and second ribs [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/11-14\">",
"     11-14",
"    </a>",
"    ]. In one series describing six children with first rib fractures, two patients had associated vascular (subclavian artery) injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Lower rib fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injury to abdominal organs can occur with lower rib fractures. This was demonstrated in a retrospective review describing adults and children hospitalized with rib fractures in which right and left lower rib fractures were associated with liver and spleen injuries, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33768?source=see_link\">",
"     \"Overview of blunt abdominal trauma in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Flail chest",
"    </span>",
"    &nbsp;&mdash;&nbsp;A flail chest occurs when the chest wall loses stability as the result of multiple rib fractures (",
"    <a class=\"graphic graphic_figure graphicRef79746 \" href=\"UTD.htm?23/19/23857\">",
"     figure 1",
"    </a>",
"    ). The mechanism usually is direct impact or crush injury. It is an uncommon injury among children as indicated in the following reports:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one retrospective study from a large trauma registry describing 262 patients with flail chest, 2 percent were between 0 and 14 years of age [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In two large retrospective series describing chest injuries in children, 1 percent of patients had flail chest [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/6,17\">",
"       6,17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A flail segment can occur in different locations:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Anterior &ndash; Fracture of the sternum and multiple costochondral junctions",
"     </li>",
"     <li>",
"      Posterior &ndash; Midaxillary fracture with fracture or dislocation of rib heads",
"     </li>",
"     <li>",
"      Lateral &ndash; Row of rib fractures both anteriorly and posteriorly",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with flail chest can develop respiratory compromise because the flail segment responds to changes in intrathoracic pressure rather than to the pull of respiratory muscles (retracting with inspiration and bulging with expiration) (",
"    <a class=\"graphic graphic_figure graphicRef79746 \" href=\"UTD.htm?23/19/23857\">",
"     figure 1",
"    </a>",
"    ). Ventilatory disturbances develop because of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Paradoxical movement of the chest wall results in inefficient expansion of the thorax, causing a significant increase in energy expenditure for breathing.",
"     </li>",
"     <li>",
"      Pain from fractures causes hypoventilation, resulting in atelectasis.",
"     </li>",
"     <li>",
"      Patients with flail chest often have pulmonary contusions that cause shunting and ventilation-perfusion mismatch. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/38/29285?source=see_link\">",
"       \"Pulmonary contusion in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As with other types of chest wall injury, mortality from flail chest is typically related to associated injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Clavicle fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Posterior dislocation or displaced fracture of the medial clavicle can be associated with injury to intrathoracic structures such as great vessels and the esophagus [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. The medial physis of the clavicle does not typically close until 23 to 25 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/20\">",
"     20",
"    </a>",
"    ]. Consequently, these uncommon injuries to the medial clavicle are typically physeal fractures, rather than dislocations. They are usually caused by a fall onto the shoulder rather than thoracic trauma.",
"   </p>",
"   <p>",
"    Clinical features that have been reported in association with posterior displacement of the medial clavicle include dysphagia, dyspnea, hoarseness, and signs of vascular injury. In one retrospective series describing 13 children with posterior sternoclavicular fracture dislocations, mechanisms of injury included sports (11 patients), play (1 patient), and motor vehicle crash (1 patient) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/21\">",
"     21",
"    </a>",
"    ]. Three children had dysphagia at initial presentation. One child had brachiocephalic compression noted on imaging, without associated physical findings. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/32/40457?source=see_link&amp;anchor=H335289#H335289\">",
"     \"Traumatic causes of acute shoulder pain and injury in children and adolescents\", section on 'Sternoclavicular injury'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Sternal fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sternal fractures occur infrequently among children. Although they may be associated with significant mechanisms (such as motor vehicle crashes), observational series have described children with isolated sternal fractures that occurred as the result of direct blows or flexion compression of the spine without associated intrathoracic injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. Sternal fractures have been reported as the result of inflicted injuries but do not appear to be specific for abusive mechanisms [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Blunt cardiac injury occurs uncommonly in association with sternal fractures. This was demonstrated in two retrospective reviews describing 70 adult patients with sternal fractures in which one patient had a cardiac injury [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Scapular fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Scapular fractures are uncommon among children [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/27\">",
"     27",
"    </a>",
"    ]. Anatomic position, chest wall compliance, and surrounding muscle protect the scapula from injury. As a result, significant force is usually required to produce a scapular fracture.",
"   </p>",
"   <p>",
"    In several retrospective reviews describing adolescent and adult patients with scapular fractures as the result of blunt trauma, those with scapular fractures were more likely than those without scapular fractures to have serious associated injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. The following injuries were noted in these reports:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Rib fracture &ndash; 48 to 53 percent",
"     </li>",
"     <li>",
"      Pulmonary contusion &ndash; 15 to 44 percent",
"     </li>",
"     <li>",
"      Head injury &ndash; 24 to 61 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Injury to the axillary artery or brachial plexus may occur in association with a scapular fracture because these structures are in close proximity to the ventral surface of the scapula. In one of the reports noted above, brachial plexus injury occurred in 5 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PRIMARY EVALUATION AND MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Initial assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among children, chest wall injuries typically occur as the result of forceful mechanisms such as motor vehicle crashes. Consequently, many patients may have life-threatening",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    serious associated injuries that must be quickly identified and stabilized. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above.) A primary survey should rapidly identify airway compromise, the possibility of a cervical spine injury, respiratory failure,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    shock. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/16/29962?source=see_link&amp;anchor=H9#H9\">",
"     \"Trauma management: Approach to the unstable child\", section on 'Primary survey'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For those children who do not have obvious multisystem injuries, historical features, physical examination, and selected diagnostic studies typically identify those with significant chest wall",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    associated injuries such as flail chest, pulmonary contusion, or abdominal organ injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;A detailed description of the mechanism may identify those children likely to have significant injuries. A discrepancy between the history and physical or radiographic findings (such as healing rib fractures on the chest radiograph of a child being evaluated for nonspecific respiratory complaints) suggests an inflicted injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once life-threatening injuries have been identified and stabilized, a complete physical examination should be performed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/63/27640?source=see_link&amp;anchor=H6#H6\">",
"     \"Initial evaluation and stabilization of children with thoracic trauma\", section on 'Evaluation'",
"    </a>",
"    .) Vital signs, including respiratory rate and pulse oximetry, may indicate respiratory compromise. Patients with altered awareness or agitation may be hypoxemic or hypoperfused. Children with asymmetric pulses may have intrathoracic vessel injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following specific features of the examination should be noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Abnormal chest wall movement (as may occur with splinting from pain or with a flail segment)",
"     </li>",
"     <li>",
"      Ecchymosis, abrasions, or deformity of the chest wall",
"     </li>",
"     <li>",
"      Focal tenderness to palpation over ribs, sternum, or scapula",
"     </li>",
"     <li>",
"      Subcutaneous air",
"     </li>",
"     <li>",
"      Abnormal breath sounds",
"     </li>",
"     <li>",
"      Muffled heart tones or a new murmur",
"     </li>",
"     <li>",
"      Abnormal upper extremity pulses or sensation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Muscle splinting or the use of positive pressure ventilation may conceal the paradoxic motion of a flail segment, delaying diagnosis of a flail chest.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Diagnostic studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ancillary studies (such as blood gas measurements or computed tomography of the head, abdomen, or chest) may be required to identify and treat associated injuries. Children with sternal fractures should receive troponin levels to screen for blunt cardiac injury. Electrocardiography and imaging may be indicated to evaluate some chest wall injuries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Electrocardiogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with sternal fractures should receive electrocardiograms (EKG) to identify those with myocardial injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with symptomatic chest wall injuries should have imaging performed to identify fractures and associated intrathoracic injuries (such as pneumothorax, hemothorax, or pulmonary contusion). These injuries can generally be diagnosed with plain radiography, though computed tomography has a better sensitivity in identifying these potentially life threatening injuries. Rib views are not routinely recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/31\">",
"     31",
"    </a>",
"    ]. However, for inflicted injuries, the addition of oblique views may improve identification of rib fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/32\">",
"     32",
"    </a>",
"    ]. Specific views are required to identify fractures of the scapula and sternum.",
"   </p>",
"   <p>",
"    Posterior sternoclavicular fracture dislocations may be not be apparent with plain radiography. Computed tomography (CT) should be obtained to confirm the diagnosis and identify associated intrathoracic injuries for patients with concerning mechanisms of injury or physical findings [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/33\">",
"     33",
"    </a>",
"    ]. Children with first rib and sternal fractures are also at risk for associated injuries to the great vessels and should be evaluated with CT.",
"   </p>",
"   <p>",
"    Echocardiography to exclude blunt cardiac injury should be performed for children with sternal fractures who have abnormal troponin levels, ectopy, or abnormal electrocardiograms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial management of children with chest wall injuries should be directed toward stabilizing life-threatening associated injuries. Indicated interventions may include endotracheal intubation with positive pressure ventilation for respiratory failure, decompression of a tension pneumothorax, treatment of hemorrhagic shock, or treatment of increased intracranial pressure as the result of a severe head injury.",
"   </p>",
"   <p>",
"    Patients with rib fractures who require tube thoracostomy to relieve pneumo or hemothorax should have tubes placed at sites separate from the areas of fracture. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1226?source=see_link\">",
"     \"Placement and management of thoracostomy tubes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children with flail chest should receive respiratory support. Those with respiratory distress should be intubated and receive positive-pressure ventilation to provide adequate oxygenation and ventilation, as well as to optimally expand and splint the injured segments.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     DEFINITIVE MANAGEMENT",
"    </span>",
"   </p>",
"   <p>",
"    Patients with multiple rib fractures should be admitted to the hospital. Management should include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pain control with epidural analgesia or intercostal nerve blocks may improve respiratory function among patients with chest injury (including rib fractures) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/34-36\">",
"       34-36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Children should receive age-appropriate pulmonary physiotherapy to prevent atelectasis.",
"     </li>",
"     <li>",
"      Splinting rib fractures with external devices can worsen ventilatory compromise and, therefore, is not recommended.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For patients with flail chest, the following management strategies should be considered:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Limited evidence describing adult patients indicates that continuous positive airway pressure (CPAP) and continuous negative extrathoracic pressure may be alternatives to endotracheal intubation with positive pressure ventilation for the management of respiratory insufficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/37,38\">",
"       37,38",
"      </a>",
"      ]. There are no reports describing these interventions in children.",
"     </li>",
"     <li>",
"      For patients with flail chest who do not require respiratory support, aggressive pulmonary physiotherapy along with pain control is the preferred treatments.",
"     </li>",
"     <li>",
"      Careful fluid management is essential for those with underlying pulmonary contusion. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/38/29285?source=see_link&amp;anchor=H9#H9\">",
"       \"Pulmonary contusion in children\", section on 'Definitive management'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Surgical fixation may be helpful for rare patients who develop significant long term respiratory dysfunction or persistent instability of the injured segment [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Children with isolated sternal fractures who have normal EKGs and chest radiographs and are comfortable can be managed as outpatients. Those who require more aggressive pain control or have associated injuries should be admitted to the hospital.",
"   </p>",
"   <p>",
"    Because of the numerous muscle attachments supporting the scapula, nondisplaced or minimally displaced scapular fractures can be treated nonsurgically. Displaced fractures of the scapular neck and displaced glenoid fractures may require open reduction [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12807/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prognosis for isolated rib, sternal, and scapular fractures is excellent with most healing within six weeks. The chest wall typically remodels leaving no permanent disability. The prognosis for more severe chest wall injuries is usually related to the severity of associated injuries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest wall injuries in children are significant primarily because they often occur following forceful mechanisms that also cause serious associated injuries. Included in chest wall injuries are rib fractures, flail chest, and sternal and scapular fractures.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chest wall injuries in children occur primarily as the result of blunt thoracic trauma, often involving a motor vehicle. Mortality is usually the result of associated injuries, particularly head injury. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The thoracic cage of a child is more compliant than that of an adult. Consequently, chest wall injuries usually occur as the result of considerable force and are more likely to be associated with intrathoracic injury. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Anatomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common chest wall injury is rib fracture. Flail chest, sternal fractures, and scapular fractures occur infrequently. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Injury types'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial management of chest wall injuries must focus on identifying and stabilizing life-threatening associated injuries. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Initial assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Plain chest radiography is sufficient to identify rib fractures, although the addition of oblique views may be helpful when an inflicted injury is suspected. Children with first rib fractures, sternal fractures, and posterior sternoclavicular fracture dislocations should generally receive computed tomography of the chest to exclude associated intrathoracic vascular injuries. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children with sternal fractures should receive electrocardiograms to identify myocardial injury. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Electrocardiogram'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children with flail chests who are in respiratory distress should receive assisted ventilation. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Flail chest'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children with multiple rib fractures should be admitted to the hospital. They should receive intravenous analgesia for pain control. We suggest epidural analgesia for children with any respiratory compromise or for whom intravenous analgesia is inadequate (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Definitive management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/1\">",
"      Holmes JF, Sokolove PE, Brant WE, Kuppermann N. A clinical decision rule for identifying children with thoracic injuries after blunt torso trauma. Ann Emerg Med 2002; 39:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/2\">",
"      Peclet MH, Newman KD, Eichelberger MR, et al. Thoracic trauma in children: an indicator of increased mortality. J Pediatr Surg 1990; 25:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/3\">",
"      Schweich P, Fleisher G. Rib fractures in children. Pediatr Emerg Care 1985; 1:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/4\">",
"      Bulloch B, Schubert CJ, Brophy PD, et al. Cause and clinical characteristics of rib fractures in infants. Pediatrics 2000; 105:E48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/5\">",
"      Barsness KA, Cha ES, Bensard DD, et al. The positive predictive value of rib fractures as an indicator of nonaccidental trauma in children. J Trauma 2003; 54:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/6\">",
"      Cooper A, Barlow B, DiScala C, String D. Mortality and truncal injury: the pediatric perspective. J Pediatr Surg 1994; 29:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/7\">",
"      Black TL, Snyder CL, Miller JP, et al. Significance of chest trauma in children. South Med J 1996; 89:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/8\">",
"      Sartorelli KH, Vane DW. The diagnosis and management of children with blunt injury of the chest. Semin Pediatr Surg 2004; 13:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/9\">",
"      Garcia VF, Gotschall CS, Eichelberger MR, Bowman LM. Rib fractures in children: a marker of severe trauma. J Trauma 1990; 30:695.",
"     </a>",
"    </li>",
"    <li>",
"     Kadish, H. Thoracic trauma. In: Textbook of Pediatric Emergency Medicine, 5th ed, Fleisher, GR, Ludwig, S, Henretig, FM (Eds), Lippincott, Williams and Wilkins, Philadelphia 2006. p.1433.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/11\">",
"      Al-Hassani A, Abdulrahman H, Afifi I, et al. Rib fracture patterns predict thoracic chest wall and abdominal solid organ injury. Am Surg 2010; 76:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/12\">",
"      Logan PM. Is there an association between fractures of the cervical spine and first- and second-rib fractures? Can Assoc Radiol J 1999; 50:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/13\">",
"      Harris GJ, Soper RT. Pediatric first rib fractures. J Trauma 1990; 30:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/14\">",
"      Ozel SK, Kazez A. Horner syndrome due to first rib fracture after major thoracic trauma. J Pediatr Surg 2005; 40:e17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/15\">",
"      Shweiki E, Klena J, Wood GC, Indeck M. Assessing the true risk of abdominal solid organ injury in hospitalized rib fracture patients. J Trauma 2001; 50:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/16\">",
"      Borman JB, Aharonson-Daniel L, Savitsky B, et al. Unilateral flail chest is seldom a lethal injury. Emerg Med J 2006; 23:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/17\">",
"      Nakayama DK, Ramenofsky ML, Rowe MI. Chest injuries in childhood. Ann Surg 1989; 210:770.",
"     </a>",
"    </li>",
"    <li>",
"     Kwon, Y, Sarwark, JF. Proximal humerus, scapula, and clavicle. In: Fractures in Children, 5th, Beaty, JH, Kasser, JR (Eds), Lippincott, Williams, and Wilkins, Philadelphia 2001. p.751.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/19\">",
"      Stanley D, Trowbridge EA, Norris SH. The mechanism of clavicular fracture. A clinical and biomechanical analysis. J Bone Joint Surg Br 1988; 70:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/20\">",
"      Webb PA, Suchey JM. Epiphyseal union of the anterior iliac crest and medial clavicle in a modern multiracial sample of American males and females. Am J Phys Anthropol 1985; 68:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/21\">",
"      Waters PM, Bae DS, Kadiyala RK. Short-term outcomes after surgical treatment of traumatic posterior sternoclavicular fracture-dislocations in children and adolescents. J Pediatr Orthop 2003; 23:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/22\">",
"      Ferguson LP, Wilkinson AG, Beattie TF. Fracture of the sternum in children. Emerg Med J 2003; 20:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/23\">",
"      DeFriend DE, Franklin K. Isolated sternal fracture--a swing-related injury in two children. Pediatr Radiol 2001; 31:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/24\">",
"      Hechter S, Huyer D, Manson D. Sternal fractures as a manifestation of abusive injury in children. Pediatr Radiol 2002; 32:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/25\">",
"      Chiu WC, D'Amelio LF, Hammond JS. Sternal fractures in blunt chest trauma: a practical algorithm for management. Am J Emerg Med 1997; 15:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/26\">",
"      Sadaba JR, Oswal D, Munsch CM. Management of isolated sternal fractures: determining the risk of blunt cardiac injury. Ann R Coll Surg Engl 2000; 82:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/27\">",
"      Bowen TR, Miller F. Greenstick fracture of the scapula: a cause of scapular winging. J Orthop Trauma 2006; 20:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/28\">",
"      Stephens NG, Morgan AS, Corvo P, Bernstein BA. Significance of scapular fracture in the blunt-trauma patient. Ann Emerg Med 1995; 26:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/29\">",
"      Veysi VT, Mittal R, Agarwal S, et al. Multiple trauma and scapula fractures: so what? J Trauma 2003; 55:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/30\">",
"      Weening B, Walton C, Cole PA, et al. Lower mortality in patients with scapular fractures. J Trauma 2005; 59:1477.",
"     </a>",
"    </li>",
"    <li>",
"     Westcott, J, Davis, SD, Fleishon, H, et al. Rib fractures. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000; 215 Suppl:637. Available at www.acr.org (Accessed on February 20, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/32\">",
"      Section on Radiology, American Academy of Pediatrics. Diagnostic imaging of child abuse. Pediatrics 2009; 123:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/33\">",
"      Ferrera PC, Wheeling HM. Sternoclavicular joint injuries. Am J Emerg Med 2000; 18:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/34\">",
"      Rankin AP, Comber RE. Management of fifty cases of chest injury with a regimen of epidural bupivacaine and morphine. Anaesth Intensive Care 1984; 12:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/35\">",
"      Cicala RS, Voeller GR, Fox T, et al. Epidural analgesia in thoracic trauma: effects of lumbar morphine and thoracic bupivacaine on pulmonary function. Crit Care Med 1990; 18:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/36\">",
"      Karmakar MK, Ho AM. Acute pain management of patients with multiple fractured ribs. J Trauma 2003; 54:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/37\">",
"      Gunduz M, Unlugenc H, Ozalevli M, et al. A comparative study of continuous positive airway pressure (CPAP) and intermittent positive pressure ventilation (IPPV) in patients with flail chest. Emerg Med J 2005; 22:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/38\">",
"      Linton DM, Sviri S. Conservative management of flail chest after cardiopulmonary resuscitation by continuous negative extrathoracic pressure. Crit Care Resusc 2006; 8:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12807/abstract/39\">",
"      Engel C, Krieg JC, Madey SM, et al. Operative chest wall fixation with osteosynthesis plates. J Trauma 2005; 58:181.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6557 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-5682FA82D5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_32_12807=[""].join("\n");
var outline_f12_32_12807=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      INJURY TYPES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Rib fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - First rib fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Lower rib fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Flail chest",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Clavicle fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Sternal fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Scapular fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PRIMARY EVALUATION AND MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Initial assessment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - History",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Diagnostic studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Electrocardiogram",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      DEFINITIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6557\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6557|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/19/23857\" title=\"figure 1\">",
"      Flail chest",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34426?source=related_link\">",
"      Initial evaluation and management of blunt thoracic trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/17/4376?source=related_link\">",
"      Initial evaluation and management of rib fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/63/27640?source=related_link\">",
"      Initial evaluation and stabilization of children with thoracic trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/26/3495?source=related_link\">",
"      Intrathoracic injuries in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/30/13802?source=related_link\">",
"      Orthopedic aspects of child abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33768?source=related_link\">",
"      Overview of blunt abdominal trauma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1226?source=related_link\">",
"      Placement and management of thoracostomy tubes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/38/29285?source=related_link\">",
"      Pulmonary contusion in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/16/29962?source=related_link\">",
"      Trauma management: Approach to the unstable child",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/32/40457?source=related_link\">",
"      Traumatic causes of acute shoulder pain and injury in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_32_12808="Solar lentigines face";
var content_f12_32_12808=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F81287%7EDERM%2F61452&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F81287%7EDERM%2F61452&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Solar lentigines",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF6AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwCtcWz2sguYlzxiQD+JfX6itTTI0dxIpzEefSowTKipnkHtV1bcGBkLkEjGfTHNG70PXXZli9WGaDyAMnGT6CqNpvjkCgAqOMe1SQS7pC8hKknpUzLtkQqN2c9Ki/N7xSjbQdLsVN54H8qcF5SQHjGfamyOPskwI52kYI7nirSKqKqkdFAx9KGgiiMkuoc8Ko5ApFUsEZeOcVYZB8ob5cg5FR28ZhBEoJQng1lJdC0upYEP3GBB7YHBNPlhVnBbcAOCPeiPCuPvcDIzVuSNGfa5ycD296qyGkyl5hQhT9xTkcVpWpV5T82FwTntx0zTbO1WSNmcqAp25Y8GojG0RkVN2xRk+lKN0kx8tzXsQs1xFJj5SRk56VNqDok0OFBGCCnvng1lWFwC0JMm1Dzuz92teGNJL545XIYgGE/3s/41ondaEtWepY06dI45PLZfNyPmPGc/4VrW0V3PbsfMXAzmYDaARxgeuaqvY5VZYIyJo8o0B+9gVBZaptlntrsvHbnmMKe+elXzctuYyl7y906a5t82eRGJ1cgfu+3FcprWktb7Wt5toUiQKw+6QccVvo11ciOYy+RCuchOAwH9aqs9uS0bb3Y53bj/AAnuM9DVtJozp3jo3c5+Jh9pedwHJySNvB9RVxrW5uCxgVY7dR9xDkg069t9rjyiI4X48th8wArOtTNa3DZuPL7hhnp6Yrnas7M6d9TRS5e1iSIyeUA3+tPII65xVqW6adS0rEggKDwCx9RVUX8d3bNE0Mauy/64ckY7YqhbXpjkRFQTpGckk/L/APrqua2l9CbXd7ajpXkidkbcqn7wb+lMV1eU/MEXrjvT3naZChXPJZsjgD0zVCdVklzACQew7VjJ9UaRLc6IYiiFnc4Gc5zUc0MtukYlUgt056Y9qqiSRcBOGU9fQVY+0SS5aUmRRxubvSumOxDM37vvnsagPmLIBu2jHQGrLPtGzdkdST/Kqd5KPL3Ro3mDgjsRUSdlcqOuhYZgqnb8v9agMyuxye+SQOlZlvezRylHUFCucnqD6CnLIGbGwA+vrWDqqWxpy2L0hbyswgFhyAaitbwyThGRhIOoxVdhIrKFwP8Aa7U0M8bZHHOOnenGo7k8qNcz4whBBHWmwsN5YduTVGFndWLZDDjNSxbto3nJB5NdKl1FYuSuxkDY4pPNxxtJ9xUQLEj7vTgg8Urv5fltyYhnfjr7GjfVEOyJvK3xgg8HtioLi2wQcAnk5zVxpVVMoflIyDWbdPNIoMIDY7McVreysQc/qawgXsbf8tB+RI6V4/qFgDosSE7mEpSQgZ2ru9a9q1C3eZohtXzGHK56V5rqVs+nJfWrKSxuA4OOME0m9TGSOUFncafPNcwKrW0ah5YwuQv+3j374pVk/t3iwYwvg7pU+8FPUD1+ldcyJbXtzMmPJSEK27pg8kGua+wCzjmZEaN72VWwvBhz6CrRi1bQZaahcrPNPdpEYbYeXEi/LvwMZAPWt/Q3mtI7y9uomEkyLnLD5RnARf5YrJuClxc2OkRR/aJkZpXAXLLz8ufSumstHlXWbJJ7oCKIeZ5RGQpHJJPc96pEdbDYDNFZXcl1lTLGYzCAMxL2H1JqbS7K3iuExHGvkIoc4zgkdPrU0wQWdxKXDqW87PQF/wCEe/rWTe3NxPANP09BJczEG6kXpET6ntTbCyuZdzLLrl4ui2wEVtHMzzSkZUL3Y49hgV3UNhbW2glokZYoYysMIGA56Ak1znh+xaK/ZYM/Z/uAquBI2eT9PTNdt4ljnNvFZx5iV3CjH8KjliP8aaelwSOFsdHn3pOWjluZz5ewjjGedvoPetC00S9Ed1PFOybpBGSX3An6VtaEijUozGP9TARGpHOTkZ+tbtvpzR6U4jIxuLHb61N7lKCMSy0d54Lq1n2NJlSGHVwB1rc03w1EthcSLCDczEY46Ecgj0NaWnWSs1zIFPlyooRs9RjB+nNdHoyL/Z5kRGJUNn25xmqgrlONjhLrSx8pMZ2SfuipXjJHWtfRbF7aIbQSE+baRjjuK6g2kVyPLlYKHlXAPUkVHBaCJJfmIQOcEjnryDScbbFJFSSOaRi52rEoyFU/dH973rn7+y87UPtMEhE0A+VjyM+49K6tbZI4JI1Dbw2evAGO1UdMijPmzSjqd2R1PYEn0rNrmdjREekPLMCk5WO4Q7irc7vcetW3RYklZuVPIHQHPelurJDCC+7Jb5WDYbd7GoNOuRZ30NvqTEuDsLkYVx6f7Le1Hw6MPMe/MTgStgEbU6ZHesq5Yo7hSMnrjoK376MQJGWRRu3YjzyAPWufu0Zn3j5eMVnUdioq+pkXTgvubhuhrkfFY2wNIpx7V1k6hpDjO71JrmvEKHynWTBzzXPdmyWpxELPETMhygyTGTxmiui03SVu7dV2bN/O49TRXcoqxyqbWh1luFgl6Zx2q4WV1yuQwpsUQEu8nNPeMohJOATxRqjXRu42JRhi67s5BqWzKPZR5P7xcqT9DUQ+RhyG54I7VK0CoGbcw3ndjtzSTSQ7XZI0BmiYgjkgnntT5TyBnAI4JpbXGxkzjAyfepJEVjsYAsRgH0qW7q6Gl3FYFvVyPQ5pUOxo1m/iAYZPaooAYmwxI25BPvVzctxIoypMagEk9jSTuikh6JwAGABOQxPSpwSs6qpTb3LenSq8AyjRspztypzgVNbSh5kicqqMhAZu1JstIu2toSsAD/JI3OOxqzqNo6XCgf6pz95eBxyRUMbGHzIEIki3h0cDH5VqP5ksMzxNjy8Hyz2zwcVrFJoht3uZGpWqQXG6DmIhd4/un2o026f7UkdwcvGwAY8fL1AFbFikUmmzeWjNIo2kHJG3/wCtWJc2rQrujy8TdDSlHl95Dj72h2M84bd5TmVpRhpFOD7H6j9ag1COJlgRjDG6PxvG4vxySfSsHT7wyWrwzF93Xdn06VrTCO502FpHC4Yne3DB8fyp83NExcOVj47xIk2XZZjE2QqjCtjoR7UXV2ZyqoVEsvUHk/nSzXH2gwJND5ca8mbbnPFFmlpc3TCUpExGVJ4A9vxppvYSa3aJJoJxDH9oOMA4XOCtZF+QZAYySOAT1BrV1I20UBYSPNK3GGOcZqj9immt3ESYO7iIL1GOCKmor6IuD01M941QbI5g2D24xTo1iiidFwvX5arTEJMsTMEcruAI6ikl/wBUVJxu/u9jWF7bGlr6izSkrgZBPbvTQSsfyA9eQKdCoC4kUFz3JphB875WJHcVOvUdyGWRo0JRc+1T26M8QIUlupWo5Qy8biAeRkc/SrFvdSRLujfBxgGoXxajeq0IJiYmz39KjZjgkMA2OOKkLCTcW+Zhyc96hAzx6c0nuCRmXEZLnecsRk81XjZUcKMkHoT0rQuk3ZcL83Q49KynkCzYxwv6VzziomsZX0NKA7iArck4wRmopMqSCfz9aqi6CsGLbQPerJkLICMEN0pxkmgSsxF3xAEyMSW7VrREmIfLzVK0jwc7OR1J6VpISO2cCuimrasznIUBMjcNox+BoBAKnhselQsrMpYEZHIqTdIyrviUZHJBwBWhm33GIR5e3BwCRUJyoIPH49atxhUjCOd2erdDVaVc5xhRkgn2qkJbESKGV3YDJPGa4jxha7L+0uZVJt3YRzAdDzlT+deghfLtwDhlC9utc/rdv9ttjDIuyBhye/1/CtJKyIsebXcTy6q9lB5gjEyu4AyNg+vvR4vtSZYzcu0UQBJMfB46A1v+E7Z5G1aW5BDbvKjY9WQHhvzpNag+2WEiSqzSOuG4+7jnP6UkzFxTMHwTpsljdG4dAWlO5v7x47mt3XbiZZ7KVoHRXDDBI5B4/pVLQXjia/a6lEb24XbuP3jjk/8A1qq6leXWuXkSRq1tZoy5mx87eyjtVKRPKkiz4gu5JrKz0uyCpIrhrqTqsJb7oPvirE+3SdJdLWJI49hZ3z887n+I0/yfKs7ZJDlWuhJIM/N6fMe5p9/GNS1OCNUCJ5qsQRkbFPAP1NO4lHqamh6ZLZ6bFKZApIBkUryvfp/WtO+LXifaZmdrWCMom89M8sMCtaa2W102RpMOxTJYHoOn/wBas55oLvy0QbNxwmBkcCnJ2RVrFHwqTdazeyeWgjjGeOirjjiuos7cSWBZCQJATj/ZrmNGhax/tBiSqyJltpwxIOPyrtNOZUsoyCNxjxgdFGKKb0sxtaktlGojjYKPJ8jKD+8c9RWjAPslmkRCouAcE5yCc7ap2KPPbWxDARKNqg+mM1duOlukhZtzhj9MelaJ2Q0rk8cTySCQYZUXIH905p7IY1QtwXJIAGQPfHvVliqQlPkYbxtPTI7iqc9yquzlwkobIHUAdBiqbUSTIvSFjZUGDL8oz1UdyfwqxpzRKssUfOVAYjnauRzUEk01xIQI9ikc8YDDucU7Sm2agyRRAv8AdVT6noSO9czlqbKOl2Xbe3hkhkAldpPMOwP1VR9KS5EFv50U9qu/YD82DgmtrTrBLAzNcFURfnmkc/M3oo9BXJX9zJcapPIEPPIDD+HsP61U5csSY+/KxHKMZCO7ovJL87PWi7iWRQIiCRxtC4/GtXw7ZNcQ3McamR1w5bH9ai1VYUtcZxc7R8wPLe//ANasoxbjdl31sjjriMRzSZOG9PSuU8SylbeQHAGDz3ruNVmHlLGF+cnccjkVwuvAzednhcnArCemiN492WvDq4sYxneuBxRVrwuoeCJsqUxgiiuvWxxtWbLUU/mMgb5dvY1ZOJd4524yPrWU2RtZT1NWoJfMZAG2561Uro3cR+91baVODyD61eI8yFe/HApHjWVFQH5sZWq6yMvygnGOAazeiGvItQ/uhuPLH+VWJZUIjKEFnB49B61UtPPjuIy4QKCDtbuKneB4CHREkOTtycKMjqaS20KsnuSeWs0bSZIZP1FNgb58KAGx17GnWLmONgxBLLwfTFWb2AeTHcwY2vzgDp6ijlduZCvbQmjUERsz4k7Ht9Kd5MSJgEqCT/k1UjkVny2cdeKulU6lvnOMAdPrRvqMuWsTNAwTB3Lvi59OoxToJJkiZUxtb5gT1FUzMEmIRsKoyDjgeoqyjiQpImUgY43Mfu+//wBaqQWuXIJ5Ipt6AqhODs7560+7UmPyYm8yIkYGPzxWRdTy2crRk5gc8OvQH1FS+cyOP3uTjK45xR7RbByPcT/UXJVxjOCATwa0IrqFxtO3zQec8hv/ANVVZytwipGEyeVbHOe4qiwkVwTgYOAwrO7g7oqyZ1UN9MbXb+7EGSAoPXPfFRzRxzRt5UTRBcL8/wDE39KzYpY4xuIJmBDD0+tWmme4dgZW3uBw3C/WtufmRi42ZGAFlDSOqOvGQMkVObhrkJNbMqXAOwjPOPaqEvkiTauJAuPn6ZNRKWjRkAJbPBAwaz52timrlu6CsiGRBI6Z3Z4HtzWYUCvycZ/GrYLS/JGHJ25ODjJ981FIpUjcRux93oc1EncpEZlEYIYBuKrSSgMOSR2pWUvcrtABAxz61EU2MyggDqSec1lOTZcUTtM8gG9twPr1pGwMBlwO1V/MbeQsYHTBz1qcAynLcMp796Sd2FrA/wAq5GSexxTFDEZUkClcOCeeOmKI147n0ob1JYm0Y9M9M96qTW8bElRx3J61ckGe2cVBeMFTKnbJ/Ce1D2BPUzmECMQyh8d8dKdazx7wAhwOFGKgXKvKHVTJ1XB7VXtnVZ8HOCCSc/drmUrO5ty3ib6MokZQ4PPSrKbmAHUdmrAMhBGwjJOBk81etryUsqtz71vGqr2ZnKBrNs3KqHc2OuMU2R+NuDwcetG9Qu4kg+op0fzKex65rUz23KzbVvYQ7BsRsfakkQszEEBNuOvWnNEzz724Gwgf405Ixhl6gHNaRVgsPfcse5Rn8etZV1G11Okf/LFWzJ/QVoXMpjTbHje3Cr61VhhKREFjhfmJP8TUNpskpxWsSs0O0BjLuBH8qxYQv9q3qvnZKxCfh1/Otq6kOUEbAFn6jtx1rLit90ExOC7uohbpgdvzo5iXE5+DSY57u7LEFTJu8vOAccEE1ct7QTR38kKBSihYQOpPr+lT2qsVllA2bZm3Bh1rSto47R4os4eaEEH+79fzqosho5KbLxRC2yZCRk+jZ5Y10ujWITUbW0gRp/l3yEnG4+pNVbC3hkTUYZf9VE2FAPUE9a3dEgEd3NKHwUjWM+2KqO9hJFnXo5Y3W1Lp5B+aSND2H8Oe/NRaZbEm3Eg2lJAmB2FPu4jM6ytj964Kgf3QeP8AGpropbXlqM/ISNx7buvFPVyuAuuxwxSCGIKDLIEc9SQec1ctLbyQWjwAUJCH2qtJBHPqcQ+YIh8wgHnB4/WtIs8clyqoAX2oM/wjNJaO7KUbo07YMIbZHU4EfJHQ5qSEqb47m3FjsBXlsD0FRqhZbeITcMcA9SFB54rQtLWO3Ui2wzq5CtjOfcnvVq7aB2RDcb5D86tDDECoVTzn1J/pT2ght4UMACs55ZuSfemzo8lzHC4Lufnfn+XvViJwFUSvGFB3EMMnA6U273JtYqTWj2hGXVm+95ZH3Se1MtLDEwuScSqR8p4xnv8ASr8jPJMJ3jzKQWPcEHj8MVJM7WtjEAodgSCzdGz0HuaXKm7jbdrDNUzBawyCMtIQAwLHazn69eK5q5HlufnDFm3HB6GtW/vJbiR3mkEaRfu1RvvdOa59pC05fqvoKyqyTZpSi7anRWE88VjtjuUhVTjaBzJnt/8AXrN1VP8ATpFKurqgYknJHp7VNpMT3U7tHC0hiAcBT1/Co751e7ebaFZnyyMc4UdvanLVCirSOX1iVWRXXcuB03ZzXIaxOFgdVy3y+ldb4hVS5Ac5HQ+vPeuM1udV5IO48e1csnZnVBXNDwhMAifLuyMYB6UUvgaLNtucZJ6EDpRXZDY5ZpXJY4jtA3fLj8qlgysZcgZB4qTGxcKRzxUK5WXax46EUubojVal2GUhoy2cHoRVu9TcfOHAYA7R/OqlvEvlZOCfSteBUxCrHKuuCp7Gps3uK6WxUgcuoUcgDbk/yqeY+VG2wnAYKQe4qlL5lvO0ZVsA5HGN1XbdVct9pB24yPfmhbWG7IhRgGXnrn8PrWvp00TWz2o2F2PU9M+1YlzF8xVeCCeKtoCYo3iAEiDa3v8A/XqE2noNpMteQ2yVT8ssbZA7OPY1FI7xPskQ4YdVphuiwQOC2PlJ6H6/WrSeVNG8U27OP3cmcbaNw2EtpxECJOjcDNWVmO4K+THnkD+E+tZcyPGWSVgSPukdCPalS5cBV+8o+9xzj60k7D5bm20vnR+WU3YPy+3vUMMbD5WIIB54qrDclG/dlxuGD7+9T/Mu7Mh+Y8qarmvqGxfXyIYA4IEmSQw7e1QmRn3bkMsZGDt65qohKTDJBAOQetW3KOZJEbaRwwX+KhvmQbDYZSg3ZGQMYI6mrJuQ+0yfIx5AA7VXI3KGZlAC5HrQWiCgEksT0FCfKhNXZLFJEkrNszkfKCcYNOMsnnFmbG/AXPXiqyrtY5UkDv71ejWBWVnzP+mB6e1JXYSVkMVmeTDAxgn5nHeoFR/OkkclgOcnvVmUNK0pIWNB91Bzj8agjEhc54iQ8+lTZk+YhMC2zO4AnZhge3v71WkYbN/y7/ugH0q1cNDLKkcZXb3buaqXEOWB+6uOM9/epqN20NIpdRkLYw3UDoB/OnwOk0QlGQOxx0p0cbEGOM7QfvN3A71YMbbdkYCx44GOuKcY6Ce5BKMAEAHjiq8rrApdyGDDgZ61bZUGBIw3HncOgrLvHEsm2I74x0OaznLlXmOMbkMt06kEjBx07e1V/OllkO592BnGevtVoR/uGbKuRjgcjB9T2qrbRgOTGeS2MkVzNO+5qtEVp0Zn82QlWHIP9KgWORsuFBUnt1/KtiSIyKWYDC5XJPAPofes+LfFlFcQknlmXIApSVnqCdxAc7FCgk9T6VIu4R/uyev50kUbyAuBux+G73xSxrnB5XPLZptA2aFpK8IxMmVPT3+lakbqynecDHUVzN7ctcSL5StHt4wD6Vt6cJJoEZ16n71b0J3biZ1Ipaksbo0+0sSe1WlO3cV4zxVZ4RGyMi4yfvGp45gCykA8ZzXVfl91mTES2Bk3Ow3YwM9h6Ci8iWO2+UAseuOcU8yY2Rrh+efX6VWupDjaCcnqQOnrVKzViWjn5FL3iWiE75W28dk7n+laE8GL63wqhBhQo7elNggb7V9rkTa3AUY+6vp+NWL7MsIcHEu/AA6gjoalRVgZlfZCl5fq/CZ3A9iSORVS8jCXUJUNvA8r8COD9K1NjylcEhAcknr71LeWxmuyFIDhcKT0zTWpNrGPb2JFwB13ny3H4d/xqzpfFxNGxGHbD+xXjH405ZQJmdiFwArDP8Q6modKgma0nMnys0jSFu+e3PpRF2YNXNcOpuEdmyIlzgdh2pmvyZ0wSlSGidWDAdDnmo7bDyhpQd5I3r6Y7/Sn+IZnk0e4/vbdoQcVTegKKLWnuJFa7cE5xtA9B0rSjPnXBZT+7+9gjOSaw9IPlaZbMgLOUVAB13Ack+1dNaRmER+fJt+XCgjp3pxdx2sXLNUjaKQ7WwMbT2ANakTxm225w2eTtxweTiqVq4khTcB0JLfWpGlLQhEcAq3PfA9q2uomT1Y5QwuZJYwN8nCrnPBH6VG6yBs7UC7SB6YHWoWlkMzeXlVPRx/Omnb5iZZmAGGDdPwrNtNaFE4maaZFAYqe2etTajebUj248pF+Xj+Ic1RWZyjBkZXzmM9yPSql7eAK0atnzOSp7YpOfLHUOW7MzUrppiFd9zHrj65qKOTahGcAdKpTS77liPu+g9atD5o/Y1yqV3c6bcqLen3Elu8rI53MpC7WII+vrVtrfNkIRLETK+WfHO361kLIVyQQHU5qK/1FmidAVZiAC23p9DWiklHUnlbehg+KryNXcRZZVO0H1HrXF6pdCS2G0HPTmt/UP3rt6dCM81zjQm41CKBOUJyfYVyxUpSudKSjE73wbbeTpsQbO8rnHTrRWpo0QW3j25IGBmivUhFJHA7ydzmg3mKACQzd6WMMJCeoPXPWkbKjgYANW0X5CWHfIIrlT946L2JLcSYDDGD0P+NXEy0abs7wwxVdApiymQepX8amgBCuvRge/ercrkNalvH2qWSBhkgExbmxtP1NQO7ofLk+VgcfSoLiRgQW5ydxIHQ1LOfOIZgSDyOaz5rlJDkBJJOQR0xUuQ4yuRIO9RIdkTHJGKYrHG/cCDzRcbLE8bNElyCDk4bA6VLbMo+bdxj1+8KgS8Cqw28EYxQFyoAO0dvpTbT2AskxXLLEpYx9UUDofeqxDxswOc9CD3qVmWMh1l/eHuBj8KCqzKd2RIvKnOcik32GhUkVUzgtj+Ec1dt2V4sso5Hc1l2QbfnGT0GTVpMqMuQF+vSlzX1Blt9qkmEsVIx704IAcqMDp9KrxswX5jtOcD3q3DulY7HAbHOcYxRcVhZY5EXYyEAc5pkQAmVQVcnjOeKmmYyD7zHI5PSoIQyMWwHUcHPepd76FJ6amglxGi+XIrHyzjAHy/WhoGtYUbzklkmJJRf4V7Z96qTyiST92Nq9FGc7famwhhINzbD2x1+tU2RZss+Yf9XbIfMzkyPzg+1R+XKsDq7FEY8+596nyV++3B5ZgOcUyV0mUBS2Txgj+dDBdiOwsoy0lwzKmB/qx1PvViGFXkEkzgp2yMfhSxwAKGJxj+HPJqQRssZw+V6kE9GoS0ByuyEiVpSI+ZMDBXoaW681iPtQ2Snncp49qc8ypC3ljDHhc96ks0F1bsbxxGNvDMeAR6Cmt7INbXM28HmRAY2jgO2fve9Z7NDGWQoQp/uj71at8TLEY0I+zxc4/vfjWPaO8pKtEYwxIBJzxXNN2kaR1VyJoUGTuCpnhB0+makYiWHdvUbeWwuM+hqO5cuRGMMyjaGA/nVlLZ0tWuQuFK/MFGc//WqbalMhit1kkCz3Kxqck7iAG96glaGbc/zl92ACc5HakKxMFM0exVBZQecmpzCzqH+4oO4BRyKW+grFee4WGINLlpRgAAYwPrTYd7whXY7sHA65Jp1u8Eszic8BGJDH75HpUkbNFJJMsZkVQCuDjFJLqVboNtEDXiKyYUcOa6WO2WGxW4bBQkhF7E5rE0/fJLGQuwu24/TPFbMoxdFHy+wY+XoTXRh7K7Mql3oMuFAWJyNqqcEcnn0piLlTJt3D0HXP0qWZ1WJd2ZCzZIPG31psE/2cl0PlhQWGR37Ct3a92ZLUgZlTLM5GOc+lJYQttkuJ3cMw3bMdR2/KqlzOl1cLEqSYYbnLdvX9avtKBEwViQMA88n8KINFNMgfMrMDwMHGf5VGsRO8dGbH4VbzG7AN94nCt29c0s7lfmjIWQYw39anzE1czJCLe683GUY4kHofWhptpjkKknBIB5J9qmuQDDICMuWwP9rNVjC1pcr53K/wE9Yz6EU9RGfcWsiXyzOcSSjaw/u+hNaB2xL5Q5UYXPtVq+BmXzSM5xuHt7VBI4eRFTGC3cdqbstiUiZEWVwQoYhgo9z65p08SSq6yYIxjGaTT1DysG4CHdx3qxEYxekoqFUTkE9z61a2Aq6RbNb2o2MWDfL/ALozW3seZ98p3AEfiazbb/VgDlC/UdcZ61pwMS8mMbRwM9qaSsD01LtvJs3ozAqSAB6D0p8ckSqSwHfAB7+tRW5VUEwdSC2GHcH3qtcTIVJRRljnjtWjdlchK7JA4GfmPy9BSyHfE0Ixwc5/Cq467wxPG2hSCD82Mmsr9xiDzjlgcBVAz2Hrism9k/eOwyFUYwe9XLq4cqsag7AemeKxL+dllkyflCghT0JzXPOWli46sl0623uz46881emyPb2NJZkJACSCTycfyptzLliMZx0NUrJD5m2U51MUm/OPasy+LEEA474AxWhcSFg2cZFY1/cKvRjms5FwlqY10fJ3uzZ4PBqLw3Zs7vcuCSxwvsKRIG1K48sMwgB+d8dfYV1tnbJbxBY1woPTpxWtGn9pjqVOiNLThiJQDxRSwvg4T0ortWhitDnDGpkwee9WCcQDYN3XrUc5CggAZ7e9PgKvkc4POB2riTLV2N87Yu3dg1YUGTn5m45x1FVbi338phgvf/GkDyPHmElJE6kdxRsaWutC/tBhVmO4A4JAqOSTDnawwOKpl3KKQSD1NIh8xvvY55PqKTGodzQL/J/fx6UzKhtoz0zVUZST5HIUHH/66kZcMzBjwc4FHQOUk3gSYwDVnzlCZJ5FUDIhUY4TOeO9TkhgF4Oe4pbDsTRvvbLHgdAKsSXCAKYBhx1FUsFRkc+wpU3ZDD5eKLhY05AzoZI1Ck8kCqc3zR7OzdaZBdSh9hbb/n+VPcNnavzA+nahvm1QJW3HEyDIAJPrVqDc6qx49QTVVt5j2n5vpU9sWZgCAAB6Vlrcb2NCOTdHh8iMnaSDkgU64lZrdUVUAB4IXBpkZC8HGOuKkyCeob29K1TZJBuJBJ4Y9KkVHZcsA2TwRTvIYjzAoEY/i/pTk5YE/ID26Cla24nItRSEwgOSzKu1cjoKbEpEinruBAbpyPWpLTy2bZMcxE5Izgn8anuuQos93kkZOWFXbqZ3IJZlOPNccDg+g9qlhheRMxg+SRwT6+tQyhbmQAqI8c4Xk/ianiaYKvl7yVHJ7KKXXUTIpFgdFhfJZcluev0pGCGRUuMBs5x6enAqJo1jYysSJAeCpqFpVEnn8qGyu319altLcu1xb+YpbnzEYQklVbHJrBd52g3BtoHGc81JeXdw8mHc+WpPBPftVYBtweU4+X5K5Jz5mawjZFm0kXzfMkJBHT/e7fUU+e+kWILtZsfKR1Vh9aoxRyXE6orY9cd/WroWSGUxuODyuen40lJ2K0HGHzDFLMwEbA52/wCelTt+4h2wSBkfq68sR6VnSl5pAGldH6ovbFTKssWGt2+Y8bcZye9XGVtkTYr7v30hghUAdQxyQPWrscDzQ5lzjbtCr34rOiBaXy1JVi3Kr3PrXRRPtiWJesYwDj7wNOkua45yaC0iZY0add0wUKoA+6BUxGJNwf5zg8fzqwiwiFBFcHzmzkd81HGVhjMaqd+cnd1I7V2JJGLdxzqVcCUCRVHbtn+tQzxhYyZAxGMrzx+NTxsrF0DdcFif5fWormYRjJjSTB+VDyD9aqS01ISfQx42HnM7su5jtAHUAVKm52BPYknA6Cs9cGSUggOGJAPapwxW3Y+aQc9D34rDmN7FuBvN8+VGQxwkKUJ5fP8AdqeGNH+/xg554AqhBtIgcod5yGOMY9zV+ZFwyA5H972qou6uTJW0IpXwhCnO1xzTpZDJMS/zKwz9c1SkciYRICNoGT61ZVf3wC9R39acZX0M5KwtzbS2iOw+ePaCFXnYD71jPO7yANwuCcjuK6aaRpURFG35SS2euB3rA1O3VWEkJClVyynox9vStZQ0ugWhb0+6VbhyoAUgA55qwW2o6qB8zZJrE06UZKMQHHIHfitBXDGJGYg5yT6+gqVK+gmjRt22AKfur3qxveMMrElmPPpVAr8p4K5YDB71YZy5cE5JHOKtPoLctC7aNHjKjD8E1FJNyir0qtyGYucg4ximq5BJyCaUmNI0A+QQCOfSogckkcelQrIQpA6mkMmVwhqG7k7D5XXHJwe59axdQ5YhBneRwfarszFTjn61mzvuvSqDdtXOKyk7qw4bmpbttQB8dKrXkgPcnnvQJgI8nvxiqU0pXJxnvzVaWsCK97d+UremOp7Vh24OrTFfM2xdPdsf0o1aRruQIhxHnLYNaelLFENjxp5qgDeOhFaUqV/ekKVTl0juaNraeVCqquAowBU6j5sjoMAe9QtPti4Jz3qEXQMShjxuyK3b1IXc2AypgDAPUEUViXWoCMs7EAenbFFNrsVqVGIby3Izz071YTDPwSFHAHr9aSOPk4A46CrFvEyuOQIn6e3+FcZvdWJIkBTP3WX0pjrtYqeCeSwHQ1JGAsvJO0ii6DbVycSYAPHSn0EmVUUKCZDyRx2pu5EHEfBOOKZKuVGGy47UioUx3xzk96lmsdR8TJHcSxSruOBtI9anmXcQozjGCR0NVZR86SZBJ7Dv9atRs2BuBI6cdKFIJdyMW4UZU8dvXPvViNAgCkrmo5E2coc55waYvzHf90gYIzRdBqywylWbDAmnIqlSzMD/ALI6miJi33iOBSxFGlIdOG9Dijcm410VmLqMZ9auxZjj8ssM8E1DOoTGxg+Bk54quH3uDHwxGDnpUt8u5a1LByJGAdSe+eAasWyMoByCTzxUUULEDzDv9e1WbdDG5HJpR1ZLJtzO2GzwOcVJHEwJw3zCot21hvyvv3+lXIHR4ywOJDwQOuPWtErvUhuwwuwj8rkAdR2JpIY5HUDcNwOADTo5XiYZyfwpxlkLkk8dQQOhpWs7hurBHP5a+Ww3HJ/Kh5pD8yIwXjGOlRLlt2R0PXFWopWVOMcZyDyMUai2GQxCMmR8s5PyjtT/ADpZnVUJROmSevtTWkIK4JDdhTJnl2tg5b731ofkIlYq48tuxz06msq+LxZ289iR2FTvcPlVB24HfvVa7O6PaNpPqfT0qJy5o6FRjZmVgTSn5zjPfufSlkQsxVmLEc4z0NRSRtGWKttHPbpTYnMcRMu4O3BAHUVybHR0J4gY5F8vh85DDgKKkkuJpQfOcbR94+tV8PIh2YMfTB4OalDwSwqLtHLKPk28DFHkSyUShm5Xfx0H8X1NPiE2FzIYw/3SOmKa7MIttuSd3rzwO1PsQzFnllIjZs7RyVHfH+FWl0C5JpRbzWSKHDNmPzDzgd8Vf4+chMEsMOD0AHTFORsxF4lGzoT/AI1OivMwdFLBuCSK3hCysQ5EUhA2kEq3V8j+VRmSRnG5gecknqP/AK1XJbcK4EYO/oxbnBqvfZihK+WS5/i9KvlcdRKQ+W8iVFQR/N/HJ29sD6VQvLhEYsc8c5U8/wD66R7lppoYVThR83/16dLAWVtwQMwJYN2HrUSm5pjSUTLZwreZED5X8Y7/AFp4kSRnMfRcHOOOf61JFsACrgDJqSSOORgLcMkY5J/rWaV4lN6k8UiMo3jORxg9D71JCWRBuIIY4561Tj6ZUbe/PervkhMbx95cqSeTWsLkysNeHfLIeQQ2R7ipvMSBo3GW42lSeppiTMyuyYCgFBnoaZdOoiBGfLzj5h0rVWSMtWM85ZI5HKMoLN8p4xiqVzmYIEOedzL6VPuMzqqMVXqzHuKrywBriWOLLOR82D0FO91oU7dSjLEkswlfcNpwT3zWpbwvhpGOSp4bv+IqEW58pEUAnncQfStMMEjI4APQ9cCnTWupE3cVsyMgZxgnt/OpMhUG7B4x9aYeEDOowe4FRG4zjBJHpiquSkWOFj3djVcMu4j19qSWbBwcDHQUIx2bmA3dsVMrMeqRK7jG0daRZAoJ6etML71ywHXFV5mOSoPPvWcvddydySaTehYduRWbY7XnmkJ+8cD8KluJtsJBI6GqenHMXcjJOaV7hFaFmduTtPArJ1a+WC3eSRwqjgH3NakyEKDzmua1e1/tKRrccIBk4GadrFxszm21Qx3rchy3UrnFalvrOcErgjpVez0UPbuk27zUO059R3p8umleMDd9K19qkCp33NJ9b3AgkCq7a5bJC6OpZz91lP6Vh3Fv5OSQTg9qrNaN5nzDbnpxS9qP2RNqOqz3ZCAlUHUA9frRSQWfONuB/OiolUuzZU9D0uNCF3DG4Dnn9aSLEU25icEURQMZBGflcHCg+lOnj+zruYZBODnv9KFrqZWRYL7o+DjAyPcVHLk5DsGyMg0o8oplcnJzx29jUMpVQSOmOV64ob6ghUCo4I5Dc8dqfGUO5DHvDA4B52+9Rx/KAANwHWi0Z4JWdQxXPAPanFpFvYaIt2SADg8U8HawzwTTJ2cRglduO1RIzvjkD0rNvUq10TlsEcZGeaYCUckDgdSDzSLJhmLA4HQdxUcu8AO33m744FDGl0Li8jBG0+9LHj5dnOeo9Kgjm3KGcZOMYp0UiqS23I9qLoXKXIiQCSQu3khqItpfeWVR7d6jAMq7l7c5/SpobYyR5X5pAOO3FJasL2ReCGSQv1Dd+xqRt6fNtwD0qpZ+bbMxdd0R44PNWZ5jGRuU4I6jtVaWId76EsRVwI5Pl5yD/SlQovI4AHTPWqRJdwDjJ+Ye/vVpUiZAkm4DuQelKMxW7jLi+lDk7VYAcfN1qW2ZrhA86iLJ4C5II+tVpAtuAxMZ2nByMkj2psV6S/k7dxZjtbP3R9KXNrqVy3WhpSS+SdiHcvUHGKQnzF3IDn2FNiGyQK673IOFJqe3uGBZNwUMfmJHFVe7IaEjjJALc+1Oml3MduMrVbzsyEDheuB0oZm8zCgEY/ChNJaAl3IJlUgsB83rmo2XzE2gdPTk0+cYGQOKhiciMnpzUXsy+mhFLarIoVmJFMlhXGFRlKjkk9afHMwkbep68AelOuG+UgH9al8r1QXaM4+ZGNzBtvYgcUsRRsb2UjqNvOfqe1aJlJtBE53xngjH3fes64Uq6vaxmNPYYGaycbbalp30JxdTxDO8Ar0UChp5DJEzlHRmyVTj9P61E9qkwJkkVCBkEEjJqbTLfcQ6I7Pn+Lp/+qkrvQehqWabowRnkk4xzj0q2szhdpYImecHtVVZZLdSoZFIOW29fp9KduUMGOCpAOOp+ldSdjJouOY0RdxwFPyqTnI96ivZRsYqn7zblef1xTBbONrYO3OQuecVFM6hWZj+8xgVpztrUlIiRfImUs6FpoxkA9CfT3pk6B02M5Q5wc+lJFb7n3K3ynrTooiwIcgY7k5xXMau19CmYQnoF3Eg5zmrAbzBI0YIGOATjPrTblQS3J8vGQ3ejYZokSBMKDk5pR3sD2uLGw813YHaeF46U9JH3yIjKN3Vj0p5jcnyxgJ/ez1pSsRULIgIB3D3NdELozbsNcsIP4V2klSp9famSpmXMhztCt+PvSCUKXYL1b5T19qjdzIsqvw2QM05SBK4xFJldgcq7YAFWI7WSSKUrtADcnP3j3qgXzOJEU4xtUf1q1bPMsQBJCH5uegPeinIJIVfkeUAAxqAFPvTUmKjCjAJ5749qji3MA7AlcEhelORT5bluCeg9DQ3YhE0bSFNwyFDdAabJPIW28jI7CpIA3lc8YHIpp2OMk5xxwafQadmVGBbPOcnqauKQYwN3TrVRkAYAZIPallYoQqHGevtUQXLqKbuWSRjrgfSqrnexxkAVEzrt7knvmkDHdjJ9+abdyOUq6rMPIfnBxgUyxLbFTIHvVPV5vmjQgjL/nUdtchbhwTg1OiKSbR0gx5e3I3EdKhtLQvdtcNEBHJ8g2jkYqBLpcfKfm9TW/pNysQ3Phtq8A9ya0VpNJkapGbLpbJK7eXtP3ifasq/tgWIjXnPOBXoGqXdsLJPKiSSUpnfuzlvX6VznkJIrSTsRjJyvdvSpqws7JmtOWmpxNzZbicDLKeeODUMdgso4yTXT3cC+YVAOO341HFa7BkYC5IJrDW50X0MW30zb0Hy980V1emWTSPL5mDGlFawpuSuTKrZ6GdC7MNz5z61duIt9oJEdWBGdueRiq8UTSOFlO0AFQewPvUcqmBCHI9M5yKteZNrsIcffyzADJA5ofBO0qVP8JHes5POiYLK2EbkbTx9KuSSloQykArwf/rUmtC5Qsx1m+zcGUhgeQe9XoZtxCl8cnoKowNHIrb2BbuSKd5Dr86yZU54J7VF2tibJ7ly8hiaAyPIrOeTnrVK2RkTkF06A+1QtIuHQeYcetaNmxCjbwpHQ96S95id4qxCD8qtwCeMHk0y5xJHGAcN3xU1zFhg6lTu5wOv0rPmZlYD7uT8oNNtrQqCuWooS3zN91eBnirK221g24cnIFGn3AELb1Adhj1pnmvjGenT1qrJLUV3qXo1MTK2NyDIxn1qQSeWNzfeA4zxVSOR2BK/LgZ4qw1x50QBQlvbildE63sSpN+7LbiUPJFI0hdAmMgc9cYp8PlxwMWGCVO0DofrUQdZQInDbScge9ErtDViFsxuoHI9T0NW7fdNwcq3cKOtSNbeUCHO/bx1z1pi5iOI3wR79KzSaeo3qTtGHi2uF2A5z1qA28Uczom3PJ39f/1VNFukAD4G7360xIFicgkhjx1rRpMiLaJleSJyD8zYHJHIoVlYF3bjO7FMuYQ5ASQ/L1bpn2qYxhcL368mhDZGGU5KqAME+9ME29cAnaeopZIjjIwIweT3qEMFJ2YAAxUttBuOkmyQigkflVaWUIv3cD6U+5lUL+7O045z1rPEjS5KkFR1JqJysxxiSBy6Bge/P0oQ+awQdCeAO1RhgWXB25P4VYhBEm8DBHOe+ahMp6FiKINMj4GMYA6Z+tXpFRoXD43dQPWqcM0hyXUqc8Y71JOrAksd3rk11QskZNNsrCGNSxfJ5+8w6U5J9hYRMy9iB/FST4bZkleMj3/CqzHcWMa4fp8px+dYvTY0Rba6Zo5FI8sE5HHJNSW135czABMsuDmqttH9pV0dwJFGR24+tSKqhQQNwJxjrU8zHoXYbhtxPR+x9KLlfkLbhgckDrmq8K7T8pBI6knih5S7FQATjt3qlK6sybdhyupRdp520zbufKjrx9KNoZBsqVFaNBgHn+IH9KcVzaMNNyrKVTJZjwMbT3q6kTJCjIw2svbv9aZNa5IcsGVhkn0FMaYLuReMcCrjFRJbvoT53KiJhUPXd0/Gorh/LiX5uMZH4UxJh5coMeWIHl+3uaZMji3Dtgxk9h6Vo2ibWJFwbe2VFwp++x9az7iUo4JPyJwvcE1P81wXZHPlKMEg/oBVe9iHlxEb/mPAz0rOd7XRcByTs/ytyq9G4B5pbm58wrCjBlP3scCqbLhzENrOOcg8Yq9AhypUrvUYyelKEmEkiwiEjhgXX73HAHpSO0YlxyVx9KkQELnIHYj1PrVPYHwWwS2eprWWiMUWWmUIqD5j2JqtGCqEKeeanjChQMZPqaiPHCnIzz607j2IVlZHxyD3Jp07KAMA881PtUk4GQeuahfAOSOc8VnZobaIR0O3rTJSAmS2SetPJ2g/XjimTYC5J5PahPUiTOe1JydRRFxkLkVUVZGnmIPGRjHerMoLanI+Bk/KDWjpUCTST7l6HtRbSxpHQz/tDCL5s8da29LuzJEBGcE8im3OkupU7co/8R6A1Siil09/KmBUdVPrU2a1KdmtDqFnBVUByAOvr61bmuoxa+XGAAXHQ9q50XOFDA7l/iqXzFcApkjsTVpisTyYWRvukHgc0wTMQOhCjC8dRT0+ccr8x7HvU17bw2uoJBNP8oGZiq/cJ7D1xU8tinK+gyGRoC27ejE5Kng80VU1tp4L8pLJ5x2qVkH8SkfKfyoq1K2iBK6uQxrM8YBcgLyW7kelV5wUYFe46HuKktyTt3ZDYq1KqXKLj5SOvap1LT5XqZk8U3zOw3I525JwQfWp4YyFiJy3PIPSprtUJRZGDNgcrxx6VFBGVYuRgdVok9S2+aIkkO3dIp2g/wAIPOKsiREjIZCQB34z70KqNhmwwzhge1IYUG8Ekj+EHnikl2M79ypOyByq/L05BrStn/chiu3NZM48uVV2gAdK0bW4jEDRv8wJBAI6H2qYvVhU2Q6dGYtjvyVqndx73XbwQODVqOQvJs58xMnOeTSS+W4Q7fm79qL9Qi2ijE0ihd+fkOeKvs4V/MAyzcnFNii3CTGdi9fpV9LYPAWRuQM/SnZsbkipEy/OeV/lWl+7OwKuCRyBzn3qpDD5qsvG4D5c8A1ZhCoiMDgfxZPIqUu5Ld9jQtoonHlznafXrj2FVrqDy5AITk9jnINNZ2ZcgFiD26/WrdpKDGS4HHTnvWis9CVdFESyxNhlBJyAPWnBQylvMCzLwd3AP/16m1Df5gIRHUnqe1RG2kbEpbEfHXp9Khppl9Lk0JcxKBjA7jnNKQ8rbT1H8R4xSrKYXAKDOPXpUi3iSAjaAfcdTVN82lyOpA0MnmFGkGTxuzkVOIgkbBpAX6FetNEkkoLIqx+3TNM8zbI2RwalRSY7tgciLLY9MZ6VRneSJQFXPfd3x61dZgHLZIH6Cqly5fEa5BPJPalIEVi6yoAPvddx6moDAQ+cYjJ7dqsNsV8lcr9cVFJclicBdnQgVk9dzReQ+FEPzOc88AVZRVGVJ4J6Z6VUTapGMY6ADtV1YhJF8hBwfmX1NXBLYTJUYKv75juUkhlHJp8q+fCWGUYHkN6H0qrLOY5Q7jAjAUKfT6d6rxXHmS7m3cjAoc9bC5X0LGwxctktjqxyKQNvKqY9pPOfWow0jSFpc8Z4FNlePBKyEyY2qrHnHtQ3YaEe6aMeTGdoPJ49PepYiwjcjnJ554xVRnwg34PuR3pWfareVII+QWJ6Vn5l2LasWk2Rrhz2HpSJK6y7RjniqZuV3fuWJJ5DCrNluMgDEfLzVLXYTVkasa7VJZcsOMCkSTaMjr3yegpEZgcjuMUxysZ4z7VutDDcC4AbOeeoqscK5BGT159aku2OfNXAyOv96qzyM7ZCjdjOKhu47Cv8soY9MZO003z1WUAEsJOgH8NRSDEgKEDJ5FKq7mRx35x6ik23sVpYtwRNFATuAJz2xgelUpriPP71ZWjXPC9zip7m6VkMeSCBmqrHaBhc8ZbHYVcnfRBBdyC2Y5RFwp4JJ6Jnt71rWgIjO7kAnAbv71SiXKlsKm442gcD8KlcqzIELAx9QT1ojpqEtSzJK7AjozHGCMYFQzLwGB4PUfyqUYklXeQW28Y9T2pzgfvEGRjGfatrX3MthhbyYhs6nue1RsPlJ/iPenDmME8nHQioJSwIEQJHU0m+UVriNMVbIyFpyyB3KgjdjpUcgBTa3LZqNEG8DJHOciovqFlYlYsW6VBeSbFJxn2qRnIU45PoazriR3jLONjkdPSk3poFtTOUl1kJHJJrb8O/6yQLxu5rIjANrnncQfwq54SLM0kj5I3bRRe1jRLRnctCstvEuzKxjdmq2q6Wl5au20qB8wJ6/SteCGI6erof3vdB6UhB+xSkYwvAz3rotrZmPoedRIyEgjgEjFWFSSMAopI64NaGq2nkTF4+VfHPoabEGkCqoGenWslFbGzfUoG5IQBmbPr6V0KxS3uy4u9FllmZQS6ShFk9yD61jtEUYlgowe/StTUrS3ur57pdVtgHwSpZvlOOg9qEmTKxFexzT37i7gWGTCjy/wC4uOAPwoqJokglAF1HcYx8yZxRVxslqPYyEDNMACWRfQYyKmnIU4BbA5HtVeKR0lzGxOV9OtWI3jC5yxPOSRWG5s9dRyCNtpdhtfuB0NOeRVUoQc98fyqAO+/bjCN0J6CrKKxQgHJ/OlbUHsCeVFI5GQrAHpmoZpAGxBnBHVuopXSXzggU7vQjqPSpUjVYn3qRxwPQ0XYtLozjGXZdxJbPerYVEI3J8/TjpTIo90vztznIPrVmdsxZf72RxjpSSW4N62IFIaZSeQamuWjEi7GO4j5uOKrLjerKFBGRU0qeXMoznIDdehprYGWAwgwxPDD8PxqQSllQw4yOo9aYyK0TK4BJ9KSGE4APyg8fjVO+xCSLUU4VyVLLxxgZGadBgSHONnc1HHE7bdqkHOA3Y+1CSkKyFckdsU2u4rdi/GXRsrgkrgnGMinPb9XU/e9PWktHVows2VbHy+maVmZS245HUClokJ3uJAwEeDnzM4wemKYXy/UDPQenvT0wVwpH09alKhEOUwy8ke1D1Q1Yovv3EyDJH8XtUsKjaMAksc57VLHuMhbA2nsaWQpvzIyoOuVHpWdupSEidWcjI3HjmrLxKIQTjJ6EVDEIiEY4zjOR1qR5Y1OzOecdK1ja2pLuQSYA2qVJ6bqglVIn+Yk56bandOWAADeg6VVuW2ozPyCeD2qZ7XDfQqXDRqdigH+8R1NU2wGJhRthPPenTSqmSmT23d6BuwZGbbkDK9PyrHmVjVaA0iglA3J56VqxzIgRFj4Iwzf1BrC8xVZGYA5bv6Vp+YjR+Xu+9g4AojIJIS4G9yxI25wmetDEbdy8etJFldolQNuJGW6CgjYWVCDjoT3FHmAkjlvuSEAjHuB6VDOBszty+McipkbcRggKOPpSzxuVZSAcjO4DrSewXRVlbBT5z0+UH1qOVJZANowF/X60QwKjDzXOBye9aCPExGSCvX5h3oUbotuxTEKlSxBeRRjIGAKvafmJmRsM3c1E4VcbfvZzVlQBEWUHce5qoKzM5ssuZNoKEHnk0MFYqGbJGWJz1qCFTKrLG2049aenJQkAlMgAfzrW/MZrQZMu6VeV2hc5HABqpMynDSn7h7dXqecbmODgbsnaKQxuFDOpUjgFucCoad9BrzIWRiwCjBxmm7xGQg5xxQX8qT5HyxXFQugC9Vbvu9BVAQS3BV2VRuJ+8cdqZcXJaNPKOCeSKUrGUZQeNwyQariNlD46McgY7ehrJ3toaRsWrW7JkKvhmzyw5zxVqLM8jD7ueM+prJiR1Eu35ZMYOOg9q07d22KnTjOaqmKdlsXUG3AjPzIevpTk3NJhh8vUnPWqzIxXjjPJOelTLxCqKeCMFjXTzdDBokkb5CQOOq1XAZcHgM3pTS42qPc5PpUgzznlvT0oeoWsRsnf/OTQQNxK49KVy6OOOSKHGFwBisxXIkOUJYAZ61l6k6qSM9eB7mr8s4hQtIOoPFYl1IsxWR8jnAFQ2noi4x1uSsoS139QFI49q0fCiGKzjPXdljnvzWXcNts3XI5GK3tEUpFGp7AcjtTeti76HZ2lyIowNu1sfeHORU7KJH3oSgk+UdxmsyJnQBtwGTtzVy0uGt3VkZQwbjPOK6YyuZWKWuQBMRgZGCcD1rm0Z0wCOnTjpXUauEkheQFjuOOR1965suY3wRwTkj3qZr3i4q8SxDfJab9tvBKGAyJhnHrinx6srEl9OsNuOvl9PSqd1JHMC205PApsyhVHydFB9iKpEqKJriTz5mkMKRE4+SMYXHqKKJfIRgIZ/N4BIMZXOR2P6UUWRSsYcSSK3zcBeTirjwv5QkG7aw5zUAZQjA8gdqtW1wBGxBBU8bD15rGKRo2+hE7YULklT+lWoLjYgjdfmHII7imTLGXOQQM8nsKbINuBvU9gTQ7oW5cT98o4IkHOc96hujKkL7lIYfK+4UluZVmIZxnHDetTahK5tD5svmEHIJPJokrxJStIz7RgDgg47gValjG+Nl4GOCTVezXgPnPOcVbL7xGqrwTjGe/1qIrTUcvi0K0qDeyjBBOTjtSEKJB5Yy4HzZ6UoCtdHaflXpUblorlpVXr7cU0MsrI3ygdTxirEi7AZEG8HHANRwxhZFJOV4+YdKtSK0EivH8yk5xiizIb1FimXO7qoIIBNEsheXzE+Ut93PHNSQyBmKqNkbDIz2pZLddxPUnoRyKHdoaaQ+2lkOd0eSvzFvSrMIMjhWA3dKz0SVmL7jx/COcVZFysmHOfMGB060J9wepYSMQE7XJJ6ii4kaRc7QCnJx3FEEgV8yAYGTwOtTSsjLu+XcOB71S20IZXIlkj3Rbgp68VUl3EqSQqDpgc+9TxOwyu3Cjpg9abKgdTg49utZtJmqEhRN2Q7H1XpVsGJVxtDEHg+9UTG/RWwMdSas24fI4Ue4pxdiZIm3qPmKgk9QayL0yAkMAARjgdq2VGeWAcnpjoKoXgjk2hidwJyac1eIouzMVmVcNH90ggZGfxqAK5YeY5OBk4H8qvugVOMccAdz/9aqLuDgHcByWGetczVjW4kK771UyhDH7x6VaiTDksxJ6Y9MVXshhg7LmTnbz2xVwbXUNn68UJXVwciVWaUJGVyexzTFjUJJlmLE8A1ErMGbcRtzximvK4Iw2CDxjniquiUh0alWJxyRg57VK0vyYUgn0qmXQSk7mJbvmnyERpvQAqOpovYdtR0samFVznceamWAlAI+AOTgdaZaiPDMUPl57nvVmJyZAE5z3zVKwnJodEoON/OKadxk+U/KB+Qq28DpyBnjnJqqQsQZnYMD3FW4WIT1uTIhHMYwc8n29aljKD5M/OOd3tVVLsKiIhG48kEU4lkw7fePUYprTVCl5khzvwuADy3FNmUyDcvT61Xmm3zqAxRRT2uE/1acsevvRzXCzRVdiSIjtwOjgevXNRNbtvPlFliAwuT1960UgBTcOR1YVBIpjGCMZ5+gpOLsNTKZ2xS7IupwQx6iopS8LZkGWzmrCIsbHJIyeCeaW6tjOw3HIUZJ9aOXSyGnZ6laImQkqnCnOfWr0SBVY7wWPamQoIY9uAFNSRYByQMdhVxSiEnclUAQkMQAOx6mmyPwx6KBx7VXR97kZ5z1qSRgyMoPJ/WrUrmbIxtYygsRxyAeMU63DxkE87u/fFRQjJyBgZ796sFgchM/hSavqDYvzMVbsDgUSP/D1A701cAFeSTx9Kilz1zwKhrQVrsqX4MjhccetZlwqs6oSAMmtpMsGLYweKzbq3jeZdnBB5qeXqXGVtCO4gC2ZbGBwK2tOfMa9Rms/UCGs8KeF9Kt6dKojjz3HetJKzQKV0bIMjSYQ4HoTVp5hHAflBI5znmqUGWyWkIXHSnO4CFQc4PUd6F7pRpSTNLYbcfuSMgn1HpWDKTlGxwMda2Y3VrR4mGcjgY6Gs+7Q7FY+nStJbXFF9Com13AJwueorqXtYLD7TcC1BCqsFupXcJCf4veuUgYLKEYHPTH1rpZIY4rWRElnea1dFZi+AM9Qo7fWrhZmdVapGD4kEVnfSGFNmVUvGvRGIyQKKsazYrFclYmZ0YB1LnkgjPNFO5vTtyo5K3lJUKfug9RU+WRjtwMjoetWgiOhdFDSKvc4FWBALpG+VhMU3DkYb1/GseRrYFNPUhtWnVgko3RnrzxipXhfDIxAI68c4pY4nWNCpITHIJ70Ors6gtyvqabXQTlcjcurZwXU9MevvT73L26tjg8YqxbBkV1HVu/XFRXspMgSTk9c+lQ4uwubUit1YYUenHHWn+WXIZx8oODg80gYYBUkMvOD0p8EnzMGxzU2sLXcBGUZ5IxlAcCo2kVm2se3Sp42YJtxlfeq00amY989T6UdCk76stwNnKpk85/CrcrlYz2wMhgOtZsB2H5Rnbz9RWmSGjUJhlIyMjpVLVEve5BBMSzA8D6ZFakauI/NgKAY2MrfzrKVSsvIC7eCvercEsijLL8nQen5VMew5DiGLgx8HqPf2qSHIk4wjEFsdRn2NMiJL5j3If4j6/hTpizABwFU/MGA/SlbTULllpUG0vtcDrkYOaglkD5aLOT3JFVBKWGWJGD2HOKuCNWjy5DKBkDpTfvaBy2K0ocMmF+ZeenWpYYgRk/JnqQ1SGYqEChTnuRmnsglBkIy+MDAwKmw3IZtUIVQuTngnoakVinICn3oB2ptfIyOcDmonnClUIBJ4zindCtclkchdpHH07VEY4G5LNvxjA9KmJ3MBgnP8VQlMPlRwOx702iUUp1Dll2gOeFK8ACqnlKybmAx0wvbFX7oDZhfmOee2KpiJ9wBG1egNYvcsZCpjnDKcKP73NWZ4o1lLruMLY3Ajv3qvED5mXJ2/zp1xPI5BTaqHBPvRzWWw7NsqXUhDfuyQuccUtjMj3AjJJbHGRwaGXeSMY5zgd6fHCxBaM9OorON73Kb0sNZNtzMEQKo6A9z60iKzMVbgH1NTG2LSb2Y78fpT5LbKBmbaQDjitJd7E3tYqQs5LIAfKU9fU1p2iblDenb3qlaoS2DkA9fpWjb+WEGB81FLe7Jmy8jbsZfp/OszVZEjgd8jpwo70+6ufJgJztOMVx99fPLPtjbJ6561desl7qJpUnJ3ZYhvxDN5smWA+77VqWOqJd/KWHBwc1zk+RFgcg5OMdKr+aSGAUpGMdOrVyxk47HTKCkdjmJzlWBAOW9KsooQB9oBxwa5SwuHgy7s21T931HpXRWs5mhDkKGccKD0FdNOSlujGpBovIxZiBgZ6+/0pJ5ATlM5HeooEbyt0hJXtSz5Cgcjd7VrdmOlymFMsjM2fp6VZiKsdpPA6YpmRtz2NO+UDcfTgelLbYp6g4bJUjp0NMkBwGH3u9DTcgbdpPrSANztOfc000CuMjUKcsOT0IprgNIu3JHOabK+1zuOc/pUUkhjIfqwXjHT6007A7snSQRB8nkHFSW8i7Tuxkjk+lVAGliyWx3NPLAIQCMZ5p3JaJi2wsysQaRQZMk8rjt2rPkkZywjzjvV1JAYDs4wMe9RdPQGmhzFc+WCpAqnIpecKBkDkkUp+SQnoTRC28njAz1zTim9BbajL9D9n2LxnqKq6HcZjKSj5kJUA1ryLmHORzwK5qYG3ummB+UnDVry3Q4y6M7q02TxEZOQOKJ0CgDkAdax9GvASrK3GMZroGJuIiwGNvAAHX3qV7yLvyuw2wnEbHk89jUl2/mqpwAVOMetUow0MgP8Y6g+lTtLunXIGf0q7+7Zi2dypLAyliwODwDXR2yXrIUu9NhkaTbubzQPMx0JGeayrgHy28wcdQpFSXiQXd6bqPUoYVbB2SEho+OgFNe6KfvWJNetrlRLcXMJUscAqRheOBx0opLu+t5bfUHjlLedsjRCOW24zIfSiiT7FUk2tTzw6mkcyKWBHGRWpbXjSSJg/Lklc9VriR+8O4H5sYIPOPpW1p94UUZGWAwKi7bNuVW0OmkZ5F3AttYknnAz64pM4kxI2HPQis23uAMFzz6ZqeCVZnZoz8oNS3qRaxqIWeMByFI/HNVLpyGVsZAODnpRBdmKXkA5PzZFTXzxPC+1MHqCP5VLYtmNgdSrF/lx04zTpQGiUL1zgFRxioIXVoihJz0xUyMY3AHAPT0zS3ExY5PMkEbkrk7SB3pjptIG7O045FWVVUlVnA3E9DUdwjLJIR+IpPuVFhEuAUYgHPyk8VZjO3kEg46elVSrFCpwRnJHXFKjlG3BgVHQ+vtT5gsW2Eczfuyc8kHPP0q1DMBjewdD0zVKT7yyIAGYglDUsSqoJIC5PQ9KI6MGWZQ8KJIjE8nBPb2qWCXegYsv+1gdDVcOd5TrGe45ANLcRsshMO5RgdOhod73JXmXojG+TJH83Tg1XuUJmCuAEAyQO5qBlkUZRSSR82ev5UwSBSA5wW70OVykrFtpCmAwGzPBHalzI8gbOEA61FC7yDoCuO9IS8Jy43fN0zyKTdwsWpFZmU5/xpu1UdWZeo6+lO+0I0YKKOv3SefrTceZI0jBjxwAelDtuhepI5Axt5x6VXLE5Utye9SJGyu+0A7ucA80KuGy/wAoAz6mh3YmiAxMfkPJPeoU3Lncm7bwRVvGELZHPOc9KhjBclx06Z9alrXQWpTljJXg8Hp7VWUOU29eeB2rVTa5IYfMB3qrKoRggOTUygUpdCoUw4zz2PtSQuVkOCSv86tKNqk43BuOe1NSNVYFeSeSPT2qeXsNPuKZvNly3ygccVK+HcEPlQeoqs4lU5VcDpzViFV2ggjPYD+tNO6E+5YiiUlmkI6cHGKjSRd7YPsCO1P42tuwE9Ae9UVPlkqDnPSr2tYlK+5FeEzKy4y3TNczcWr2l2x4Abtnk110a7SjqQ0ncHgf/XrG1aBpJWllA+Xn6+1Y1IaXNYTs7GExkckElieMmrziFIYkTLSAYYYFVozsL/KNw6Adqr3KzIhmJGcdM9ayi7GrV2OluY4pNmclR0B5zW7oEgGXdyw9D0B9K4+G2M07SHcCMYQHqa6q2AGwQ8IuOD696um2ncme1joGfeBg7cdqUr8oX7wPWmwIWAkByOtSKCE3DjJ4BrrXdnIQyABSBwAajkTEQBYkdQe5p7khyOPMHQVXuJGMigDBOQT603ZFRTYkqjCue/A9qsK24bEIG0YAx1qmWfeuQMDqKsI4xvBwCOgpLcctBk6KW3MTgdvWmwpkuSv3h17D2pvlsrb2fIPIWo/tH7z5jhapLqKxZdhGcP0bjFVWG58qPlpqs0sp3HC5wBUzuI12gc44FDXUS8gihQK2WAJ4xinYWM4TgY6etRoT5YaTJ9KZK6ku3IwKgW4yRvMYY7VPEAkY4yelVUBX5xzxVyHayA8kkdKuKEx1wcrzgHH5VRktvNhckZFXG5TB9aWNgIWG0CtoOzM5baHOaVd/Zrxrd+ADlf8ACuwtbx1jZ0IIIxwelcZq1ufN82M/OORirGkamJk8uQkFeCKXLZm1OSmjrLd3lkYk8dc+tTSqULOOfQ1mxXicIQQO1XTd5iWNQCw+79KLJIrVstGbeqq5O3I59BWtfTvbNfCG1gb7OqPEvlAlo84Jz3rFgQsqqxG5qs6i1np18Fe51D7RCuzfGwAHfAz2p7Gckm9Cl4nn2ag3AVpERwoGNmVHy49qKyL6ZJ7ySSNppIjgh5mBYnvnFFZvc6adlFXORjiUgFeG7kVaiTYQMciqlvKoyVOcitG32yAHcAe9WZRmRyOfMR9+UB5zzg/Sr1nJGpGx8r3GMU42KhC+MhuajNm6naF75JB61g4vc1U4yVjdt4klh8xSpI46Us7ottMWUbgMjHGKh0hSp6ZPQ89qk1RFiVtrZVxwDV8r5bmHN71hum4dN4xgjjIqzNtimKkfKecVSsisducEZXtU75kk3gkZGOf89KnpYrqSMQ28ofl7DvUyIrW6ksQ3UZqK3Qk5Uglup9avw4VGyAdyYwe9EUDfYrKgXHZvbnIpqqA3llRwcgjsKCjIoYffHT3FErq0gkXO7HOepodkUicbIlKuSQDnPYVbiUYMgAdBxz3PpWb5oIGRwe5qSAtH83Hurc/pS5ugJFgZil5Xg/w1Jv2H5vmiPp1qqZ9kgBGSehajfgjPC9CfQ0rq4WLEsoDKYSxAHUmnRypcMTjGOmKghjdicrhM8YqwYZ44tyKpUZHTr7UO49tCNwyM3lcjHrSiWaXr8pHUVHGzZLABGXoDSiRVIzywOSB2rNsstJEzMC52tjvUrP5bLk7o9wBHrVUIzAPkgE+v6U67DfZ9yFeCC1XFmUrll2TO5OQT930qvIGJb5sYGOajBbfn0ORjvSzAAEOSDmh6lJW3K0szmEADoeOaUyOdvofSpWjAXK4LNz9BSQtHsDNwRwOOtRqmNktvEdpYAHsSae0Sy9dv1z3qCFj5LYBBByM05JkI+6MMckirTVrENPoQyZiV1YfMpxgUy1UyOFxliMCrZCSDAJz1zQqCJwFUAnuKHHUL6WGpG/AkUkKeCBTpVWJCxI3dcAVMknZyQPrVOeZGBCndjj/9dN2SM9W7DPMM8gAXaR6d6mEAVSzEbv4TjOKis9yyFwvHTmnybmYnseD71MdrsqT1IfLeMbsn8aq30H2iM88jp9adfi4OAhHljqDVaW6aO1LEA7efqamU1s9ilF7ow9RV7JgHGcj71ULkPJbiQElR29aW+u5buYMeTjA/2RSs48ooCWcjC4rmVuh0pPqJZM8ER2qDIxwc85rWBbywAfmb361k2nmfaljlHCDPHTNdFZ2iNtmOWYE7QelXFOT0JqO25o6Y8hjPnLhV6CrFxMCmBxx+IqJCVUKcAY6+tR3W5uwB7V2WcY2OTRyuIXVj1y3Y03Yigls5HQ56GobYGJ90h3Fjz6CpLx/kGCc9eBUx2uy3o7Igkk+Zwc7COp65pYGVAH3fIOMU3ByGbHPTPWnMq7ST36U7Mcn0HO5kbB4Aqs6IxJJJ56U91YjcxGKW3wz4AAA5NNN7E7IVMQxM5HOOKoiYzMxDfNnr2q1elgTGuCtZylY5EAI2dAM1UkOL0uaJcsiqSDg4pLlhkIAAOrfSkmDRxq59c1V3bnYsTnFJ6ELUlklL4QfKKu2yFUwTlsZrPtdrSbm5I6Zq4JSOoOaaVtRPsh8shCqSOopxzsPoaru7TSLtHAFSMdqHviriZvsVblF2EnrXI6msltOZoj8xPI9q6e5fGc859a57U1BQnvnFa76GesXdBZeIUJw7EEdc+tdNp+pLKUYHkjrXBXVmpQDj1H1p1vJPFhrd2I7r6UODWxcMR3PXVnjUIQSWJ7DJIrc1lr5ZgI9LjmtwAI2aAuxXHUmvNNA1W3lR/wC0rt7N0A2jyi+/8ulbNzqUFwmIvEd0hPfyZP8AGlZlTnEg8QXTR3bCaBbaQAZjVNgAxxxRWBrFtdXN64gvWuosLi4dSGbjpg+nSilyFKtFIzbRFf5icH0q5EXiJx0B55rLsN8LBXJK561pTEDaFJLGpaJhI1rXUA6qrN0GB71bhuADuPBIxgVzsEWyYEg4PNX2lAdF5yDz71ndo2sjp9PChVO0lc5Yd6r6qjgBo2LxgnKsOVBqG3dmACZx7ntWgsck6biCQ/BH8qd+ZWJStK5XsId0LDOT1qdR84JY8flUNq7RytGwwV4zU4yCNx+QcBvep0sO7u7ksfVQOGHWr0asyHyiN4G7bWdnynO45GOoPapbWRlQnOcHgjrTT6Da6jizspbBQg/LgUroZDlsBjjCgYzUxKsNwGSRz6UK7MhWQoV/hPpQ0nuVcjSIHeGPJ4Xjqe1CKCpJJL9xSAMGz8wx6dc0I212y2PRsdazkupSCfG75lwCMg1PBsBBiJYDqetQEK7gHBb1z1qzbsiLj3xx1ppAydoty+ajAA9eM04SGJRlmIA6dqrq7ofLDkoO3SoJJm8zoGXriiUktQUblq5ljuXDooA6EDiqz27LuOcAjAx706Fo/LLINrnpntSQs+7rnHY9axbT3KtYswrIFVeDx0PNLKxkVo8YOOg709JG2AqoDHp64qvK6xnDfe7DvmqlpsTuNeFmiDBzu+tT87FDDIxkH3quzELz94HG2nK6rgMSO2O1TFhK48ozAHk/hSlQRnHHTPpTpJk8sBOAeMjqKqGVQ6qGbGPzq2xWbJpZeNw6DjgfpTYwGIIAUHtTllUxYZTg9xVcuWlwmcD9KV7MLMsY2sdjY57d6WV2j+ZuWz0p0bBYyVyM9jSXDxGPLfezWklZbmfNqRswlYYYjPFVMeRLsxlWPOKXcpbOSoPFSOdw+XAbHBrNK6K2diRpyMBB7dKVVbcDxinRIBGGc9R1NEkiHAVhmqSa1ZDaI7jIHzjIP+cVzd8d8hUORGex7mujYiYgcEjsKxr6yeW5DDhR6VnWjdKxpTZQS1jXcQg3nt61EsO2R3wN2flyOM//AFq1Y7dGcneRtOMYpb+3OzMYBf0P86z5HbQ151czYY9rgKAefmJ9a1oCyqQ/yj27VSsLV8bnOT1rRQAg8fKP1q6cWkRUld2HSyoSAGHqfakbeCADuOABTJlXGSPw6GmRO2G6Edc1rz30ZFklclljCmJicMOT7VNHGJkaRm+X+dVVbcN0hJHvSwn5DggAmrWhL1C4cDhPmYDFVQ7oy5HJqwE2v3OepNQTuBuO0Y7GmlqC7BcSliAAMDt605CIkDD7xGT7VHbqGjMrH5j0FBjfy2JPXoKb8gb6FS6vVYtgZAxj3rH85vOLYGAc4NWb9ESRlIIzVaGPzWIYYwePesW7uxrFJI0munlhG4/WkLt5e0A5qtcMYYfmUZzhR60luZMr5uc5yQD0rRIjQ04BsQA96liOWI5yKqGQtwMZNWoMbuTwKtIybJWXy1yDz3qF5euW4PaluCrElW9sVXmPGOvHarSI3IpyWJ9B3rGmYSXaq3O3kitWVysJBGD1rMt3QeY23MjdzWqM5bFaeMSHjAxnFMtImAyq896nKhRjPOKt6fEEUA5OfWqcjKKNDRtJur8O1pCHMeCwLBev1rWHhfVGAP2YD2Ei/wCNMtYkKRh1GGIAzXT3Fho9ul6DbXMhsyiyES43Z6kDtUc9y3FnN3GnvaXBiuECSKASoII5+lFXNcgigvXS3j8uLYrx8k7lIyDz60UOQ1C6PKbDUg0ZjnwJVOGB9a3LYhyrIRx1FYOq2gVo7yPG2T5WA9fWpNOuJLaXY4yvaiorE0pX9TrlUPEBgEHvVbG2/YsckdKbZ3oVc5BHdaZHOv2gt2asHZnXBm7aSoygZw2ea2LHmEqcqOxzXDXt+bS4UqQYz19q6fR7wtECPmSQdQaSaTNJQfLclvv3VzuBIyAWq7byho3G3K8E+1V7uJprVmQbmTniq9jKUyAxb29ab0dxJXRfGJJHTbwBwatW0YjUMME/3D0IqtA6mZDnGeDkd6sPtjkZQTg9TUod76D42IlOQAoOPWh9+75QuSfujtUKyHzH2YIA6j0q7CUlBEa7m25U9MUXvoVa25W80LICy8DqD0J9ac4wWdcEMOCB39KcypvIKjnlcnqfSmDfG4DDbu5xikuzBW6DEkRXx3HUgcirERVHJbaSRgGqrsNzbx354pCzFMAbsn8anmtoXYtSjIBThR3NQFhkc8pyQO4qRZinRQcjGCOlRyAom/H3uCKyn3Q42LqyQsVKqucYIp0eFc7UKjptrNdSAvlNk5yfpVxHwwJY5xkikndiki3KwIyCAe4qszrwSuTjv3pZQT3+UjO5aqShy2FOAOBW/QSiWmjj8sknDdSTVeV280A/dYYBqRSzRkNyR1FVtzB1z8wBz9KykEbltmEMBZwAw6ZqjLcgOpYct0IFSz/OPmHTnrVZIyzBiDgdM9qiTd9Ckl1LuFaJSrNv/iXtSsEUqVBHH61LGwUDkHpxTG+dxuHAOcVpa6Mm7Mnhy6HK/hVHULZpCHQnA9DirwkGzAzmonAckMcZPWraTjYhOzuVY1Lw4k3YBwTU0seIwQc5H6U25kdeIguAR+JqKSVkC7uSeMVPw6D3Jmkdowp/D3qKVDwAOB70yeZSABxg9M0jzBV/2u9DknoJKw7cPuhiPU0krnhQeSO9NQquCw4NJcFQdyjOOKJPQa3IfLEZGSST0Ge9PkLMo9TTYmErAlcAfrUrsSh4U57dMClG1htkEXDYG4etWYQNu7dle3FQkDaNxwT1NSjCqew7ZqkTJjbpwyFVGPeoYgoQAHn0qdtpPC1QknS3ZmkO0dKq1tQTvoiySuGBGeeaRRly3TI6VSt7tZn4ztz3q68i7DjmmrPVCkrMZPPtyBxgdaoIDLLtyQuf0pLqdN4j6+wp8WI1BOd3f2pvUeyLckiqTt47CoZZXRcnmmNLubJ4weKgmlBPzNT9SblSVftLZfIFPiVIySRkDoaTzVOdvOKWJgFIJBNSopjlLSw2aUSAMVwM+nSonkWKMlyOevrSXt4i7lyCT1FZD3LSvtUD5uBTbsCuzZtZN6hgDtU9avpMG6Y59Kw7eYD92Dwp5Oa1IJFTBzmqUrkyViw/AIHU1VZgmQeaGkchmddi54z1qOVsKuDziqWjIK15IRFyevFV48Rpjq3apLhvNlRfSldCIyw+8TWl7shojTlSHGX71e0zEsig9BUMMXm5boavafanzgcYwKTCKNpIwQB0Xp9a35JLmHUUju3tC8sKxzhxlcdvMx36dK5+OKUKXTJCYJIGQPTNb9zHb3UxuLm21OKaQAyRxQ7lY+oPbNJDkznvEEl6mqTm/wBgkGABH93bj5dvtiires3P2u8YyW7Q7AqpG45VQMDNFQ99zWK01RwugWxvLZrd8EMNuT296xFT7FqMlrO24o2AT3FdJpObaXcjYVzjI7VQ8aQqbe2uY4xvhfYzjuDW/wAUbdjhStIsvbRm0MsbAcdPeqkYbcGAB9cVnRXjLb+XJkKeRW5pzJJt6ciuedmdtLRFaezW5H73lSema3NHItY8IRs649KBZgxHAyOtJFGYiFb7hqVodHtOZWN7T5Vy27LKeSPamXsAt7gGPPluNy1Tt8hcoRx0NXGBmhBzkr2ovoSlqPQ5QNxj37U9JlkUBic+vcGqkMm35ewq2iq6gjO4HJ7ZpPVDtbcG/dyb2OMjqo4NWbaYJFiIlc9faoZog8Ma4YbTjioreBmkUNJsPIHcGsveTujRWa3L+7zTySpHYnPNLIzMFBfhjzu7UoWNQAyqSvfpROxZiAhVDyNvStbaE+RBcRKqK4l3kdvSo0lRwCjDLDkVI2SplO1uqEenvWY37pSUdBJnp3xWNSVrNGsY3NWEHccDJ681JHuAPmcrjtVWzmfy0bCs3erqEyA78IMdRTWquS1ZkZUoPRB0NPilLEkYODzxTfMQg7sYBwCaVlxgISN3U0cvUSsSyTEI2SB2xVZTKfmwMelKELFixzimJ5jSYz8vpijVsNi0i+egXkN3+lBsx/CSB2Heljfac5AA6mpRMSSTjHtTaTZDb6EcUCMCZAS3T6VBKiJnBPvU5YbDjiqpJOQQCfQUnoEb9R0DqQxB5HrUcs/zMMZx3FNUjad+B2qExFWLg5J/lUuTtZFWV7j/ALQVIBPOM471PDPnPeqITbMSzcEdKtwhVXdngUQuyZtAxbIJB3Z7d6iVvMkYuSp/lSSsWfjOewqq8jEtjp0xQxLXQbPDKoMuS+DwKiEmGXJy57VZFwSdjHA6VBNDFuBDAMvIIrNxd7otPoXYGZxuYg5qQAb/AJlGAeDWdZSGMck4B5zVtnMhwDj0q07oiRZdWC5AAA9KZ8pUDPze9MaQwx5clhTI3DgMq5+tamY4gc8jI/Wl3kpziogSzksMEdAKRyFDMSMelLYCSWUInBycdayrxftCAdMcnIqwXZ5FULgEdfeopMgksufpV6vQqLSIoYxHGCvT606aY7CobINEjAqMcY7CqcSscjsefpTWmgXvuO08FpXmYcDgZqxNc7jkfe7AUxM+WUCbBnGc9aq3Mnl9cZzgU72QnqywZQg+dst6Z6VVnEpfjof0qIAM29zyDwKivb0WqFypZj0FJ7ait2J5GaKMhccck1UEnlq7klQfeoY7trhBvUjPb0qtey4UhRntiku6D1KV9cmeUiPIPaltdyKS2c9qZBbk5fGHNXlTCbTgmp9R3sOtGbACn5eprYgct6DFUbWAgKFXkVoqAq4wM9TVxTJk7kspMhHYDtUDvsQnv2qUYKkHjvVK4cM+0EkCtCPIZFvaYsec1bRfMYopB296ghI3+grSt4Ni7u5qkyZIiSEI2cZPateyjOzkHnqartGCPlFW7SNgm4fMT/DQ9xJXRaRpER1idwj43KD97HT610E8kVtceRca9erJgbgEJ257HmsAg4G0bSOceldFHZm/C3l5pchuHAPyXCoJffaeefagTVtyjqumAG5lW8kupotvm+auG2n7pB7iikvtSfN4j23l3MxWNsnGxF6IB/WipaVzWF7annulEfZ2ZjyRmrE1s15aT27DO9Dj2I6GqGn5U7WHAOK6fQ4tshafGz19a2he6RyytY8+jt926KRdrpwcetWdOd7WZQ2dvTmruvQx2uvXcY4Vj5iY6YNDW+6DeDzis6is2jWk9Eb9jIJogARn0ofDNgg5NZOmzPHhWyK05HMqHGAxPrWTd0dKVmW7M+WWVsFTxn0q2oUMuwnrz9KpQZjiAYc+tWoD8qsRnnBprQogY+TO2eVJ4zVlJC0QAbnrxVe6jxdsu7AOCBUwjCnIO1v9n+dLyKJra4XILEg+uanK5dWGAo6kdDVF3CleApB9MZq1EfmGVODzmpvbQqxeV2lwowT2yamYHziCpJHHHb/61QBVCqUBIPUd6fFOx5XkHp6079ySC4iBdSp6fewTn8KqNbeYzNwCBgA9z7VsXLqQHjVlwBw3U1TbZtB5JPX2rOcE9C4SIoVdAuVC8dPWpkZpupx6Y6UjsQnGMdPemRHbjbx7UJJaDbuSSAMfLYYwO1JGTtxk7j60pj3PvZiOM4pysEbB5GOtCWtwb0E2FX+TOetIHYSbsEClZ+WKj9aYQzEdvU03uSiWVgPud+tOikUAZII7kVEgABboc9aRlXls43GkxaEs7hGAjUle+aqO53Ng9emKdI7IpDHINVImw306moe4+hZDARkHJNVllPzKhP41Mzrs4xn1pVVdp+Xr1NFrivbcihUyTK0o6Dp61bYbA5/h6YqGRwFBUfWojMXYgMSD6VasiJNsmBBO7HzDjio2jUtnHHX8aAw5BIFRmVuw70N9BFKcsH2Y4J6+lCnYCXZTn86knK+U4J7c1QL+bnY3yjrWUrI1WpbtVeQOWOB2q7HhUBPU8dagtXCx5K4OOBStJ5hGe3b0rSKSRDuy1vDjnoOMVDJuQnZ0PSmvLhQFIwPSm+arAmRse2KuxC01E80qwAyT3NBXdne3HeoS248DC9qHYBccmiwmSFzklDwOlVbuRlwynLHk1Jtyv9BVS5OwYb8qprQV9SKW4OMtwewFTxOI4wx+83JqkmGO9/lC0NdoTwSeKLWQPUsNPk/McZqrPIkkilQfbNQylpAGGAuaieUDgcentQO5ZDxopLDc1VbpxMoyoz2BqJHJfG7jNNaQLISSParW2omA/dx7iAPaoNoL8jAzmmSO7uCD36Vat0UsCxzUoluxYjRVYbVxxRFCjXBwCe+akO0KcHNSRsAC2Kdrg3Ym3rGhxgmo45hgls1nzTBdwU85qt9sIYAknNFwsaNzebIzyMniqSzOxyDwaruwlYLketTwZlkwnQcE0NjSL1nG0jqOSSa6WKLACuPlx1rN0uNN+SOR0rXlJABJ4J6VUdrkS1dhXjyAiDINWkTysDJzRAduSBgkd6VCGJLE8U9x2sPZtpDdRnp61s6lCL+5a5gvrVYpMH95JtaPjpj29qyY7Z7iNvJieRl6hFJx+VVzpt4xObS4Pf8A1R/wpXC1zT1eeG5vWlhfzAqqnmf3yowW/Gima+BHqATAT9zF8uMc7BRQ5WCOx55DvCll+XnP1roLC5JiUH9K560ukMCgj5uhrU0hy7KCO9Vez0MUm0VvHNkRNYXakgSKVwR6VR0uTzwEbgg4Ndh8RbUDQrKZOQoB/GuJgDKyzRDDY6irrRtIdF3Rui2Vl+UgMpp0jBYkOMMpxmizdZIC4POOlJGwIO8HjjFYux0QLsEgUjB9+e9WbVyJcEYVjyKpLHhVK9COMjpVmJsEhuMdDUmhZ1eIfu54+Qpxx6VXDFMOBnJxV3eDblXydw5461SjyBtz8uaJ90EHpZlxVSUBn4UckdakDIFCj7vX8KZD8iLtx9SKRhiQkZweg7Uug1qy9CpdQ6khF4BxwKjlZ4mBjYMM9AMVDBMVcqGIBHTtSuSRhTgmpchpa2Y+SVpDsDcDrTAr7M4OTThCyAPk57ighlUlTwefapd7lXQpYkAYBxTgSEzgZBqHzAUOeM/hSCToMHn3pDJlcMSepP6VBdNIqDBOAegpySAggLg1GZsYVkz3J9aHsNIlWYbAT94DOMU8knGG6j8qo/aMFiw+b0p8UxEecEEnvRqkU4lliejYweuaZcMqcgkmkJ5IPemSIhUZOVHoafQjQqTXEhb5vunvTmfI45HpTJypX5QeOxpiFsZ6YrOzuU2WY2CggnkjpSlnQheoHWqjygqWY5x696cH+UFSKozeo6eUuCoOKbEzKMCq8rHcCCcntUgY+tCFsiwrNnk80vmsOARkdKrsSScnDUgcLwRlqpakMSeFpEbHfrSWEES54NSmUkYbAHpSBwQShpcquO7tYkmC7s9MdarmZF3BabdTLsPXngVUQnOO1O/YEtC6JEC5fJyO3rULS5YsxwBxTFbBO7gY6Go1MbqxYfLTQromeYkhYwdv96pBKqrgsfc1nAt5pIb5e1PknyOnXmrirktlua7WNcg5J6YrFu9RJJGfmqnqV27vsUHNUVSUNk9T3obvsJJInuL2VmVE3EN1Aqe2+4d5zjv6VXjjMh256dSKnKkIFUhVHXnrTUXuxOdtEWDJtGC3yCqUsvmv8vCVFcTZGwHjpmoFcjaOo+lMVzQT5UPt1qqzF3woOPenk4UZ/KkJdyOOewqiUAXc2K0YVGAWqK3tyfmIyewqwylQwJwcVNraj3HEptwM1FPLtjytJEjGI9Sx7iklTahDCgZSJ3E+pqBvlJHU1PIgYgICDV2w04ySjcMkCklcZQghZzyvJPati1jEa/Kn1qeK3WCQhgN1WYocvgCpe9hljTFDAswwfWtOGMNLz0FVLSPy/lXOTWkqmNMqvJ61SdlYloS4XK4DYOenrUkOY0Ixk96juQxwx4p5IMYY9abYdB9reTRSN9luJIy3DFGxmrLaleqmPttxn13mmaNbW+28urhDKlugIiBwCScZPtU91axanbvLpi+TcwjdNbAlsr/eT+opxu0DsmUJFmnka4uJGdiPvMck0Vb8SL9lujHAoWIRRnaPUqCaKltR0YRTkro8p0+YMY15yOCK6axdFf8Ac5AzxmuOt8pOOwbtXRaVKPPCE/nWj3MIvQ7jXbuO88GPDKQDHkhsd/SvO9EJDiOQ5HTBrpL6Q/YXjyShHFYNhARMrZ5qqknJl01ZMvs/2S4IUHy26Y7VfgiE6nafmI5qC5t2lhGBggZqLTpCjFGOD0rNpJ2ZrHa6NFFZEBBJweeae+7hlOR6HtTICS5UEHmpGT5QVOQTg57VDNE+5ctWzjcTkd/WqxBF4/VY+wNPhCoQrdD901JeSq5U7SChwTRug66Ey7ZGAyB7VJKW2ZyNoOOe1VQyiPIzj/PFSq7beuT70kMag+YbRyeauJgKAfm9KrRIhbjI9QKsx/eKrx3BNJje4TSlAVduOppDxHlcYPvVbUmwVZTnswNOt5Ce+R71LlrYpLQeFGOR+tJs7DJApxLK3IG31oLAk7SSDxSHcRlJY4JAI4xVSTcVCA896tFtpKZ7d6g4D8etO1ylIihjIuBuznH1q1jbKG7DtUDOFlG0456UtxccrjOT1NFrIblclLfNyTg9KqSyiJ2G7jsKhnuhGAVI3dhmsu4kaaXL5BPI9qhy0shKPc0Gvo3JWMZbODVaa7ERAX5s1EFjXlTg9z71Ucglqm7KsjSSaOfqQvtTlYRJ8pBHJNYykrIFAJ7n2qaaYhgCTx6dKrmIaNNp96Er8tMM/Qg4bHSsKW7kDBEByx/Kr9orJgsxbdz0qlqQ1YvLK24yMcgfrU+8SIGC4NU8BmJAwB2qcSjIXgYFVyshsnwFXLHJPakwoGRz7VXST5uTmpy6FOeKtRsTcjkjXAzy3Ue1Q7QmXJyV9KhlmaNvvHmoWuSo2Zz61Ngu7EzXQ5yCQarvJuyA3A7VBNLsHz8DtVWW6KnCgnPeq5RXsWmm29D7AVE0p2M27ntmqc9wV61C0m5BuO1epzVqNyJSHqRvaRzk0ySfcSFPy+tU5LxXkMcf3B1aq8twAu1OOadiea5pfafLXA4HtUMl0W+9wpqhEWY5ByferChUOWwadrEtkiBnbIHy+9SxhvMwBgA0yOYOwUdu1XUHG6kO46KFQMk5NWo0WmRxl1ywIFXYYwI+BigB0XygAKfqajniaT7oyTVpFORu+72qysX90jFDVx3sZarJHwB+VQyCWV8EHaOtbJi28ZGKhlT51I4HeoZaZShsDwxFalvb7Bkdanj+4DipwNq9uaED1I1tVbDv1q0kaBecUwP8uCPoafj5gAMnvTBali1HloXZcelPMpc57ChYSWzuwPSlbO8YGAO1TZsaB3Hyq3U+tMYmNcAjmnSwF3MmcEVBcPu2gHml6hoW9Kkv4rl5NNjeVgNrqqbwQezD0rS06w1O1mE8dtcrKDnIjI5rM0f7RY30dzCSWPBQZ+cdwRV7UU1Mb2jjvkhJJAyx2j0zVRZMtxmsNcXd85v0Mc+0ZUrt4A44orIE0ssu6SRmYjGWOTRT0e5Sjy6JnnDqyosi8itLTJvMdSCdwqjpEoljCuAwNSSI1jeCWPPlk9K1aOSLOwQiW2IJzgYwayYwYp8DgjoaihvSxDKcKeoqzdDOwqR74pSNoaFyK5JB3fMaS4iUOzKBnHaooyGCjncOPrUrDj2qGbLQZBKUdOeehrVjcbiCOpyMViKSkhIIwT0NaFnIC3B5qVqXLbQ0WKPEq54zx6inKRkB16d6qs5kc7cAjqMdafk8E5z60Xsw6F2JIsgHPvntTwFDYzkdjVLzGA67qmUk4LcDsaNBLzLaLGXwBtb1pr5WQDOc89agXeWJz3oLvzjH1qQ2Y27baxU4IPrTI5dqDHGPTvTJtzMxOGOaimyqZU4qbO5si4sw2tk5JpwkUDGOT1xVKGTcBuGDU+AOQTmi3cViQj59x+YYoLkHgZA7CmA5YAnrTAQj7SSw6cULQYE8YPPtVS5mKLtX+LrU87AL1IA5z61iXE+GbdwP6VEmio6jpmLHqdw6UinBLFvmz3qLcHwc/Q01ztHynLelSkUK8hklYKtIQ2FwOh4qNpFT5h8vr7UwO7AsDx1xQlcBTK0TFmxz+lMWXzGwGwuOeagUm4GJOO2PWpIrfy+Apwegp8tyGTLCu7zATz2rQtixVeKgiUJEEByffmrUK/Kf1rWKsZyZa+Vc54HrWdcSKJOOR7U27ucR7FG7HaqbFgBuxk+hqm7ma7suNKEAOcMO1D3W4ADNUSwz8/X61DLc5yGAX6U1dibRdnmDcDr61UlkUHOeRVQ3ABxnmoJJ+Tz9atRuQ2WZ7kuSBytVZ59rY4H1qtc3iomAeT3zWczyzt3C+ppqPQhyLk16TJtXJPtVOaeXLGRzwPu00kiTEYBb1xT5beSRMvwMjgdaqxDlcr25coOTknPFXEgZwMirUNssajC9BxV+C3MgyvA+lAFaG3UAYH/66DbneSy4Faa2xUDByRUVwrNgHtUtjSKkCx7jsXBHersZwBxVFQxkIjGP61pQA7RlOR1zWXP0NuUv2+XjGFq3DEQdzDK0aeMR4wMdc1aaZFOD0qyPJCkxleMZppZgOoC1Hbqu8sOSalkUk5waL3HboG0HHIz6UsUBzhuVp8UZbBPFXIY+P60rXHe2gwKqgDiiQbumCKkli+bI60qRspxwSaV9RoYE6ZqaA7CT/EaQISetSRwsJBxn3pdSiyiMwznrUmzAJyM0zlT14FMaQr19au/chasbLuKkE4zUWnwZlyy5UfrTzIZZFXGcGrnmBUEajawostws1oammS4N0lvLHBdtGBC7nA68gHsSKhNprvn7xLNH3DtcDA9yc1XsbeJ47q7v1aSG3UHy1ONxJwMn0ptzawXlk9zp6yK0QzLbM24qP7ynuPWmRazKOvOs2szSQMrrtUO6DCu4HzEfjRU2vRR2t80cCbYvKjYDryVBNFKxa2PFdBnZY9p4I7+tdZF5d1aukoySOCK5LTomjZojxIjbSK6OzfYQG4I/WtpXuccTPWRrSYxPnGeDWvYziYBSw+tQXccd3LsK47is7ZNp8uHzszwazaOiLOoXAIwfm9avxqHhGSPwrCtLtJ1A3AjHWtG1kMbdcoaSNdy28MZRiVG4d6ghYbjgAECpgNzHnjOTUcqCMjHKn2qXHU0Ur7k0LsT8tW8u2MPtGOeOtZnmGNx8wx1+lXI5BIuQ3PpUeQ2TCV02hhkmpXLNtYNz3FQsAAvNBGMY707E3LdvKPmDEZPvTTMNpCDn61QyrE/eBHfpTROVGCOD3oj5jsTvMysTnKe9NMu5P61DglNxOAfWljyoIPIqb6l3LSPuHP4U8sTkAduvpVEORJxn2qzHISc8lj2oHclDlcFqRm+c/N3yKjEm4/OM44pXAK7uKEhkdzkg91Pb0rGniUs5Y9B09a1JW3qV3Eise7bEhyxx6Cs59y4Mjhk+6F5z2qeUqc5OSP0qsk4HCqAw60rSnqACT1qY7FSYr4246gikEnIVcc1XMhZTzxmnIhchhn3NNLUzb7ksX+tx096uHPlEE8etQ20AdSS3PTNWyu1VU4Yd61jGyM3IijlQDBH4025nK4MfTHNQ3c8cOehPoKoNLkF2Y47CqsQ2W9wAy521E0zEvnjB4qrPcKMbmGOOM1BNcE85wvrVWM3IsPKFyzckdqz7m5JY4GFFQ3F8v/16zp7nfnBx7Voo3M3IvSXShu3FVJrwuxCZx7GqkQlmbgfjV+109i4Cg89arZE6vYhhTcwLgkelWhDJOcKMIK1otPWMc4P4VYhtljjyOCe1JuwrXKEdqsOMJlu9RXr7ADxwa0ZdzfLGOT1qpdWrNHhs8VDmaKIQt5i5PFaljHtj65zWfawliuPu1uWMa7QP4hURlqU4ihMt0wKJrX5SR0x3rRRARnjAFMuChwCevGKcnpqNIzLSwLsX24OeM961IbNF+9gY/Wp4EKxjPBokOCQR9KSSQ7t7DwgUYXGKqTR7z8oOasGTgECnoQVywoeoJW1IrdGUAMuKu7NyY6e9Nj2kfSnj5gfSiKsD1YKdpA6ircTLgcDmqkeM/NjAq3Hg9OlVuJoGRlP605AGzjJ96c7cHHPvTY265GAaXUCUxYAxihd27nrQzBF5bGarvM3mbVOaTaQ9y1I2EwOahCbidxpkm5h8ueKW2VmcA9PWle7BaFi2CRMcLk0XMg3blGWq08ASMv6iqIGHJBzVSbtYFYs2WoSWsu9SmGG145BlWHoRUYuHt7hJ7WUJIpJBH8selTafZx3EzSTJ5oQqiR52h3Y4UE+nUn6VPFdPcXs9rItjNFECVjEQUS46hGHIOM4zRG/UTt0M3UbiTUbk3M4QMVC4QYAwMcUUajEsFyY4STCyrJGx67WGRn3HSindgttDzLxBpwsL/wC0wFjG5+Yn19atWhE8YIIzjrWt4vA/4R8HAzu/pXKaSxG0AnGPWuuS1OFM0YSxlwecHBNbLpHcWRiYBmx3HSsiw/18v+9Wlb/62sGuU1TMJEaznKn5QDity3m3xAjkGqXiADHSmaYTgcnoKnZ2N0zehd+zEDvU7OcbDhlNU4vvH6U5T8x+lJlp6k1xCrcYwMcUtqBGME5bvTH+4PpRF/q6zNL6F4yo4IXj6Ux5SFHtUNt0qR/vCrWqE9CJpJnPyqDzzTkyfldcY7GnjgjHHP8AWmXh/fj61PLpcOYQvhSB27UqSru+cHp0qsv3j9asJyzZqWihiT5k6FSPWrEkyjB3ckUycAXHAH3arTfdFJFJXLCSHd97g1JLJlR3FUk61Of4PpT6DktQVmC9MCqtzCkrHrn2qy33GqCD/VUrXAovbBRuPH9agJWMYJxWtOP3Q+tYt5940mktieZsVfLbJHWnwHaxx3/Wom/1Y+lOtuv4U0tRSkXPO2ADHNNkuNqnJOfrUMtUWJMoz61rYybJXILFmGcdKoXdysannjPT3qa4J3HntWJc83g+lOxm5dCQOXfzJ2yeyVWu7vf8u8getLc/dFZh/i+tVYVyzHumcIMkk1pW2lPkGTr6U7w8AWOQDXTwgZHFO5PUy7ezxjKgVuWFjgg4GMVXbqta9n9wUrlJEM8Sg/KBVXyW3gkcVonr+NTRgYPAqZLqVHRFCG0XOdvWifT/ADG2joe1aKd6cn+s/Gpa0HfUyYtM8tggxWhBaqq7QcGrR+/TB/rjUqNir3K4CpvDnAWiOJJAGzkDuakugDG+R2pLIfuabWtgj8JM2VGFHSmnDDLVYT7hqt/GaUtAWo9Y9w4qxGqhMEDNMh6GpF6ULQGxyoF4xTSMKQtWR91ahfvTeiEnqU33YJojumTHB+lS9mqtddayemxrFXNO3uA0ec04TktjHFZNkT61pJ94fSjmuNxsTgeYvzdKUQxx8gE1PGBs6VAv3m/GtEjNskXuFH51NG4jBGPmqOHpTl/1hq2rkoS4mdUJb8BWeLgM5wauXnSswj5qzbuyopI2NLugjSJM5hjkKssgGfLdTlWx3HUGtFkjR5JgthbM4INxHOZMAjkpH1yc9+lYcf3D9KRBwKpOwpR1JdSnFxdM6KY4lURxoeoRRgZ9/wDGiqU33/xoq7Af/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Solar lentigines presenting as brown macules on the dorsum of the hand",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple brown macules are present on the dorsal hand.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_32_12808=[""].join("\n");
var outline_f12_32_12808=null;
var title_f12_32_12809="Pathogenesis, clinical features, and diagnosis of pediatric multiple sclerosis";
var content_f12_32_12809=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis, clinical features, and diagnosis of pediatric multiple sclerosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/32/12809/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/32/12809/contributors\">",
"     Timothy E Lotze, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/32/12809/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/32/12809/contributors\">",
"     Marc C Patterson, MD, FRACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/32/12809/contributors\">",
"     Francisco Gonzalez-Scarano, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/32/12809/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/32/12809/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/32/12809/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple sclerosis (MS) is typically considered to be a disease of young adults. However, pediatric MS, defined as onset of MS before the age of 18, is increasingly recognized. This disorder was previously known as early onset MS (EOMS) or juvenile MS.",
"   </p>",
"   <p>",
"    Since pediatric MS is rare, clinicians who see a child with recurrent episodes of acute neurologic symptoms and white matter lesions on magnetic resonance imaging (MRI) might initially consider a differential diagnosis that includes leukodystrophies, vasculopathies, sarcoidosis, lymphoma, mitochondrial defects, and other metabolic disorders, rather than MS. However, the calculated prevalence of pediatric MS (1.35 to 2.5 per 100,000 children) is in fact very similar to that of all forms of metachromatic leukodystrophy (2.5 per 100,000 births) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given the availability of disease-modifying therapies for MS and the impact on future prognosis, it is important to consider the possibility of pediatric MS in all children with white matter disease.",
"   </p>",
"   <p>",
"    The presentations, diagnostic evaluations, treatments, and prognosis for children with MS may differ from those of the more common adult form, and have been the subject of relatively few studies. Nevertheless, research in pediatric MS may provide clues into the underlying genetic substrate and environmental events that trigger this disease in both children and adults.",
"   </p>",
"   <p>",
"    This topic will discuss the pathogenesis, clinical features, diagnosis, and differential diagnosis of pediatric MS. The treatment and prognosis of pediatric MS is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/32/21000?source=see_link\">",
"     \"Treatment and prognosis of pediatric multiple sclerosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple sclerosis presents before the age of 18 in approximately 5 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. Less than 1 percent of patients have onset of MS before the age of 10 years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/1\">",
"     1",
"    </a>",
"    ]. Pediatric MS affects girls more than boys, with a female to male ratio of 2.8 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MS is a rare disease in the pediatric population, with an estimated frequency of 1.35 to 2.5 per 100,000 children. In the United States, it is estimated that there are 8000 to 10,000 children with MS [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple sclerosis (MS) is caused by dysregulation of the peripheral immune system leading to injury in the central nervous system. Its pathogenesis requires the combination of a genetically susceptible individual and a particular environmental trigger.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Genetic susceptibility",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evidence supporting genetic susceptibility comes from risk projections for the development of MS in family members of affected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/7\">",
"     7",
"    </a>",
"    ]. In general, the lifetime risk of MS in first-degree relatives of MS patients is five percent. Studies of monozygotic twins have consistently demonstrated an even higher risk (ie, concordance) of 25 percent for the development of MS [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/8\">",
"     8",
"    </a>",
"    ], whereas the risk for dizygotic twins is similar to that for first-degree relatives.",
"   </p>",
"   <p>",
"    Twin studies have suggested a non-Mendelian inheritance pattern for MS that likely reflects complex interactions between a number of immunologic, neuroprotective, and myelin-related genes [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/9\">",
"     9",
"    </a>",
"    ]. Certain immunologic human leukocyte antigen (HLA) genes are associated with an increased risk for the development of MS, including haplotypes HLA DRB1*1501, DQA1*0102, and DQB1*0602 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/10\">",
"     10",
"    </a>",
"    ]. The HLA-DR15 haplotype has been strongly associated with early disease onset in the MS population [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Environmental triggers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Environmental exposure to a specific infectious agent during a window of immunologic vulnerability in childhood may predispose some individuals to the development of MS [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/11\">",
"     11",
"    </a>",
"    ]. Many viral and bacterial pathogens have been putatively linked to demyelination. Of these, the Epstein-Barr virus (EBV) has attracted much attention.",
"   </p>",
"   <p>",
"    Exposure to EBV results in persistent B-cell infection, expansion of EBV-transformed B-cell clones, and the production of antibodies directed against specific EBV viral antigens as well as lifelong T-cell surveillance of infected B-cells [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/12\">",
"     12",
"    </a>",
"    ]. EBV nuclear antigen has a similar structure to myelin basic protein, a major component of central nervous system (CNS) myelin. T-cells directed against EBV antigens may be redirected to attack CNS myelin because of similarity between the antigens, a process termed molecular mimicry.",
"   </p>",
"   <p>",
"    Adults with MS have near 100 percent seropositivity for EBV in comparison with 80 to 90 percent of healthy controls, a statistically significant difference. Nevertheless, given the high frequency of this infection in the general population, the pathobiologic significance remains uncertain.",
"   </p>",
"   <p>",
"    Evidence of an etiologic role for EBV in MS may be stronger in the pediatric than the adult population. As examples, a multinational study found that serologic evidence for remote EBV infection was significantly higher in children with MS compared with age-matched controls (86 versus 64 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/13\">",
"     13",
"    </a>",
"    ], and similar results were reported in case-control studies from Canada and Germany [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because the pathogenesis of MS is thought to involve the immune system, it has been hypothesized that vaccination may increase the risk of developing MS. However, substantial evidence exists that there is no association between vaccines and MS in adults. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32458?source=see_link&amp;anchor=H4#H4\">",
"     \"Epidemiology and clinical features of multiple sclerosis in adults\", section on 'Role of immune system stimuli'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, a well-performed large population-based case-control study in children found that vaccination against hepatitis B was not associated with an increased risk of childhood-onset MS [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is a higher prevalence of multiple sclerosis at more northern latitudes, which has prompted other environmental considerations for the disease. Specific interest has arisen with vitamin D, which requires exposure of the skin to ultraviolet radiation for its normal biosynthesis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32458?source=see_link&amp;anchor=H6#H6\">",
"     \"Epidemiology and clinical features of multiple sclerosis in adults\", section on 'Geographic factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On a sunny day, up to 20,000 IU of vitamin D can be produced by cutaneous exposure for 15 minutes. Vitamin D is known to have immunoregulatory effects that include enhancing regulatory T-cell activity, upregulation of anti-inflammatory molecules, and downregulation of pro-inflammatory cytokines [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/17\">",
"     17",
"    </a>",
"    ]. Benefit of treatment with 1,25 dihydroxy-vitamin D has been demonstrated in the experimental autoimmune encephalomyelitis animal model [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/17\">",
"     17",
"    </a>",
"    ]. In addition, vitamin D may have important perinatal effects on normal immune system regulation that persist over a lifetime. One study demonstrated a greater risk of MS for patients born in the month of May in countries of more northern latitude but a lower risk if born in November, suggesting gestation during winter months with less sunlight might adversely affect normal vitamin D production in the fetus [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/18\">",
"     18",
"    </a>",
"    ]. Other studies have found an inverse correlation between serum 25-hydroxyvitamin D levels and the risk for developing multiple sclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. The greatest risk reduction was found for individuals with higher levels under the age of 21 years. A small study of pediatric multiple sclerosis found that there was a 34 percent decrease in attacks for every 10",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    increase in the level of circulating 25-hydroxyvitamin D [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple sclerosis (MS) is characterized by recurrent episodes of demyelination in the central nervous system (CNS) separated in space and time. Acute inflammation and demyelination in a critical area of the brain, optic nerves, or spinal cord will produce a corresponding clinical deficit. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32458?source=see_link&amp;anchor=H9#H9\">",
"     \"Epidemiology and clinical features of multiple sclerosis in adults\", section on 'Clinical symptoms and signs'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H116553095\">",
"    <span class=\"h2\">",
"     Presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with MS generally have a similar clinical presentation to adults. However, a European observational study of 394 children with pediatric-onset MS and 1775 patients with adult-onset MS found that children were more likely than adults to present with isolated optic neuritis, an isolated brainstem syndrome, or symptoms of encephalopathy (ie, headache, vomiting, seizure, or altered consciousness) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/5\">",
"     5",
"    </a>",
"    ]. In addition, a multinational observational study of 137 children with MS reported that the first MS attack resembled acute disseminated encephalomyelitis (ADEM), on the basis of multifocal symptoms with encephalopathy, in 16 percent of children [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/13\">",
"     13",
"    </a>",
"    ]. The mean age of children with ADEM-like presentations (7.4 years) was significantly younger than children with multifocal (11.2 years) or monofocal (12.0 years) presentations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/52/25416?source=see_link\">",
"     \"Acute disseminated encephalomyelitis in children: Pathogenesis, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H116553109\">",
"    <span class=\"h2\">",
"     Course",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 85 to 90 percent of affected adults have relapsing-remitting multiple sclerosis (RRMS) with a clinical course characterized by intermittent attacks of increased disability followed by either partial or complete recovery to their baseline functioning. In children, RRMS is the initial form of MS in 97 to 99 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/2,5,13,22,23\">",
"     2,5,13,22,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Primary progressive multiple sclerosis (PPMS), a disease type characterized by continuous disability over time in the absence of specific attacks, is much less common than RRMS in children and adults. The rarity of PPMS in children should prompt the clinician to carefully exclude other possibilities that can be confused with it, including leukodystrophies, inborn errors of metabolism, mitochondrial disease, and neuromyelitis optica (Devic disease). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1352?source=see_link&amp;anchor=H9#H9\">",
"     \"Differential diagnosis of acute central nervous system demyelination in children\", section on 'Neuromyelitis optica'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H116553222\">",
"    <span class=\"h2\">",
"     Fatigue and depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fatigue is one of the most common problems affecting children with MS [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/24-29\">",
"     24-29",
"    </a>",
"    ]. Fatigue may result simply from typical daily stressors encountered at school or home. It can also be related to deconditioning, becoming more pronounced in the setting of demyelinated nerve fibers.",
"   </p>",
"   <p>",
"    The prevalence of depression in children with MS ranges from 20 to 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/24-26,28,30,31\">",
"     24-26,28,30,31",
"    </a>",
"    ]. Depression is often associated with fatigue in this patient population [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H116553116\">",
"    <span class=\"h2\">",
"     Cognitive symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cognitive impairment is a common manifestation of MS in adults, and is increasingly recognized in children with MS [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/4,24-26,30,32\">",
"     4,24-26,30,32",
"    </a>",
"    ]. Cognitive deficits may include problems with general cognition, information processing, language, visuomotor integration, and verbal and visual memory. Although the degree of cognitive dysfunction may be related to the duration and severity of MS, cognitive problems can also occur in children with no physical disability.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Diagnostic criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The McDonald diagnostic criteria for MS, first published in 2001 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/33\">",
"     33",
"    </a>",
"    ] and revised in 2005 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/34\">",
"     34",
"    </a>",
"    ], were revised again in 2010 in order to incorporate newer evidence [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/35-37\">",
"     35-37",
"    </a>",
"    ] and to simplify the use of neuroimaging while preserving the sensitivity and specificity of the criteria for the diagnosis MS [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/38\">",
"     38",
"    </a>",
"    ]. The McDonald criteria have a high sensitivity and specificity for the diagnosis of pediatric MS when applied to children &ge;11 years of age without features suggestive of acute disseminated encephalomyelitis (see",
"    <a class=\"local\" href=\"#H12036727\">",
"     'Unusual presentations'",
"    </a>",
"    below) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The core requirement of the diagnosis is the objective demonstration of dissemination of lesions in both space and time, based upon either clinical findings alone or a combination of clinical and MRI findings.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Dissemination in space",
"      </strong>",
"      is demonstrated on MRI by one or more T2 lesions in at least two of four MS-typical regions of the CNS (periventricular, juxtacortical, infratentorial, or spinal cord)",
"      <strong>",
"       or",
"      </strong>",
"      by the development of a further clinical attack implicating a different central nervous system site [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/38\">",
"       38",
"      </a>",
"      ]. For patients with brainstem or spinal cord syndromes, symptomatic MRI lesions are excluded from the criteria and do not contribute to lesion count [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/38\">",
"       38",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The International Panel on Diagnosis of MS concluded that the 2010 McDonald criteria for dissemination in space will also be useful for most pediatric patients with MS, especially those with acute demyelination presenting as a clinically isolated syndrome, because most pediatric patients will have more than two lesions and are very likely to have lesions in two of the four specified CNS locations (periventricular, brainstem-infratentorial, juxtacortical, or spinal cord) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Dissemination in time",
"      </strong>",
"      is demonstrated on MRI by the simultaneous presence of asymptomatic gadolinium-enhancing and nonenhancing lesions at any time, or a new T2",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      gadolinium-enhancing lesion(s) on follow-up MRI, irrespective of its timing with reference to a baseline scan,",
"      <strong>",
"       or",
"      </strong>",
"      by the development of a second clinical attack [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The McDonald criteria can only be applied after careful clinical evaluation of the patient. The amount of additional data needed to confirm the diagnosis of MS depends upon the clinical presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/38\">",
"     38",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with two or more attacks who have objective clinical evidence of two or more lesions or objective clinical evidence of one lesion with reasonable historical evidence of a prior attack, no additional data are required. However, it is desirable to make the diagnosis of MS with access to imaging. If MRI or other tests (eg, cerebrospinal fluid) are negative, alternative diagnoses must be considered. There must be no better explanation for the clinical presentation, and objective evidence must be present to support a diagnosis of MS.",
"     </li>",
"     <li>",
"      For patients with two or more attacks who have objective clinical evidence of one lesion, the criteria require evidence of",
"      <strong>",
"       dissemination in space",
"      </strong>",
"      .",
"     </li>",
"     <li>",
"      For patients with one attack who have objective clinical evidence of two or more lesions, the criteria require evidence of",
"      <strong>",
"       dissemination in time",
"      </strong>",
"      .",
"     </li>",
"     <li>",
"      For patients with one attack who have objective clinical evidence of one lesion (ie, a clinically isolated syndrome), the criteria require evidence of",
"      <strong>",
"       dissemination in space and time",
"      </strong>",
"      .",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Until 2006, the Poser criteria were considered most useful in making a diagnosis of pediatric MS (",
"    <a class=\"graphic graphic_table graphicRef62382 \" href=\"UTD.htm?14/57/15260\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/40\">",
"     40",
"    </a>",
"    ]. These criteria were developed prior to the widespread use of MRI and rely upon the clinical presentation of symptoms separated in space and time. While MS is now diagnosed with utilization of MRI in most of the developed world, the Poser criteria remain a part of the diagnostic paradigm in countries where MRI is not readily accessible. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/19/35130?source=see_link&amp;anchor=H2#H2\">",
"     \"Diagnosis of multiple sclerosis in adults\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12036727\">",
"    <span class=\"h3\">",
"     Unusual presentations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The McDonald criteria should",
"    <strong>",
"     not",
"    </strong>",
"    be applied for children who present with encephalopathy and multifocal neurological deficits, and should be applied only with caution for children who present with insidious neurological progression [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/38,39\">",
"     38,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 15 to 20 percent of children diagnosed with MS initially present with encephalopathy and multifocal neurological deficits suggestive of acute disseminated encephalomyelitis (ADEM) and most such children are younger than age 11 years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/13,38,41\">",
"     13,38,41",
"    </a>",
"    ]. Lesions associated with ADEM are typically bilateral but may be asymmetric and tend to be poorly marginated. Almost all patients have multiple lesions in the deep and subcortical white matter. In addition, children with early-onset MS (younger than 11) tend to have larger and less well-defined brain lesions than the more typical MS lesions seen in teenagers [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/42\">",
"     42",
"    </a>",
"    ]. Thus, in children younger than age 11 with encephalopathy and multifocal neurologic deficits, application of the revised 2010 McDonald criteria for dissemination in space and time on initial MRI is considered inappropriate, and continued follow-up of clinical and MRI findings are needed to confirm a diagnosis of MS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/52/25416?source=see_link&amp;anchor=H13#H13\">",
"     \"Acute disseminated encephalomyelitis in children: Pathogenesis, clinical features, and diagnosis\", section on 'Neuroimaging'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/52/25416?source=see_link&amp;anchor=H16#H16\">",
"     \"Acute disseminated encephalomyelitis in children: Pathogenesis, clinical features, and diagnosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As noted earlier, 97 to 99 percent children with MS present with a relapsing-remitting course (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Clinical features and diagnosis'",
"    </a>",
"    above). Primary progressive MS (PPMS) is considered extraordinary in children, and children who present with insidious neurological progression suggestive of PPMS should be carefully evaluated for alternative diagnoses [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/38,43-46\">",
"     38,43-46",
"    </a>",
"    ]. For a diagnosis of PPMS, the McDonald criteria require evidence of one year of disease progression plus two of the three following criteria (for patients with brainstem or spinal cord syndromes, symptomatic MRI lesions are excluded from the criteria and do not contribute to lesion count):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dissemination in space",
"      <strong>",
"       in the brain",
"      </strong>",
"      based upon one or more T2 lesions in at least two of four MS-typical regions of the central nervous system (periventricular, juxtacortical, infratentorial, or spinal cord)",
"     </li>",
"     <li>",
"      Dissemination in space",
"      <strong>",
"       in the spinal cord",
"      </strong>",
"      based upon two or more T2 lesions in the cord",
"     </li>",
"     <li>",
"      Positive cerebrospinal fluid findings with isoelectric focusing evidence of oligoclonal bands",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      elevated IgG index",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Clinically isolated syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;A clinically isolated syndrome (CIS) is a single monosymptomatic attack compatible with MS, such as optic neuritis. Approximately 80 percent of pediatric-onset and almost all adolescent-onset MS cases present with attacks similar to those seen in adult CIS [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/15/37112?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinically isolated syndromes suggestive of multiple sclerosis\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An episode of CIS can create diagnostic and therapeutic dilemmas (",
"    <a class=\"graphic graphic_algorithm graphicRef73311 \" href=\"UTD.htm?18/19/18750\">",
"     algorithm 1",
"    </a>",
"    ). The majority of children will not have recurrence after a single demyelinating event of the central nervous system (CNS). Clinical investigations, including brain MRI, cerebrospinal fluid analyses, and other laboratory studies, can provide useful information regarding which children are at higher risk for developing MS among those who have a CIS, but even with these studies, the ability to identify those at high risk for recurrence is inexact. In a cohort study from France that followed 296 children for an average of 2.9 years after a single acute CNS demyelinating event, the diagnosis of MS was confirmed in 57 percent of the children by the end of the study [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/50\">",
"     50",
"    </a>",
"    ]. Factors present at the time of the initial attack that were associated with an",
"    <strong>",
"     increased",
"    </strong>",
"    risk of a second demyelinating event included:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age 10 years or older (hazard ratio [HR] 1.67, 95% CI 1.04-2.67)",
"     </li>",
"     <li>",
"      Optic nerve lesions (HR 2.59, 95% CI 1.27-5.29)",
"     </li>",
"     <li>",
"      An MRI pattern typical for MS (ie, multiple well-limited periventricular or subcortical lesions) (HR 1.54, 95% CI 1.02-2.33)",
"      <br/>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Factors present at the time of initial attack that were associated with a",
"    <strong>",
"     decreased",
"    </strong>",
"    risk of a second attack included [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/50\">",
"     50",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Spinal cord lesions (HR 0.23, 95% CI 0.10-0.56)",
"     </li>",
"     <li>",
"      Acute mental status changes (HR 0.59, 95% CI 0.33-1.07)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As noted earlier, the McDonald criteria require evidence of dissemination in space and time for patients with a CIS to make a diagnosis of MS (see",
"    <a class=\"local\" href=\"#H7\">",
"     'Diagnostic criteria'",
"    </a>",
"    above). The 2010 McDonald criteria allow dissemination in time to be met on a single MRI demonstrating the presence of both gadolinium-enhancing and nonenhancing lesions. This includes the baseline MRI taken at the time of the patient&rsquo;s initial presentation. In the absence of meeting such criteria at initial presentation, careful monitoring with detailed neurologic examination, psychometric testing, and imaging studies should be employed. A repeat MRI performed at any time after the initial study (most likely about one to two months later) that shows a single new T2",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    gadolinium-enhancing lesion will also fulfill the dissemination in time criteria. Such close surveillance allows for early diagnosis and initiation of immunomodulatory therapies that may prevent greater disability over time. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/32/21000?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment and prognosis of pediatric multiple sclerosis\", section on 'Interferons and glatiramer'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Brain MRI",
"    </span>",
"    &nbsp;&mdash;&nbsp;A typical pattern consistent with MS on MRI is that of multiple well-demarcated lesions in the periventricular, juxtacortical, infratentorial, and spinal cord white matter. These areas of demyelination are best recognized on T2-weighted sequences. T2 fluid-attenuated inversion recovery (FLAIR) image sequences are the most sensitive in this evaluation, especially for periventricular lesions (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82694 \" href=\"UTD.htm?12/15/12528\">",
"     image 1",
"    </a>",
"    ). T1-weighted sequences may demonstrate \"black holes\" or T1 hypointense lesions that represent complete tissue loss resulting from a previous inflammatory event (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82694 \" href=\"UTD.htm?12/15/12528\">",
"     image 1",
"    </a>",
"    ). Enhancement of active areas of inflammation and blood-brain barrier compromise can be seen with T1 gadolinium contrast sequences.",
"   </p>",
"   <p>",
"    In patients with an acquired demyelinating syndrome, brain MRI can be helpful for assessing risk of developing MS. In a prospective population-based cohort study of 302 children from Canada presenting with an acquired demyelinating syndrome who were followed for a median time of three years, the diagnosis of MS was made in 63 (21 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/51\">",
"     51",
"    </a>",
"    ]. The factors most strongly associated with the risk of MS were the presence of one or more T2 lesions on initial brain MRI (HR 37.9, 95% CI 5.3-273.9) and the presence of oligoclonal bands in the cerebrospinal fluid (HR 6.33, 95% CI 3.4-12). A subsequent report analyzed 284 children from the same cohort using a multivariate model of MRI parameters of MS and found the likelihood of MS was predicted by the presence on baseline brain MRI of either one or more hypointense T1 lesions (HR 20.6, 95% CI 5.5-78.0) or one or more periventricular lesions (HR 3.3, 95% CI 1.3-8.8) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/52\">",
"     52",
"    </a>",
"    ]. The risk of MS was highest when both findings were noted (HR 34.3, 95% CI 16.7-70.4).",
"   </p>",
"   <p>",
"    Retrospective data suggest that children at MS onset have more T2 bright lesions in the posterior fossa and more gadolinium enhancing lesions than adults [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/47\">",
"     47",
"    </a>",
"    ]. In addition, the lesions in children were more likely to be reversible on follow-up imaging than lesions in adults, suggesting better recovery of demyelination in children.",
"   </p>",
"   <p>",
"    While rare, some children are found to have large, tumor-like demyelinating lesions (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef60288 \" href=\"UTD.htm?29/55/30591\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/53\">",
"     53",
"    </a>",
"    ]. Some of these patients may have only modest neurologic deficits despite the remarkable size of these lesions. It is important to consider tumefactive demyelination in this setting so as to avoid unnecessary brain biopsy. Distinguishing characteristics might include the presence of \"black holes\" and MRI of the spine showing areas of demyelination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Cerebrospinal fluid analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Detection of increased discrete immunoglobulin production solely within the cerebrospinal fluid (CSF) is often useful for supporting the diagnosis of MS. A positive CSF is based upon the finding of either oligoclonal IgG bands (OCBs) different from any such bands in serum, or by an increased IgG index. The 2001 and 2005 McDonald criteria stated that a positive CSF in association with the development of new lesions on serial MRI scanning can be used to make the diagnosis of MS, even in those patients with a single clinical attack [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/33\">",
"     33",
"    </a>",
"    ]. However, in contrast to the earlier 2001 and 2005 McDonald criteria, the CSF findings are not incorporated into the 2010 criteria for dissemination in space except for the diagnosis of primary progressive MS.",
"   </p>",
"   <p>",
"    Children with MS may have a different CSF profile than adults [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/54\">",
"     54",
"    </a>",
"    ]. However, data are limited to mainly small retrospective studies, and these have yielded inconsistent results, with positive OCBs reported in 8 to 92 percent, elevated IgG index in 64 to 75 percent, and pleocytosis in 33 to 73 percent of children with MS [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/55-60\">",
"     55-60",
"    </a>",
"    ]. In addition to chance, the wide disparities between these studies may be related to differences in patient age, timing of lumbar puncture, and laboratory methods used to analyze CSF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Evoked potentials",
"    </span>",
"    &nbsp;&mdash;&nbsp;Visual evoked potentials and somatosensory evoked potentials are electrophysiologic tests that provide information on the integrity of axons and their surrounding myelin. In adults, these studies provide supportive evidence for demyelination in the optic nerve, brainstem, or spinal cord [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/61\">",
"     61",
"    </a>",
"    ]. While abnormal findings supportive of demyelination have been described in pediatric series, their direct utility in confirming a diagnosis of MS is not yet defined [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12809/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple sclerosis is still largely a diagnosis of exclusion, and therefore requires intense investigation for other conditions that might present in a similar manner (",
"    <a class=\"graphic graphic_table graphicRef70259 \" href=\"UTD.htm?19/55/20347\">",
"     table 2",
"    </a>",
"    ). The Figure provides a diagnostic algorithm for various demyelinating diseases of childhood (",
"    <a class=\"graphic graphic_algorithm graphicRef73311 \" href=\"UTD.htm?18/19/18750\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1352?source=see_link\">",
"     \"Differential diagnosis of acute central nervous system demyelination in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the setting of nonspecific cerebrospinal fluid abnormalities and MRI evidence of white matter lesions, various inflammatory, demyelinating, infectious, metabolic, and rheumatologic conditions should be considered, including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Acute disseminated encephalomyelitis (ADEM)",
"     </li>",
"     <li>",
"      Optic neuritis",
"     </li>",
"     <li>",
"      Transverse myelitis",
"     </li>",
"     <li>",
"      Neuromyelitis optica (Devic disease)",
"     </li>",
"     <li>",
"      Central nervous system malignancies",
"     </li>",
"     <li>",
"      Leukodystrophies",
"     </li>",
"     <li>",
"      Mitochondrial disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most important alternative diagnosis to MS is ADEM, a more common and a temporally limited disorder than pediatric MS. At initial presentation, the two disorders cannot be distinguished with absolute certainty (",
"    <a class=\"graphic graphic_algorithm graphicRef73311 \" href=\"UTD.htm?18/19/18750\">",
"     algorithm 1",
"    </a>",
"    ). In children, subsequent attacks of MS may not occur for months or years. Furthermore, a small subset of children with ADEM may eventually develop MS, but it is difficult to accurately predict which patients will do so. Therefore, prolonged follow-up is required to establish a diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1352?source=see_link&amp;anchor=H6#H6\">",
"     \"Differential diagnosis of acute central nervous system demyelination in children\", section on 'Distinguishing ADEM and multiple sclerosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/31/40447?source=see_link\">",
"       \"Patient information: Multiple sclerosis in adults (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/47/17138?source=see_link\">",
"       \"Patient information: Multiple sclerosis in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pediatric multiple sclerosis (MS), defined as onset of MS before the age of 18, is increasingly recognized. MS begins before the age of 18 in at least 5 percent of patients who have MS, while onset before age 10 occurs in less than 1 percent. Nevertheless, pediatric MS is a rare disease, with an estimated frequency of 1.35 to 2.5 per 100,000 children. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MS is caused by dysregulation of the peripheral immune system leading to injury in the central nervous system. Its pathogenesis requires the combination of a genetically susceptible individual and a particular environmental trigger. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MS is characterized by recurrent episodes of demyelination in the central nervous system (CNS) separated in space and time. Children with MS typically present with a clinically isolated syndrome such as optic neuritis, transverse myelitis, or a brainstem syndrome. A minority of children present with symptoms of encephalopathy (ie, headache, vomiting, seizure, or altered consciousness). In addition, the first attack of MS can resemble acute disseminated encephalomyelitis (ADEM) on the basis of multifocal symptoms with encephalopathy in approximately 16 to 20 percent of children, most of whom are younger than age 11. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical features and diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinically isolated syndromes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The McDonald diagnostic criteria for MS require objective evidence of dissemination of demyelinating central nervous system lesions in both space and time, based upon either clinical findings alone or a combination of clinical and MRI findings. In a number of patients, the diagnosis of MS can be made with these criteria even in the absence of new clinical findings, and, for some patients, at the time of the initial attack. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnostic criteria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A clinically isolated syndrome (CIS) is a single monosymptomatic attack compatible with MS, such as optic neuritis. An episode of CIS can create a diagnostic and therapeutic dilemma. Most children will not have recurrence after a single demyelinating event of the CNS. However, the risk is probably high enough to be concerning, though as yet not defined precisely. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinically isolated syndromes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most important alternative diagnosis to MS is acute disseminated encephalomyelitis (ADEM) (",
"      <a class=\"graphic graphic_table graphicRef70259 \" href=\"UTD.htm?19/55/20347\">",
"       table 2",
"      </a>",
"      ). At the initial presentation, the two disorders cannot be distinguished with absolute certainty. While certain clinical features may be helpful in supporting the diagnosis of ADEM or MS, there is substantial overlap. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/1\">",
"      Gadoth N. Multiple sclerosis in children. Brain Dev 2003; 25:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/2\">",
"      Boiko A, Vorobeychik G, Paty D, et al. Early onset multiple sclerosis: a longitudinal study. Neurology 2002; 59:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/3\">",
"      Duquette P, Murray TJ, Pleines J, et al. Multiple sclerosis in childhood: clinical profile in 125 patients. J Pediatr 1987; 111:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/4\">",
"      Bigi S, Banwell B. Pediatric multiple sclerosis. J Child Neurol 2012; 27:1378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/5\">",
"      Renoux C, Vukusic S, Mikaeloff Y, et al. Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007; 356:2603.",
"     </a>",
"    </li>",
"    <li>",
"     Pediatric MS information for health professionals.  www.nationalmssociety.org/for-professionals/healthcare-professionals/pediatric-ms/index.aspx (Accessed on September 19, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/7\">",
"      Oksenberg JR, Hauser SL. Genetics of multiple sclerosis. Neurol Clin 2005; 23:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/8\">",
"      Willer CJ, Dyment DA, Risch NJ, et al. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A 2003; 100:12877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/9\">",
"      Banwell BL. Pediatric multiple sclerosis. Curr Neurol Neurosci Rep 2004; 4:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/10\">",
"      Ramagopalan SV, Knight JC, Ebers GC. Multiple sclerosis and the major histocompatibility complex. Curr Opin Neurol 2009; 22:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/11\">",
"      Ascherio A, Munch M. Epstein-Barr virus and multiple sclerosis. Epidemiology 2000; 11:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/12\">",
"      Bray PF, Luka J, Bray PF, et al. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology 1992; 42:1798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/13\">",
"      Banwell B, Krupp L, Kennedy J, et al. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 2007; 6:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/14\">",
"      Alotaibi S, Kennedy J, Tellier R, et al. Epstein-Barr virus in pediatric multiple sclerosis. JAMA 2004; 291:1875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/15\">",
"      Pohl D, Krone B, Rostasy K, et al. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 2006; 67:2063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/16\">",
"      Mikaeloff Y, Caridade G, Rossier M, et al. Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. Arch Pediatr Adolesc Med 2007; 161:1176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/17\">",
"      VanAmerongen BM, Dijkstra CD, Lips P, Polman CH. Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr 2004; 58:1095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/18\">",
"      Willer CJ, Dyment DA, Sadovnick AD, et al. Timing of birth and risk of multiple sclerosis: population based study. BMJ 2005; 330:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/19\">",
"      Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 2007; 61:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/20\">",
"      Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296:2832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/21\">",
"      Mowry EM, Krupp LB, Milazzo M, et al. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol 2010; 67:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/22\">",
"      Gusev E, Boiko A, Bikova O, et al. The natural history of early onset multiple sclerosis: comparison of data from Moscow and Vancouver. Clin Neurol Neurosurg 2002; 104:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/23\">",
"      Simone IL, Carrara D, Tortorella C, et al. Course and prognosis in early-onset MS: comparison with adult-onset forms. Neurology 2002; 59:1922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/24\">",
"      Banwell BL, Anderson PE. The cognitive burden of multiple sclerosis in children. Neurology 2005; 64:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/25\">",
"      Amato MP, Goretti B, Ghezzi A, et al. Cognitive and psychosocial features of childhood and juvenile MS. Neurology 2008; 70:1891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/26\">",
"      Amato MP, Goretti B, Ghezzi A, et al. Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. Neurology 2010; 75:1134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/27\">",
"      Goretti B, Portaccio E, Ghezzi A, et al. Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis. Mult Scler 2012; 18:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/28\">",
"      Ketelslegers IA, Catsman-Berrevoets CE, Boon M, et al. Fatigue and depression in children with multiple sclerosis and monophasic variants. Eur J Paediatr Neurol 2010; 14:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/29\">",
"      MacAllister WS, Christodoulou C, Troxell R, et al. Fatigue and quality of life in pediatric multiple sclerosis. Mult Scler 2009; 15:1502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/30\">",
"      MacAllister WS, Belman AL, Milazzo M, et al. Cognitive functioning in children and adolescents with multiple sclerosis. Neurology 2005; 64:1422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/31\">",
"      MacAllister WS, Boyd JR, Holland NJ, et al. The psychosocial consequences of pediatric multiple sclerosis. Neurology 2007; 68:S66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/32\">",
"      Julian L, Serafin D, Charvet L, et al. Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network. J Child Neurol 2013; 28:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/33\">",
"      McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/34\">",
"      Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the \"McDonald Criteria\". Ann Neurol 2005; 58:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/35\">",
"      Swanton JK, Rovira A, Tintore M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 2007; 6:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/36\">",
"      Rovira A, Swanton J, Tintor&eacute; M, et al. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch Neurol 2009; 66:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/37\">",
"      Montalban X, Tintor&eacute; M, Swanton J, et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology 2010; 74:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/38\">",
"      Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/39\">",
"      Sadaka Y, Verhey LH, Shroff MM, et al. 2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Ann Neurol 2012; 72:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/40\">",
"      Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/41\">",
"      Mikaeloff Y, Adamsbaum C, Husson B, et al. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 2004; 127:1942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/42\">",
"      Chabas D, Castillo-Trivino T, Mowry EM, et al. Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype? Neurology 2008; 71:1090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/43\">",
"      Yeh EA, Chitnis T, Krupp L, et al. Pediatric multiple sclerosis. Nat Rev Neurol 2009; 5:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/44\">",
"      Banwell B, Ghezzi A, Bar-Or A, et al. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 2007; 6:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/45\">",
"      Venkateswaran S, Banwell B. Pediatric multiple sclerosis. Neurologist 2010; 16:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/46\">",
"      Hahn JS, Pohl D, Rensel M, et al. Differential diagnosis and evaluation in pediatric multiple sclerosis. Neurology 2007; 68:S13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/47\">",
"      Waubant E, Chabas D, Okuda DT, et al. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults. Arch Neurol 2009; 66:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/48\">",
"      Ghassemi R, Antel SB, Narayanan S, et al. Lesion distribution in children with clinically isolated syndromes. Ann Neurol 2008; 63:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/49\">",
"      Yeh EA, Weinstock-Guttman B, Ramanathan M, et al. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. Brain 2009; 132:3392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/50\">",
"      Mikaeloff Y, Suissa S, Vall&eacute;e L, et al. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr 2004; 144:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/51\">",
"      Banwell B, Bar-Or A, Arnold DL, et al. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol 2011; 10:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/52\">",
"      Verhey LH, Branson HM, Shroff MM, et al. MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study. Lancet Neurol 2011; 10:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/53\">",
"      McAdam LC, Blaser SI, Banwell BL. Pediatric tumefactive demyelination: case series and review of the literature. Pediatr Neurol 2002; 26:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/54\">",
"      Chabas D, Ness J, Belman A, et al. Younger children with MS have a distinct CSF inflammatory profile at disease onset. Neurology 2010; 74:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/55\">",
"      Riikonen R. The role of infection and vaccination in the genesis of optic neuritis and multiple sclerosis in children. Acta Neurol Scand 1989; 80:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/56\">",
"      Hanefeld F, Bauer HJ, Christen HJ, et al. Multiple sclerosis in childhood: report of 15 cases. Brain Dev 1991; 13:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/57\">",
"      Ruggieri M, Polizzi A, Pavone L, Grimaldi LM. Multiple sclerosis in children under 6 years of age. Neurology 1999; 53:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/58\">",
"      Ghezzi A, Pozzilli C, Liguori M, et al. Prospective study of multiple sclerosis with early onset. Mult Scler 2002; 8:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/59\">",
"      Pohl D, Rostasy K, Reiber H, Hanefeld F. CSF characteristics in early-onset multiple sclerosis. Neurology 2004; 63:1966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/60\">",
"      Atzori M, Battistella PA, Perini P, et al. Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study. Mult Scler 2009; 15:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/61\">",
"      Gronseth GS, Ashman EJ. Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 54:1720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12809/abstract/62\">",
"      Boutin B, Esquivel E, Mayer M, et al. Multiple sclerosis in children: report of clinical and paraclinical features of 19 cases. Neuropediatrics 1988; 19:118.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6229 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.25.216.6-3FB984B900-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_32_12809=[""].join("\n");
var outline_f12_32_12809=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Genetic susceptibility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Environmental triggers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL FEATURES AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H116553095\">",
"      Presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H116553109\">",
"      Course",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H116553222\">",
"      Fatigue and depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H116553116\">",
"      Cognitive symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Diagnostic criteria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12036727\">",
"      - Unusual presentations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Clinically isolated syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Brain MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Cerebrospinal fluid analysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Evoked potentials",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6229\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6229|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?18/19/18750\" title=\"algorithm 1\">",
"      Diagnosis of demyelinating clinical event",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6229|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?12/15/12528\" title=\"diagnostic image 1\">",
"      MRI pediatric MS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?29/55/30591\" title=\"diagnostic image 2\">",
"      Tumefactive pediatric MS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6229|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/57/15260\" title=\"table 1\">",
"      Poser criteria for MS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/55/20347\" title=\"table 2\">",
"      Diff dx pediatric MS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/52/25416?source=related_link\">",
"      Acute disseminated encephalomyelitis in children: Pathogenesis, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/15/37112?source=related_link\">",
"      Clinically isolated syndromes suggestive of multiple sclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/19/35130?source=related_link\">",
"      Diagnosis of multiple sclerosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1352?source=related_link\">",
"      Differential diagnosis of acute central nervous system demyelination in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32458?source=related_link\">",
"      Epidemiology and clinical features of multiple sclerosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/31/40447?source=related_link\">",
"      Patient information: Multiple sclerosis in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/47/17138?source=related_link\">",
"      Patient information: Multiple sclerosis in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/32/21000?source=related_link\">",
"      Treatment and prognosis of pediatric multiple sclerosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_32_12810="Pneumatic dilation and botulinum toxin injection for achalasia";
var content_f12_32_12810=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pneumatic dilation and botulinum toxin injection for achalasia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/32/12810/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/32/12810/contributors\">",
"     Linda Nguyen, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/32/12810/contributors\">",
"     Pankaj J Pasricha, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/32/12810/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/32/12810/contributors\">",
"     Nicholas J Talley, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/32/12810/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/32/12810/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/32/12810/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 7, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Achalasia is an esophageal smooth muscle motility disorder in which the lower esophageal sphincter (LES) fails to relax. It is thought to result from a selective loss of inhibitory nitrinergic neurons (which contain nitric oxide synthase) in the myenteric plexus, resulting in relatively unopposed excitation by the cholinergic system. Clinical symptoms include dysphagia, chest pain, regurgitation, heartburn, and weight loss. The diagnosis is confirmed by esophageal manometry.",
"   </p>",
"   <p>",
"    There is no cure for achalasia. Treatment is focused on palliating symptoms by decreasing LES pressure to facilitate emptying of esophageal contents. This can be accomplished by mechanical disruption of the muscle fibers of the LES (eg, with pneumatic dilation or surgical myotomy) or by biochemical reduction in LES pressure (eg, with injection of botulinum toxin). For patients at low surgical risk, treatment aimed at mechanical disruption of the LES is generally recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review the advantages and disadvantages of pneumatic dilatation and botulinum toxin injection for the management of achalasia. The pathophysiology, etiology, clinical manifestations, diagnosis, and surgical therapy of achalasia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/7/43124?source=see_link\">",
"     \"Pathophysiology and etiology of achalasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/26/14759?source=see_link\">",
"     \"Clinical manifestations and diagnosis of achalasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/39/18039?source=see_link\">",
"     \"Overview of the treatment of achalasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19001?source=see_link\">",
"     \"Operative management of achalasia: Laparoscopic and open Heller myotomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PNEUMATIC DILATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumatic dilation (PD) weakens the lower esophageal sphincter (LES) by tearing its muscle fibers. A number of different balloon dilators have been used (eg, Mosher bag, Sippy dilators, Brown-McHardy dilator, Rider-Moeller dilator), but most are no longer being manufactured. At present, the most popular pneumatic dilator in the United States is the Rigiflex balloon (Boston Scientific Corp, Boston, MA).",
"   </p>",
"   <p>",
"    The Rigiflex balloon is passed over a guidewire and positioned using fluoroscopy across the LES. The balloon is available in three different diameters (3.0, 3.5, and 4.0 cm). The smallest balloon is typically used for the first dilation. If symptoms persist, the procedure can be repeated with incrementally larger balloons (the so-called \"graded approach\").",
"   </p>",
"   <p>",
"    The standard approach to balloon dilatation is one dilation per session, with additional dilations being performed if symptoms persist or return. Patients are usually referred to surgery if three consecutive dilations do not provide symptom resolution.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Technique for PD",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient is advised to fast for at least 12 hours prior to the procedure. A liquid diet should be prescribed for one or two days preceding the dilation in patients with clinical or radiographic evidence of severe food retention within the esophagus.",
"   </p>",
"   <p>",
"    There is no consensus on the optimal method for performing PD. Reported protocols have varied widely with regard to the types of dilators used, the maximum diameter of the balloon (2.4 to 5.0 cm), the pressure to which the balloon is inflated (100 to &gt;1000 mmHg), the rate of balloon inflation (rapid versus gradual), the duration of balloon inflation (several seconds to five minutes), and the number of balloon inflations per dilating session (one to five) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. None of the variations in technique has led to significant changes in outcome.",
"   </p>",
"   <p>",
"    We use the Rigiflex balloon for PD [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/6\">",
"     6",
"    </a>",
"    ]. A 3.0 cm balloon is used for the initial dilation in most adults. Prior to the procedure, the balloon is inflated and checked for leaks or deformities.",
"   </p>",
"   <p>",
"    Prior to dilation, a thorough endoscopic examination is performed, with particular attention given to the cardia, where malignancy can simulate achalasia (called pseudoachalasia). A guidewire is then passed through the biopsy channel of the endoscope into the stomach and the scope is withdrawn to the gastroesophageal junction. The distance between the incisors and the gastroesophageal junction should be noted using the markings along the length of the scope.",
"   </p>",
"   <p>",
"    The endoscope is then removed, taking care to maintain the position of the guidewire in the stomach. To aid with initial balloon placement, a marker (such as paper tape) can be placed on the shaft of the dilating catheter corresponding to the previously noted distance between the incisors and the gastroesophageal junction. This distance should be measured from the middle of the balloon on the dilating catheter so that, when inserted, the middle of the balloon will be positioned across the LES.",
"   </p>",
"   <p>",
"    The balloon and tip of the catheter are lubricated and passed over the previously placed guidewire until the marker reaches the incisors. Using fluoroscopy, the balloon is then gradually inflated with air, noting the position of the developing \"waist\" in the balloon (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef66408 \" href=\"UTD.htm?24/19/24881\">",
"     image 1",
"    </a>",
"    ). Small adjustments usually have to be made in the position (deflating the balloon each time) to ensure that the waist occurs at the center of the balloon (this is critical for both efficacy and safety). We often inject a small volume of dilute contrast into the balloon to assist in radiographic visualization.",
"   </p>",
"   <p>",
"    Because patients may be extremely uncomfortable during balloon inflation, we find it useful to administer a dose of an opiate one to two minutes before the balloon is inflated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/22/24936?source=see_link\">",
"     \"Overview of procedural sedation for gastrointestinal endoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    After a satisfactory position is obtained, the balloon is fully inflated so that the waist is obliterated, taking note of the pressure within the balloon using an external gauge. In our experience, about 7 to 15 pounds per square inch (psi) of pressure is required for waist obliteration, which usually requires approximately 120 mL of air.",
"   </p>",
"   <p>",
"    Inflation is maintained for 60 seconds, after which, the balloon is rapidly deflated. We then perform a second full inflation for 60 seconds and again note the pressure required to obliterate the waist. This is usually at least 3 psi less than the initial pressure.",
"   </p>",
"   <p>",
"    After the second inflation, the deflated balloon and guidewire are removed and the patient is transferred to the recovery area. The patient is observed for five to six hours, since serious complications, such as perforation, will usually become clinically apparent within this time period [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/7-10\">",
"     7-10",
"    </a>",
"    ]. The patient is subsequently discharged if the recovery was uneventful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Efficacy of PD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 71 to 90 percent of patients respond initially to PD [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/11-14\">",
"     11-14",
"    </a>",
"    ], but many patients subsequently relapse. Although retrospective analyses of PD outcomes suggest good to excellent sustained responses in approximately two-thirds of patients, prospective studies suggest a less favorable prognosis, with more than 50 percent of patients relapsing over a five-year period [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. One-third to one-half of patients treated with PD will require at least one additional dilation, and a subset of these patients will require surgery.",
"   </p>",
"   <p>",
"    PD may not be equally effective for relieving all symptoms of achalasia. In one report, for example, PD had little effect on chest pain, which is present in approximately 40 to 60 percent of patients with achalasia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/17\">",
"     17",
"    </a>",
"    ]. In another study, chest pain continued after PD in about half of the patients who initially complained of this symptom [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/26/14759?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations and diagnosis of achalasia\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Short- to medium-term results",
"    </span>",
"    &nbsp;&mdash;&nbsp;Short- to medium-term results have been described in both retrospective and prospective studies. Retrospective studies are limited because patients for whom treatment was unsuccessful may have been lost to follow-up or referred elsewhere. In addition, many patients who continue to be symptomatic do not seek medical attention (38 percent in one series) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data from prospective reports are generally more reliable. Small (7 to 29 patients) prospective studies of PD using Rigiflex balloons reported success rates of 53 to 93 percent, but most had less than two years of follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Two larger prospective studies of about 50 patients each with longer follow-up had less favorable results with a remission rate of 26 to 40 percent after four years or more [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. However, a more recent prospective study of 77 patients had better results, with 70 percent of patients in remission after a median of 5.6 years of follow-up (range 3 to 10.7 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/14\">",
"     14",
"    </a>",
"    ], as did a randomized trial in which patients treated with PD had remission rates of 90 percent after a mean follow-up of 43 months [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    PD has also been studied in children with achalasia. In a prospective study of 24 children with achalasia who were followed for a median of six years (range two to seven years), the overall success rate following PD (up to three sessions) was 87 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/22\">",
"     22",
"    </a>",
"    ]. Older children were more likely to respond to PD than younger children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Long-term (&gt;10 year) results",
"    </span>",
"    &nbsp;&mdash;&nbsp;Achalasia is a chronic disease and patients may need to be followed for more than a decade to judge the success of treatment. However, few studies have addressed the outcome of PD after 10 years or more. Complete symptom resolution has been described in some patients followed for as long as 10 to 25 years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/7,23,24\">",
"     7,23,24",
"    </a>",
"    ]. However, data are conflicting with respect to the likelihood of maintenance of long-term remission:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A retrospective study of 153 patients found that, after five years, 76 percent of patients reported good to excellent symptom outcomes [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/25\">",
"       25",
"      </a>",
"      ]. Of the 35 patients with 15 or more years of follow-up, 18 (51 percent) reported good or excellent outcomes by the end of follow-up. The median time to symptom recurrence in this study was 11 years.",
"     </li>",
"     <li>",
"      In a retrospective report of 126 patients, 115 (91 percent) improved after one to three sessions of PD. The median dysphagia-free duration was 60 months [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a prospective study, 54 consecutive patients were followed every two years for a period of 10 years, with a mean follow-up of 14 years [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/16\">",
"       16",
"      </a>",
"      ]. The remission rate at five years after a single PD was 40 percent. Among the 21 patients in remission at five years, 18 remained in remission for an additional 10 years. Thus, patients whose symptoms were well controlled for five years were likely to continue to do well.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The value of repeated dilations after the first relapse has been difficult to evaluate objectively. In a prospective study of 54 patients cited above, only 35 percent of patients who received three dilations were in remission after five years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/16\">",
"     16",
"    </a>",
"    ]. However, a retrospective study of 150 patients suggested that repeated dilations may help improve long-term remission rates [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/12\">",
"     12",
"    </a>",
"    ]. In that study, 137 patients (91 percent) went into remission. Among the 25 patients who attained remission after one session of PD and did not undergo repeat PD, 67 percent were in remission at five years and 50 percent at 10 years. In contrast, the 112 patients who received repeated dilations as needed for recurrent symptoms (an \"on demand\" approach) had remission rates of over 90 percent at 10 years. Apart from the retrospective nature of this study, the higher response rate may also have been due to an older patient population. Studies have shown that older age is predictive of a better response to pneumatic dilation. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Predictors of outcome'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The results discussed above are from studies in which \"graded\" or \"on-demand\" dilations were performed. A less popular regimen (the \"progressive\" method) practiced in Europe consists of a series of progressively larger dilations on the same or successive days until \"satisfactory\" manometric (eg, lower esophageal sphincter pressure &lt;15 mmHg)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radiographic criteria are met. A retrospective study of 209 patients who underwent PD by this method found that the response to a single series of dilations was 66 percent at six years. Forty-nine patients with recurrent symptoms underwent a second series of dilations 6.5 years later with a 65 percent long-term success rate [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/18\">",
"     18",
"    </a>",
"    ]. These figures appear better than the graded method but these two methods have never been directly compared. At this time, it is not clear which method is more effective or safer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Predictors of outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two strongest predictors of outcome following PD are postdilation LES pressure and age [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/11,16,24,26\">",
"     11,16,24,26",
"    </a>",
"    ]. Male sex and patterns of esophageal contraction seen on manometry may also predict the response to PD.",
"   </p>",
"   <p>",
"    A postdilation decrease in LES pressure to approximately 10 mmHg has been suggested as a reasonable goal of PD [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/24\">",
"     24",
"    </a>",
"    ]. The value of achieving this goal was supported in the prospective study of 54 patients who were followed for 10 years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/16\">",
"     16",
"    </a>",
"    ]. Patients who achieved a postdilation pressure of less than 10 mmHg were much more likely to be in remission during follow-up compared with those with higher LES pressures (100 versus 23 percent).",
"   </p>",
"   <p>",
"    The significance of pretreatment LES pressure with regard to long-term response is unclear. Many studies have found that pretreatment LES pressure does not influence response rates [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/11,27,28\">",
"     11,27,28",
"    </a>",
"    ]. However, one study of 62 patients found that a pretreatment LES pressure &gt;50 mmHg was associated with a poor response [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Young age (&lt;40 years) predicts a poor response to pneumatic dilation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/12,16,26,29,30\">",
"     12,16,26,29,30",
"    </a>",
"    ]. As an example, in the prospective series of 54 patients discussed above, the remission rate in patients older than 40 was much higher than in younger patients (58 versus 16 percent at five years) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sex has also been implicated as a predictor of response [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/11,31\">",
"     11,31",
"    </a>",
"    ]. In a retrospective study of 49 men and 16 women, young men treated with a 3.0 cm balloon required repeat treatment more frequently than young women (hazard ratio 1.65) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/31\">",
"     31",
"    </a>",
"    ]. The authors concluded that young men may benefit from an initial PD with a 3.5 cm balloon.",
"   </p>",
"   <p>",
"    The pattern of esophageal contractions seen on high-resolution esophageal manometry may also predict treatment response. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Influence of achalasia subtype'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A number of other factors have been suggested to have a role in predicting the response to PD but none has proven to be a reliable predictor. These include duration of symptoms, the results of initial manometric studies, findings on nuclear emptying scintigraphy, the size of the balloon dilators used, and findings on postdilation",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    esophagrams [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/3,24,31-33\">",
"     3,24,31-33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     PD after failed myotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;PD has been studied as a treatment option in patients who have failed surgical myotomy for achalasia. The response to dilation in patients who have failed myotomy is not as good as the response seen in patients who are treatment naive. In one report, 22 of 139 patients undergoing PD had failed prior surgical myotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/34\">",
"     34",
"    </a>",
"    ]. A symptomatic response was seen in 50 percent of these patients compared with 74 percent of previously untreated patients.",
"   </p>",
"   <p>",
"    Concern had been raised that PD following failed myotomy may increase the risk of perforation. Among the 22 patients in the last study, PD following failed surgical myotomy was not associated with an increased risk of complications",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     PD after BT injection",
"    </span>",
"    &nbsp;&mdash;&nbsp;PD appears to be safe in patients who have previously received botulinum toxin (BT) injection and some authorities have advocated combination therapy with PD and BT injection.",
"   </p>",
"   <p>",
"    The efficacy of combined therapy was evaluated in a randomized controlled trial in which 90 patients with achalasia were assigned to BT injection, PD, or both BT injection and PD [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/35\">",
"     35",
"    </a>",
"    ]. The response rate at two years was significantly higher with combination therapy (57 percent versus 14 percent with BT injection and 36 percent with PD).",
"   </p>",
"   <p>",
"    A second randomized trial comparing combination therapy with PD alone found a non-statistically significant difference in remission rates at one year (77 versus 62 percent, p = 0.1) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/36\">",
"     36",
"    </a>",
"    ]. Similarly, a third randomized trial comparing PD plus BT with PD alone found a non-statistically significant trend toward greater five-year remission rate for the combined therapy (69 versus 50 percent; p = 0.07) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     PD during pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In women who are pregnant, the short-term efficacy of PD and surgical myotomy are similar, but PD is associated with a much lower risk of complications. As a result, PD should be attempted before surgical myotomy during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Complications of PD",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Esophageal perforation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal perforation occurs in approximately 3 to 5 percent of patients in most series, although the range varies from 0 to 21 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/39-42\">",
"     39-42",
"    </a>",
"    ]. In one series from a high-volume center that included 272 pneumatic dilations in 198 patients, only one patient had a perforation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/42\">",
"     42",
"    </a>",
"    ]. Perforations usually occur during the first dilation session, tend to be small, and are typically located above the cardia along the left side of the esophagus where there is an anatomic area of weakness.",
"   </p>",
"   <p>",
"    Patients with esophageal perforation usually present within a few hours after dilation. Findings that raise concern about perforation include tachycardia and chest pain following the procedure that lasts for more than four hours [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/7\">",
"     7",
"    </a>",
"    ]. Some authorities recommend a routine postdilation esophagram; however, many experts do not follow this approach. Instead, an esophagram is only ordered if the patient experiences symptoms discussed above.",
"   </p>",
"   <p>",
"    Several studies have evaluated risk factors for perforation. These include high amplitude esophageal contractions on manometry before the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/43\">",
"     43",
"    </a>",
"    ] and instability of the balloon during insufflation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/44\">",
"     44",
"    </a>",
"    ]. Neither of these predictors has been validated.",
"   </p>",
"   <p>",
"    The optimal management of esophageal perforation following PD has not been established. Perforations can often be managed with conservative treatment, such as antibiotics and parenteral nutrition [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/41,44-46\">",
"     41,44-46",
"    </a>",
"    ]. However, it is difficult to predict how a given patient will respond and most patients do well after surgical repair. Thus, many authorities advocate surgery in low-risk patients as soon as the diagnosis is confirmed, regardless of the size of the perforation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/57/10137?source=see_link\">",
"     \"Complications of endoscopic esophageal stricture dilation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinical deterioration or the presence of free-flowing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    into the mediastinum requires immediate thoracotomy and repair. Videothoracoscopic and endoscopic repair have also been performed in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/57/10137?source=see_link\">",
"     \"Complications of endoscopic esophageal stricture dilation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other complications of PD include bleeding, intramural hematomas, esophageal mucosal tears, and diverticula at the gastric cardia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/7,12,44\">",
"     7,12,44",
"    </a>",
"    ]. Postprocedural fever usually resolves spontaneously without antibiotics. Approximately 15 percent of patients complain of severe postprocedural chest pain that is self-limited. Chest pain following the procedure that lasts for more than four hours is suggestive of possible esophageal perforation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/7,12\">",
"     7,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite PD-induced disruption of the lower esophageal sphincter, which is the principal barrier to gastroesophageal reflux, gastroesophageal reflux disease is uncommon after pneumatic dilatation. A review of 1902 patients found an overall incidence of 2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     BOTULINUM TOXIN INJECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Botulinum neurotoxin type A is a potent inhibitor of the release of acetylcholine from nerve endings and has been used successfully to treat certain spastic disorders of skeletal muscle, such as blepharospasm and torticollis. It is also used in the treatment of spastic disorders of smooth muscle, including achalasia.",
"   </p>",
"   <p>",
"    The idea of using botulinum toxin (BT) in achalasia stems from an understanding of the pathophysiology of achalasia. Achalasia is caused by the selective loss of inhibitory neurons, which results in unopposed excitation of the lower esophageal sphincter (LES) by cholinergic neurons [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/49-51\">",
"     49-51",
"    </a>",
"    ]. BT can reduce the LES pressure by selectively blocking the release of acetylcholine from presynaptic cholinergic nerve terminals in the myenteric plexus, thereby restoring the balance between inhibitory and excitatory neurotransmitters [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/52\">",
"     52",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/7/43124?source=see_link\">",
"     \"Pathophysiology and etiology of achalasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to being used as a treatment for achalasia, a response to BT injection has been used to support the diagnosis of achalasia in patients in whom the diagnosis is uncertain based upon manometry [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/26/14759?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical manifestations and diagnosis of achalasia\", section on 'Standard manometry'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Technique for BT injection",
"    </span>",
"    &nbsp;&mdash;&nbsp;BT is injected during a routine upper endoscopy using a standard sclerotherapy needle that is passed through the accessory channel of the endoscope. As with pneumatic dilation, a thorough endoscopic examination is performed, with particular attention given to the cardia, where malignancy can simulate achalasia (called pseudoachalasia). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/26/14759?source=see_link&amp;anchor=H7#H7\">",
"     \"Clinical manifestations and diagnosis of achalasia\", section on 'Endoscopy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most common method for delivering BT involves visual estimation of the location of LES and injection of 1 mL aliquots (20 to 25 units",
"    <span class=\"nowrap\">",
"     BT/mL)",
"    </span>",
"    into each of four quadrants approximately 1 cm above the Z-line. The Z-line is the squamocolumnar junction, which corresponds to the gastroesophageal junction in the absence of Barrett's esophagus.",
"   </p>",
"   <p>",
"    The use of endoscopic ultrasound to identify the LES has been suggested as an aid for guiding injection, but there is no evidence that this improves efficacy. Manometrically-guided BT injection by means of a double-channel endoscope has also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/54\">",
"     54",
"    </a>",
"    ]. This may theoretically permit more precise targeting of the LES. However, absolute precision is probably not necessary, since BT diffuses for a limited distance in tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients are discharged from the endoscopy unit after routine post-sedation requirements have been met and are allowed to eat later in the day. An improvement in symptoms is usually observed after 24 hours, although peak effects occur later in some patients.",
"   </p>",
"   <p>",
"    Several formulations of BT are available. A comparison between Botox 100 units (Allergan, Irvine, USA) and Dysport 250 units (Ipsen, Milan, Italy) showed similar efficacy at up to six months of follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Efficacy of BT injection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial response rates to BT injection range from 70 to 90 percent, but many patients relapse within several months [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/57-67\">",
"     57-67",
"    </a>",
"    ]. The durability of the response may be improved by multiple treatment sessions, as is seen with the use of BT for other indications (eg, dystonia). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/52/12105?source=see_link&amp;anchor=H8#H8\">",
"     \"Treatment of dystonia\", section on 'Botulinum toxin injections'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The vast majority of studies also report an associated improvement in objective parameters, with the most commonly reported being a reduction in resting LES pressure, generally averaging around 40 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/19,57,61,68,69\">",
"     19,57,61,68,69",
"    </a>",
"    ]. Although less commonly reported, radiographic or scintigraphic measures also improve [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/57,70,71\">",
"     57,70,71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Short-term results (&lt;5 years)",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a systematic review, relapse rates of greater than 50 percent were seen in many studies within 6 to 12 months following a single treatment session [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/72\">",
"     72",
"    </a>",
"    ]. Better results were obtained in studies that used multiple treatment sessions, with clinical benefit seen in 60 to 85 percent of patients at two years.",
"   </p>",
"   <p>",
"    The following studies illustrate the range of findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 60 patients with idiopathic achalasia who were treated with BT injection, 70 percent had significant symptom improvement at one month following a single treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/60\">",
"       60",
"      </a>",
"      ]. Among the 33 patients with one-year follow-up, 36 percent continued to have a good or excellent response, whereas 39 percent had undergone a subsequent treatment (repeat injection, pneumatic dilation, or myotomy). A response was seen in six of seven patients who received a second injection of BT.",
"     </li>",
"     <li>",
"      A randomized trial suggested that the dose of BT and the dosing schedule may predict a response to treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/67\">",
"       67",
"      </a>",
"      ]. The trial included 118 patients who were randomly assigned to receive one of three doses of BT (50, 100, or 200 units). Patients assigned to the 100 unit dose were reinjected with an additional 100 units after 30 days. At 12 months, patients who received the two-dose schedule of 100 units were significantly more likely to be in remission (80 versus approximately 55 percent for the other two groups). On multivariate analysis, independent predictors of response included vigorous achalasia (odds ratio 3.3) and the two-dose regimen (odds ratio 3.2). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/26/14759?source=see_link&amp;anchor=H5#H5\">",
"       \"Clinical manifestations and diagnosis of achalasia\", section on 'Standard manometry'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Anecdotally, it appears that the response to BT injections is often less robust with subsequent injections. Antibodies to BT have been detected in patients who were secondary treatment failures for various indications. In one study, antibodies were found in 45 percent of patients who were secondary nonresponders [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/73\">",
"     73",
"    </a>",
"    ]. Despite concerns about neutralizing antibodies, one group was able maintain clinical remission with repeat BT injections every 10 months in 43 of 57 patients (75 percent) for four years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Predictors of response",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main predictors of a favorable outcome are older age and the presence of vigorous achalasia. This was illustrated in a study of 31 patients who were treated with BT and were followed prospectively for a median of 2.4 years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/66\">",
"     66",
"    </a>",
"    ]. A response beyond three months was significantly more likely in patients older than age 50 (82 versus 43 percent) and in patients with vigorous compared with classic achalasia (100 versus 52 percent). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/26/14759?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical manifestations and diagnosis of achalasia\", section on 'Standard manometry'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The pattern of esophageal contractions seen on high-resolution esophageal manometry may also predict treatment response (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Influence of achalasia subtype'",
"    </a>",
"    below.).",
"   </p>",
"   <p>",
"    Factors that are",
"    <strong>",
"     not",
"    </strong>",
"    reliable predictors of a response to BT injection include gender, duration of illness, mean number of previous dilations, initial characteristics on standard manometry (except for vigorous achalasia), and initial symptom scores [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/58,60,66\">",
"     58,60,66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Complications of BT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The low dose of BT used for treatment of achalasia has virtually no risk of causing generalized neuromuscular blockade. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=see_link\">",
"     \"Botulism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Reported complications include postprocedural transient chest pain (25 percent) and heartburn (5 percent). Esophageal wall injury and paraesophageal tissue inflammation are rare [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/74\">",
"     74",
"    </a>",
"    ]. Other reported complications have primarily been described in case reports:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Nonfatal mediastinitis following BT injection [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/75\">",
"       75",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Esophageal mucosal ulceration and sinus tract formation [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/76\">",
"       76",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Pneumothorax requiring drainage [",
"      <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/77\">",
"       77",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Long-term experience with BT injection in the gastrointestinal tract is limited, but it appears safe. Support for this conclusion comes from the observation that no significant mucosal or submucosal changes were seen during endoscopic ultrasound following treatment in a study of 18 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     COMPARATIVE STUDIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have compared the efficacy of pneumatic dilation (PD), botulinum toxin injection (BT), and surgical myotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/21,61,68,70,79-82\">",
"     21,61,68,70,79-82",
"    </a>",
"    ]. A meta-analysis from 2009 compared various treatments for achalasia in 17 randomized controlled trials with 761 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/79\">",
"     79",
"    </a>",
"    ]. With respect to longer-term symptom control, surgical myotomy was superior to both PD and BT injection, and PD was superior to BT injection. The authors noted that while BT injection is the least effective treatment, it is also the least expensive, low risk, and easily performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     PD versus BT injection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Five trials in the meta-analysis compared PD with BT injection in patients followed for at least 12 months [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/79\">",
"     79",
"    </a>",
"    ]. PD was associated with a significantly higher remission rate than BT injection (66 versus 38 percent), a significantly lower relapse rate (17 versus 50 percent), and a longer time to relapse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     BT injection or PD versus laparoscopic myotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two trials in the meta-analysis compared BT injection with laparoscopic myotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/79\">",
"     79",
"    </a>",
"    ]. During the first six months after treatment, there was no difference between the groups with regard to symptom recurrence. However, after one year, laparoscopic myotomy was associated with a significantly higher rate of persistent efficacy (83 versus 65 percent). Patients treated with BT had more frequent relapses and a shorter time to relapse.",
"   </p>",
"   <p>",
"    Two trials with at least one year of follow-up in the meta-analysis compared PD with laparoscopic myotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/79\">",
"     79",
"    </a>",
"    ]. Laparoscopic myotomy had a significantly higher remission rate than PD (95 versus 78 percent) and a significantly lower relapse rate (5 versus 36 percent).",
"   </p>",
"   <p>",
"    A subsequent randomized trial, however, found similar efficacy and safety for PD and laparoscopic myotomy. In the trial, 201 patients were assigned to either pneumatic dilation or laparoscopic Heller myotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/21\">",
"     21",
"    </a>",
"    ]. Patients were followed for a mean of 43 months. In an intention-to-treat analysis, there was no significant difference between the groups with regard to therapeutic success. At one-year follow-up, the success rate for pneumatic dilation was 90 percent, and for laparoscopic myotomy it was 93 percent. After two years, the success rates were 86 and 90 percent, respectively. In addition, after two-years of follow-up there was no significant difference between the groups with regard to lower esophageal sphincter pressure, esophageal emptying, quality of life, or esophageal acid exposure. Subgroup analyses found that patients younger than 40 years were at increased risk of requiring redilation after pneumatic dilation.",
"   </p>",
"   <p>",
"    When deciding how the results of this randomized trial should be incorporated into clinical practice, a number of factors should be considered [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/83\">",
"     83",
"    </a>",
"    ]. First, the protocol for pneumatic dilation used in this study was rigorous, involving up to three sets of balloon dilations over a period of &gt;2 years, with individual sets including as many as three separate dilation sessions. Each dilation session generally means a day lost from work. In contrast, the inconvenience of Heller myotomy is primarily \"up front,\" involving the operation itself and the postoperative recovery. Furthermore, the esophageal perforations that occurred in approximately 4 percent of patients treated with this rigorous pneumatic dilation protocol result in hospitalization, and they may require emergency surgical repair with an open (rather than laparoscopic) procedure. One also must consider that the balloon dilations and operations in this study were performed by very experienced gastroenterologists and surgeons. It is not clear that their excellent results can be reproduced in community practices. Finally, the mean follow-up for this study was only 43 months, and the long-term outcomes remain to be determined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     INFLUENCE OF ACHALASIA SUBTYPE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Using high-resolution manometry, achalasia has been subdivided into subtypes that may influence the treatment response [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/84\">",
"     84",
"    </a>",
"    ]. The subtypes are defined by the pattern of contractility of the esophageal body, which manometrically appears as esophageal pressurization.",
"   </p>",
"   <p>",
"    Type I patients are those with classic achalasia who display no pressure generation in the esophagus. Type II patients display longitudinal muscle contraction and sufficient excitation of the circular muscle to generate substantial intrabolus pressure in the esophageal body (most patients with so-called vigorous achalasia fall into this category). Type III patients also have significant intraesophageal pressure, but in type III patients it is due to lumen obliterating contractions in the distal esophagus, causing a functional obstruction.",
"   </p>",
"   <p>",
"    Compared with type I patients, type II patients were much more likely to respond to any kind of therapy (OR 11.2), whereas patients with type III were much less likely to respond to any therapy (OR 0.24) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/84\">",
"     84",
"    </a>",
"    ]. Severe esophageal dilation also significantly reduced the response to treatment (OR 0.2 compared with no dilation). These results suggest that myotomy may only be advantageous in type I patients and, if validated by prospective studies, may change our therapeutic algorithms for achalasia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     IMPACT OF ENDOSCOPIC TREATMENT ON SUBSEQUENT MYOTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In animal models, both PD and BT injection induce acute and chronic esophageal inflammation, with areas of increased fibrosis in the muscle [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/85\">",
"     85",
"    </a>",
"    ]. This has led to concern regarding the effects of prior PD or BT treatment on the success of subsequent surgery.",
"   </p>",
"   <p>",
"    The available data in humans are conflicting. Some studies suggest that prior endoscopic therapy decreases the efficacy of subsequent myotomy and may increase complication rates [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/86-89\">",
"     86-89",
"    </a>",
"    ]. However, because the studies were not randomized, it is not possible to determine whether the lower efficacy was due to a true effect or to the inclusion of patients in the myotomy following endoscopic treatment who were refractory to any form of treatment.",
"   </p>",
"   <p>",
"    Other nonrandomized studies have shown similar surgical outcomes with regard to efficacy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    complications for patients who had previously received endoscopic therapy compared with patients undergoing myotomy as initial therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/32/12810/abstract/90-93\">",
"     90-93",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     APPROACH TO THE PATIENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic therapy with pneumatic dilation (PD) or botulinum toxin (BT) injection for the treatment of achalasia has the advantage of being less invasive compared with surgery. In addition, BT injection does not require specialized training and can be easily performed during routine endoscopy. Prior studies suggest that symptom recurrence with both of these techniques is common and it is not clear if prior endoscopic therapy adversely affects future surgical myotomy. However, more recent data suggest that in experienced hands, PD may have success rates similar to surgical myotomy. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Efficacy of PD'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H16\">",
"     'Efficacy of BT injection'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H24\">",
"     'Impact of endoscopic treatment on subsequent myotomy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Surgery has the advantage of offering a more permanent solution for managing the symptoms of achalasia, with the disadvantages of being a more invasive procedure and of putting patients at increased risk for reflux and other surgical complications. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Comparative studies'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H24\">",
"     'Impact of endoscopic treatment on subsequent myotomy'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/39/18039?source=see_link\">",
"     \"Overview of the treatment of achalasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Choice of treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;For most healthy patients undergoing an invasive procedure, we suggest minimally invasive surgical myotomy rather than PD. Long-term data suggest that surgical myotomy is durable and it typically only requires a single procedure. However, when performed by very experienced endoscopists using rigorous dilation protocols, PD has similar safety and efficacy to surgical myotomy. Therefore, PD is a reasonable alternative in patients who would like to possibly avoid surgery and are willing to undergo multiple procedures, provided that an endoscopist who is very experienced in performing PD is available. Patients undergoing PD must be good surgical candidates because perforations related to pneumatic dilation often require surgical repair. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'BT injection or PD versus laparoscopic myotomy'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/39/18039?source=see_link&amp;anchor=H6#H6\">",
"     \"Overview of the treatment of achalasia\", section on 'Surgical myotomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients who elect to undergo PD, we suggest surgical myotomy if symptoms persist despite three attempts at PD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/39/18039?source=see_link\">",
"     \"Overview of the treatment of achalasia\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H20\">",
"     'Comparative studies'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    For patients who are surgical candidates but are reluctant to undergo surgery, we suggest PD if an endoscopist very experienced in PD is available, since PD offers better long-term results than botulinum toxin (BT) injection. These patients should be advised that there is approximately a 50 percent chance that they will require another procedure within five years. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Efficacy of PD'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H21\">",
"     'PD versus BT injection'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    For patients at high-risk for complications from surgery or PD (such as the elderly), for patients unwilling to undergo surgery or PD, or for patients with atypical presentations, we suggest a trial of BT injection. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Botulinum toxin injection'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Follow-up",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because there is no cure for achalasia, regular follow-up is required. We evaluate patients within one month following endoscopic therapy. Patients who remain symptomatic are offered repeat dilation.",
"   </p>",
"   <p>",
"    Patients are usually referred to surgery if three consecutive dilatations do not provide symptom resolution. Consideration for surgical referral should also be made in patients with early symptom recurrence following PD. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Efficacy of PD'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The follow-up of patients treated with BT depends upon the indication for BT. As noted above, we typically reserve BT injections for patients who are (1) not surgical or PD candidates, (2) those reluctant to undergo surgery or PD, or (3) patients with atypical presentations of achalasia to help guide therapy. In the first scenario, we monitor patients closely for recurrence of symptoms and offer repeat BT injections until they become surgical candidates or until BT loses efficacy if they remain poor surgical candidates. In the second scenario, we monitor the patient closely at one and four months after therapy. If there is no response after two BT injections, we encourage proceeding to either PD or surgery. In the third scenario, patients who respond to BT injection are referred for surgery or PD if the patient is reluctant to have surgery.",
"   </p>",
"   <p>",
"    Patients who do well with the above therapies, especially BT injection, require close follow-up to monitor for symptom recurrence. BT injection patients are followed one month after therapy and subsequently every three months until symptom recurrence. PD patients are followed-up at 1, 3, 6, and 12 months after therapy and every four to six months thereafter. In addition to recurrence of dysphagia, particular attention is paid to the development of reflux symptoms and proton pump inhibitor therapy is often prescribed empirically.",
"   </p>",
"   <p>",
"    Some experts suggest that patients treated with BT or PD be assessed radiographically, with the goal of recognizing and treating early recurrence of obstruction, but this practice is difficult to justify if the patient is truly asymptomatic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/50/20258?source=see_link\">",
"       \"Patient information: Achalasia (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?2/55/2934?source=see_link\">",
"       \"Patient information: Achalasia (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The therapeutic options for achalasia include pneumatic dilation (PD), botulinum toxin (BT) injection, and surgical myotomy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/39/18039?source=see_link\">",
"       \"Overview of the treatment of achalasia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For most patients with achalasia, we recommend treatment with either pneumatic dilation or surgical myotomy, rather than botulinum toxin (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/39/18039?source=see_link&amp;anchor=H6#H6\">",
"       \"Overview of the treatment of achalasia\", section on 'Surgical myotomy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19001?source=see_link\">",
"       \"Operative management of achalasia: Laparoscopic and open Heller myotomy\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H2\">",
"       'Pneumatic dilation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In most clinical settings, for healthy patients undergoing an invasive procedure for achalasia, we suggest choosing between pneumatic dilation using a progressive dilation protocol or minimally invasive surgical myotomy based upon local expertise in the procedures (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). In settings where there is equal expertise in both procedures, we suggest offering the patient detailed information on the risks and benefits for both procedures and having the patient choose. Since progressive dilation is rarely, if ever, practiced in the United States, the results of the comparative study may not be applicable. In addition, surgical myotomy may be preferable in patients younger than 40 years of age due to an increased need for redilation in this age group. However, other experts, including other authors for UpToDate, disagree and would perform surgical myotomy as initial therapy for the majority of healthy patients. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19001?source=see_link\">",
"       \"Operative management of achalasia: Laparoscopic and open Heller myotomy\"",
"      </a>",
"      .) If local expertise in both procedures is lacking, we would refer patients to an esophageal center of excellence. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'BT injection or PD versus laparoscopic myotomy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/39/18039?source=see_link&amp;anchor=H6#H6\">",
"       \"Overview of the treatment of achalasia\", section on 'Surgical myotomy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Complications of PD include esophageal perforation, development of bleeding, intramural hematomas, esophageal mucosal tears, diverticula of the gastric cardia, and gastroesophageal reflux. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Complications of PD'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common complication of surgical myotomy is gastroesophageal reflux (10 to 30 percent or more). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/39/18039?source=see_link&amp;anchor=H6#H6\">",
"       \"Overview of the treatment of achalasia\", section on 'Surgical myotomy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients at high-risk for complications from surgery or PD (such as the elderly) or those with atypical presentations, we suggest a trial of BT (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Botulinum toxin injection'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H26\">",
"       'Choice of treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Initial response rates to BT injection are good (70 to 90 percent), but many patients relapse within several months. Better results have been seen in studies that used multiple treatment sessions, with clinical benefit seen in 60 to 85 percent of patients at two years. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Efficacy of BT injection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common complications of BT injection are postprocedural transient chest pain (25 percent) and heartburn (5 percent). (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Complications of BT'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/1\">",
"      Spechler SJ. American gastroenterological association medical position statement on treatment of patients with dysphagia caused by benign disorders of the distal esophagus. Gastroenterology 1999; 117:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/2\">",
"      Vaezi MF, Richter JE. Diagnosis and management of achalasia. American College of Gastroenterology Practice Parameter Committee. Am J Gastroenterol 1999; 94:3406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/3\">",
"      Kadakia SC, Wong RK. Graded pneumatic dilation using Rigiflex achalasia dilators in patients with primary esophageal achalasia. Am J Gastroenterol 1993; 88:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/4\">",
"      Okike N, Payne WS, Neufeld DM, et al. Esophagomyotomy versus forceful dilation for achalasia of the esophagus: results in 899 patients. Ann Thorac Surg 1979; 28:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/5\">",
"      Khan AA, Shah SW, Alam A, et al. Pneumatic balloon dilation in achalasia: a prospective comparison of balloon distention time. Am J Gastroenterol 1998; 93:1064.",
"     </a>",
"    </li>",
"    <li>",
"     Pasricha, PJ, Huang, RL, Rai, R, Ferris, C. Achalasia and Other Motor Disorders. In: Gastrointestinal Disease: An endoscopic approach, Vol I, Part II, Dimarino, AJ Jr, Benjamin, SB (Eds), Blackwell Science, Ltd, Malden, MA 1997. p.219.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/7\">",
"      Nair LA, Reynolds JC, Parkman HP, et al. Complications during pneumatic dilation for achalasia or diffuse esophageal spasm. Analysis of risk factors, early clinical characteristics, and outcome. Dig Dis Sci 1993; 38:1893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/8\">",
"      Barkin JS, Guelrud M, Reiner DK, et al. Forceful balloon dilation: an outpatient procedure for achalasia. Gastrointest Endosc 1990; 36:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/9\">",
"      Ciarolla DA, Traube M. Achalasia. Short-term clinical monitoring after pneumatic dilation. Dig Dis Sci 1993; 38:1905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/10\">",
"      Barnett JL, Eisenman R, Nostrant TT, Elta GH. Witzel pneumatic dilation for achalasia: safety and long-term efficacy. Gastrointest Endosc 1990; 36:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/11\">",
"      Ghoshal UC, Kumar S, Saraswat VA, et al. Long-term follow-up after pneumatic dilation for achalasia cardia: factors associated with treatment failure and recurrence. Am J Gastroenterol 2004; 99:2304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/12\">",
"      Zerbib F, Th&eacute;tiot V, Richy F, et al. Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia. Am J Gastroenterol 2006; 101:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/13\">",
"      Mehta R, John A, Sadasivan S, et al. Factors determining successful outcome following pneumatic balloon dilation in achalasia cardia. Indian J Gastroenterol 2005; 24:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/14\">",
"      Bravi I, Nicita MT, Duca P, et al. A pneumatic dilation strategy in achalasia: prospective outcome and effects on oesophageal motor function in the long term. Aliment Pharmacol Ther 2010; 31:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/15\">",
"      Torbey CF, Achkar E, Rice TW, et al. Long-term outcome of achalasia treatment: the need for closer follow-up. J Clin Gastroenterol 1999; 28:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/16\">",
"      Eckardt VF, Gockel I, Bernhard G. Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut 2004; 53:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/17\">",
"      Eckardt VF, Stauf B, Bernhard G. Chest pain in achalasia: patient characteristics and clinical course. Gastroenterology 1999; 116:1300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/18\">",
"      Hulselmans M, Vanuytsel T, Degreef T, et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol 2010; 8:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/19\">",
"      Mikaeli J, Fazel A, Montazeri G, et al. Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia. Aliment Pharmacol Ther 2001; 15:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/20\">",
"      Vaezi MF, Richter JE. Current therapies for achalasia: comparison and efficacy. J Clin Gastroenterol 1998; 27:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/21\">",
"      Boeckxstaens GE, Annese V, des Varannes SB, et al. Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med 2011; 364:1807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/22\">",
"      Di Nardo G, Rossi P, Oliva S, et al. Pneumatic balloon dilation in pediatric achalasia: efficacy and factors predicting outcome at a single tertiary pediatric gastroenterology center. Gastrointest Endosc 2012; 76:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/23\">",
"      Katz PO, Gilbert J, Castell DO. Pneumatic dilatation is effective long-term treatment for achalasia. Dig Dis Sci 1998; 43:1973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/24\">",
"      Csendes A, Braghetto I, Henr&iacute;quez A, Cort&eacute;s C. Late results of a prospective randomised study comparing forceful dilatation and oesophagomyotomy in patients with achalasia. Gut 1989; 30:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/25\">",
"      Karamanolis G, Sgouros S, Karatzias G, et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Am J Gastroenterol 2005; 100:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/26\">",
"      Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 1992; 103:1732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/27\">",
"      Rajput S, Nandwani SK, Phadke AY, et al. Predictors of response to pneumatic dilatation in achalasia cardia. Indian J Gastroenterol 2000; 19:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/28\">",
"      Shahi HM, Aggarwal R, Misra A, et al. Relationship of manometric findings to symptomatic response after pneumatic dilation in achalasia cardia. Indian J Gastroenterol 1998; 17:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/29\">",
"      Fellows IW, Ogilvie AL, Atkinson M. Pneumatic dilatation in achalasia. Gut 1983; 24:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/30\">",
"      Robertson CS, Fellows IW, Mayberry JF, Atkinson M. Choice of therapy for achalasia in relation to age. Digestion 1988; 40:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/31\">",
"      Farhoomand K, Connor JT, Richter JE, et al. Predictors of outcome of pneumatic dilation in achalasia. Clin Gastroenterol Hepatol 2004; 2:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/32\">",
"      Kim CH, Cameron AJ, Hsu JJ, et al. Achalasia: prospective evaluation of relationship between lower esophageal sphincter pressure, esophageal transit, and esophageal diameter and symptoms in response to pneumatic dilation. Mayo Clin Proc 1993; 68:1067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/33\">",
"      Lee JD, Cecil BD, Brown PE, Wright RA. The Cohen test does not predict outcome in achalasia after pneumatic dilation. Gastrointest Endosc 1993; 39:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/34\">",
"      Guardino JM, Vela MF, Connor JT, Richter JE. Pneumatic dilation for the treatment of achalasia in untreated patients and patients with failed Heller myotomy. J Clin Gastroenterol 2004; 38:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/35\">",
"      Zhu Q, Liu J, Yang C. Clinical study on combined therapy of botulinum toxin injection and small balloon dilation in patients with esophageal achalasia. Dig Surg 2009; 26:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/36\">",
"      Mikaeli J, Bishehsari F, Montazeri G, et al. Injection of botulinum toxin before pneumatic dilatation in achalasia treatment: a randomized-controlled trial. Aliment Pharmacol Ther 2006; 24:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/37\">",
"      Kroupa R, Hep A, Dolina J, et al. Combined treatment of achalasia - botulinum toxin injection followed by pneumatic dilatation: long-term results. Dis Esophagus 2010; 23:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/38\">",
"      Khudyak V, Lysy J, Mankuta D. Achalasia in pregnancy. Obstet Gynecol Surv 2006; 61:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/39\">",
"      Reynolds JC, Parkman HP. Achalasia. Gastroenterol Clin North Am 1989; 18:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/40\">",
"      Eckardt VF, Kanzler G, Westermeier T. Complications and their impact after pneumatic dilation for achalasia: prospective long-term follow-up study. Gastrointest Endosc 1997; 45:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/41\">",
"      Vanuytsel T, Lerut T, Coosemans W, et al. Conservative management of esophageal perforations during pneumatic dilation for idiopathic esophageal achalasia. Clin Gastroenterol Hepatol 2012; 10:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/42\">",
"      Lynch KL, Pandolfino JE, Howden CW, Kahrilas PJ. Major complications of pneumatic dilation and Heller myotomy for achalasia: single-center experience and systematic review of the literature. Am J Gastroenterol 2012; 107:1817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/43\">",
"      Borotto E, Gaudric M, Danel B, et al. Risk factors of oesophageal perforation during pneumatic dilatation for achalasia. Gut 1996; 39:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/44\">",
"      Metman EH, Lagasse JP, d'Alteroche L, et al. Risk factors for immediate complications after progressive pneumatic dilation for achalasia. Am J Gastroenterol 1999; 94:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/45\">",
"      Swedlund A, Traube M, Siskind BN, McCallum RW. Nonsurgical management of esophageal perforation from pneumatic dilatation in achalasia. Dig Dis Sci 1989; 34:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/46\">",
"      Lo AY, Surick B, Ghazi A. Nonoperative management of esophageal perforation secondary to balloon dilatation. Surg Endosc 1993; 7:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/47\">",
"      Bell RC. Laparoscopic closure of esophageal perforation following pneumatic dilatation for achalasia. Report of two cases. Surg Endosc 1997; 11:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/48\">",
"      Nathanson LK, Gotley D, Smithers M, Branicki F. Videothoracoscopic primary repair of early distal oesophageal perforation. Aust N Z J Surg 1993; 63:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/49\">",
"      Goldblum JR, Whyte RI, Orringer MB, Appelman HD. Achalasia. A morphologic study of 42 resected specimens. Am J Surg Pathol 1994; 18:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/50\">",
"      Aggestrup S, Uddman R, Sundler F, et al. Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia. Gastroenterology 1983; 84:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/51\">",
"      Mearin F, Mourelle M, Guarner F, et al. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest 1993; 23:724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/52\">",
"      Pasricha PJ, Ravich WJ, Hendrix TR, et al. Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial. Ann Intern Med 1994; 121:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/53\">",
"      Katzka DA, Castell DO. Use of botulinum toxin as a diagnostic/therapeutic trial to help clarify an indication for definitive therapy in patients with achalasia. Am J Gastroenterol 1999; 94:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/54\">",
"      Wehrmann T, Schmitt T, Dietrich CF, et al. Manometrically-guided endoscopic injection of botulinum toxin for esophageal achalasia: a pilot trial. Z Gastroenterol 2000; 38:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/55\">",
"      Hoffman BJ, Knapple WL, Bhutani MS, et al. Treatment of achalasia by injection of botulinum toxin under endoscopic ultrasound guidance. Gastrointest Endosc 1997; 45:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/56\">",
"      Annese V, Bassotti G, Coccia G, et al. Comparison of two different formulations of botulinum toxin A for the treatment of oesophageal achalasia. The Gismad Achalasia Study Group. Aliment Pharmacol Ther 1999; 13:1347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/57\">",
"      Pasricha PJ, Ravich WJ, Hendrix TR, et al. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995; 332:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/58\">",
"      Cuilli&egrave;re C, Ducrott&eacute; P, Zerbib F, et al. Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut 1997; 41:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/59\">",
"      Rollan A, Gonzalez R, Carvajal S, Chianale J. Endoscopic intrasphincteric injection of botulinum toxin for the treatment of achalasia. J Clin Gastroenterol 1995; 20:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/60\">",
"      Fishman VM, Parkman HP, Schiano TD, et al. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am J Gastroenterol 1996; 91:1724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/61\">",
"      Muehldorfer SM, Schneider TH, Hochberger J, et al. Esophageal achalasia: intrasphincteric injection of botulinum toxin A versus balloon dilation. Endoscopy 1999; 31:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/62\">",
"      Allescher HD, Storr M, Seige M, et al. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-Up. Endoscopy 2001; 33:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/63\">",
"      Bassotti G, D'Onofrio V, Battaglia E, et al. Treatment with botulinum toxin of octo-nonagerians with oesophageal achalasia: a two-year follow-up study. Aliment Pharmacol Ther 2006; 23:1615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/64\">",
"      Annese V, Basciani M, Borrelli O, et al. Intrasphincteric injection of botulinum toxin is effective in long-term treatment of esophageal achalasia. Muscle Nerve 1998; 21:1540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/65\">",
"      Kolbasnik J, Waterfall WE, Fachnie B, et al. Long-term efficacy of Botulinum toxin in classical achalasia: a prospective study. Am J Gastroenterol 1999; 94:3434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/66\">",
"      Pasricha PJ, Rai R, Ravich WJ, et al. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology 1996; 110:1410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/67\">",
"      Annese V, Bassotti G, Coccia G, et al. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut 2000; 46:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/68\">",
"      Vaezi MF, Richter JE, Wilcox CM, et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut 1999; 44:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/69\">",
"      Ghoshal UC, Chaudhuri S, Pal BB, et al. Randomized controlled trial of intrasphincteric botulinum toxin A injection versus balloon dilatation in treatment of achalasia cardia. Dis Esophagus 2001; 14:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/70\">",
"      Annese V, Basciani M, Perri F, et al. Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology 1996; 111:1418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/71\">",
"      D'Onofrio V, Miletto P, Leandro G, Iaquinto G. Long-term follow-up of achalasia patients treated with botulinum toxin. Dig Liver Dis 2002; 34:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/72\">",
"      Lake JM, Wong RK. Review article: the management of achalasia - a comparison of different treatment modalities. Aliment Pharmacol Ther 2006; 24:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/73\">",
"      Lange O, Bigalke H, Dengler R, et al. Neutralizing antibodies and secondary therapy failure after treatment with botulinum toxin type A: much ado about nothing? Clin Neuropharmacol 2009; 32:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/74\">",
"      Eaker EY, Gordon JM, Vogel SB. Untoward effects of esophageal botulinum toxin injection in the treatment of achalasia. Dig Dis Sci 1997; 42:724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/75\">",
"      Mac Iver R, Liptay M, Johnson Y. A case of mediastinitis following botulinum toxin type A treatment for achalasia. Nat Clin Pract Gastroenterol Hepatol 2007; 4:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/76\">",
"      Fitzgerald JF, Troncone R, Sukerek H, Tolia V. Clinical quiz. Sinus tract between esophagus and fundus. J Pediatr Gastroenterol Nutr 2002; 35:38, 98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/77\">",
"      Weusten BL, Samsom M, Smout AJ. Pneumothorax complicating botulinum toxin injection in the body of a dilated oesophagus in achalasia. Eur J Gastroenterol Hepatol 2003; 15:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/78\">",
"      Schiano TD, Fisher RS, Parkman HP, et al. Use of high-resolution endoscopic ultrasonography to assess esophageal wall damage after pneumatic dilation and botulinum toxin injection to treat achalasia. Gastrointest Endosc 1996; 44:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/79\">",
"      Wang L, Li YM, Li L. Meta-analysis of randomized and controlled treatment trials for achalasia. Dig Dis Sci 2009; 54:2303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/80\">",
"      Prakash C, Freedland KE, Chan MF, Clouse RE. Botulinum toxin injections for achalasia symptoms can approximate the short term efficacy of a single pneumatic dilation: a survival analysis approach. Am J Gastroenterol 1999; 94:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/81\">",
"      Bansal R, Nostrant TT, Scheiman JM, et al. Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary achalasia. J Clin Gastroenterol 2003; 36:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/82\">",
"      Vela MF, Richter JE, Khandwala F, et al. The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol 2006; 4:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/83\">",
"      Spechler SJ. Pneumatic dilation and laparoscopic Heller's myotomy equally effective for achalasia. N Engl J Med 2011; 364:1868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/84\">",
"      Pandolfino JE, Kwiatek MA, Nealis T, et al. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology 2008; 135:1526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/85\">",
"      Richardson WS, Willis GW, Smith JW. Evaluation of scar formation after botulinum toxin injection or forced balloon dilation to the lower esophageal sphincter. Surg Endosc 2003; 17:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/86\">",
"      Raftopoulos Y, Landreneau RJ, Hayetian F, et al. Factors affecting quality of life after minimally invasive Heller myotomy for achalasia. J Gastrointest Surg 2004; 8:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/87\">",
"      Smith CD, Stival A, Howell DL, Swafford V. Endoscopic therapy for achalasia before Heller myotomy results in worse outcomes than heller myotomy alone. Ann Surg 2006; 243:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/88\">",
"      Bonavina L, Incarbone R, Antoniazzi L, et al. Previous endoscopic treatment does not affect complication rate and outcome of laparoscopic Heller myotomy and anterior fundoplication for oesophageal achalasia. Ital J Gastroenterol Hepatol 1999; 31:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/89\">",
"      Finley CJ, Kondra J, Clifton J, et al. Factors associated with postoperative symptoms after laparoscopic Heller myotomy. Ann Thorac Surg 2010; 89:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/90\">",
"      Horgan S, Hudda K, Eubanks T, et al. Does botulinum toxin injection make esophagomyotomy a more difficult operation? Surg Endosc 1999; 13:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/91\">",
"      Rakita S, Bloomston M, Villadolid D, et al. Esophagotomy during laparoscopic Heller myotomy cannot be predicted by preoperative therapies and does not influence long-term outcome. J Gastrointest Surg 2005; 9:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/92\">",
"      Deb S, Deschamps C, Allen MS, et al. Laparoscopic esophageal myotomy for achalasia: factors affecting functional results. Ann Thorac Surg 2005; 80:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/32/12810/abstract/93\">",
"      Patti MG, Molena D, Fisichella PM, et al. Laparoscopic Heller myotomy and Dor fundoplication for achalasia: analysis of successes and failures. Arch Surg 2001; 136:870.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2245 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-F9B63D4400-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_32_12810=[""].join("\n");
var outline_f12_32_12810=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PNEUMATIC DILATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Technique for PD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Efficacy of PD",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Short- to medium-term results",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Long-term (&gt;10 year) results",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Predictors of outcome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - PD after failed myotomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - PD after BT injection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - PD during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Complications of PD",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Esophageal perforation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      BOTULINUM TOXIN INJECTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Technique for BT injection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Efficacy of BT injection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Short-term results (&lt;5 years)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Predictors of response",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Complications of BT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      COMPARATIVE STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      PD versus BT injection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      BT injection or PD versus laparoscopic myotomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      INFLUENCE OF ACHALASIA SUBTYPE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      IMPACT OF ENDOSCOPIC TREATMENT ON SUBSEQUENT MYOTOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      APPROACH TO THE PATIENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Choice of treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Follow-up",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2245\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2245|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/19/24881\" title=\"diagnostic image 1\">",
"      Pneumatic dilation fluoroscopy - balloon inflation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=related_link\">",
"      Botulism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/26/14759?source=related_link\">",
"      Clinical manifestations and diagnosis of achalasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/57/10137?source=related_link\">",
"      Complications of endoscopic esophageal stricture dilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19001?source=related_link\">",
"      Operative management of achalasia: Laparoscopic and open Heller myotomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/22/24936?source=related_link\">",
"      Overview of procedural sedation for gastrointestinal endoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/39/18039?source=related_link\">",
"      Overview of the treatment of achalasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/7/43124?source=related_link\">",
"      Pathophysiology and etiology of achalasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/55/2934?source=related_link\">",
"      Patient information: Achalasia (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/50/20258?source=related_link\">",
"      Patient information: Achalasia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/52/12105?source=related_link\">",
"      Treatment of dystonia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_32_12811="Types of systemic reactions to mosquito bites";
var content_f12_32_12811=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F56254&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F56254&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Systemic reactions to mosquito bites in humans*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Papular urticaria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute generalized urticaria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Asthma symptoms",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anaphylaxis",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serum sickness",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphadenopathy, hepatomegaly, fever, and necrotic skin reactions at mosquito bite sites",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Not contiguous with the site of a witnessed or likely mosquito bite.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Rare.",
"      <br>",
"       &Delta; Predominantly reported in patients of Japanese or Korean heritage with Epstein-Barr virus-associated lymphoproliferative diseases such as non-Hodgkin's lymphoma or natural killer cell leukemia.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_32_12811=[""].join("\n");
var outline_f12_32_12811=null;
var title_f12_32_12812="Ambulatory ECG in sudden death";
var content_f12_32_12812=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F57596&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F57596&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Ambulatory ECG monitoring findings in 157 cases of sudden cardiac death",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Etiology",
"       </td>",
"       <td class=\"subtitle1\">",
"        Percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Ventricular tachyarrhythmia",
"       </td>",
"       <td class=\"sublist1_other_start\">",
"        83.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        VT/VF",
"       </td>",
"       <td class=\"sublist_other\">",
"        62.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Primary VF",
"       </td>",
"       <td class=\"sublist_other\">",
"        8.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Torsade polymorphic VT",
"       </td>",
"       <td class=\"sublist_other\">",
"        12.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bradycardia",
"       </td>",
"       <td>",
"        16.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Electrocardiographic",
"abnormalities",
"       </td>",
"       <td class=\"subtitle1\">",
"        Finding or frequency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        Increase in VPBs",
"       </td>",
"       <td>",
"        75 to 90 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        Increase in complex VPBs",
"       </td>",
"       <td>",
"        70 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        R on T VPBs",
"       </td>",
"       <td>",
"        15 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        Monomorphic VT duration before VF",
"       </td>",
"       <td>",
"        167 sec",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        Polymorphic VT duration before VF",
"       </td>",
"       <td>",
"        34 sec",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        Heart rate before VT or VF",
"       </td>",
"       <td>",
"        Accelerated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        VT cycle length before VF",
"       </td>",
"       <td>",
"        Accelerated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        Ischemic ST segment changes",
"       </td>",
"       <td>",
"        13 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        QTc",
"       </td>",
"       <td>",
"        Unchanged",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     VT: ventricular tachycardia; VF: ventricular fibrillation; VPB: ventricular premature beat.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Bayes de Luna A, Coumel P, Leclerc JF. Am Heart J 1989; 117:151.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_32_12812=[""].join("\n");
var outline_f12_32_12812=null;
var title_f12_32_12813="Immunoglobulin variable region";
var content_f12_32_12813=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F68398&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F68398&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Immunoglobulin variable region",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 148px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    There are four framework regions (FR) flanking three complementarity-determining regions (CDR). After folding into the proper conformation (Ig domain), the CDRs will be near one another forming the combining site. The variable regions for the heavy chain (VH) and light chain (VL) are shown.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_32_12813=[""].join("\n");
var outline_f12_32_12813=null;
var title_f12_32_12814="Pediatric office resuscitation supplies";
var content_f12_32_12814=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F53154&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F53154&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pediatric office resuscitation supplies",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Essential*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Equipment",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_single\">",
"            Airway",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Oxygen delivery system",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Oxygen masks&bull;",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Portable suction device with rigid and flexible catheters&Delta;",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Nebulizer or metered dose inhaler with spacer/mask",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Self-inflating bag-valve-mask&loz;",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Oropharyngeal airways (sizes 00-5)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Pulse oximeter",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_single\">",
"            Miscellaneous",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Sphygmomanometer with infant, child, adult, and thigh cuffs",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Resuscitation guide (eg, Broselow&reg; tape or precalculated weight-based equipment and drug sheets)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Backboard/cardiac arrest board",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Sterile dressings",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Splints",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_single\">",
"            Personal protective equipment",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Latex-free gloves",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Surgical masks",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Eye covers",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Gowns",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Medications&yen;",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Oxygen",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Albuterol (MDI or inhalational)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Epinephrine (1 mg/mL [1:1000])",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Strongly suggested*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Equipment",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_single\">",
"            Airway",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Suction catheters (5-16F)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Yankauer suction tip",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Laryngoscope handle (pediatric, adult)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Laryngoscope blades (sizes 0-2 straight, 2-3 curved)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Endotracheal tubes (uncuffed 2.5-5.5, cuffed 4.0-8.0)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Stylets (pediatric, adult)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            End-tidal carbon dioxide detector",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_single\">",
"            Vascular access and fluid administration",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Latex-free tourniquet",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Butterfly needles (19-25 gauge)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Over-needle IV catheters (14-24 gauge)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Intraosseous needles&sect;",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Tape and arm boards",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            IV tubing, microdrip fluid reservoir",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle3_single\">",
"            Miscellaneous",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Automated external defibrillator with pediatric capability",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Point of care glucose test",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Cervical collars (small/large)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Heating source (overhead warmer/heat lamp)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Medications and fluids&yen;",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Activated charcoal without sorbitol",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Antibiotics",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Anticonvulsants (lorazepam, diazepam)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Corticosteroids (oral/parenteral)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Dextrose (4 mg/mL [25 percent])",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Dextrose 5 percent and 0.45 NS solution (500 mL bags)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Diphenhydramine (50 mg/mL, parenteral)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Epinephrine (0.1 mg/mL [1:10,000])",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Atropine sulfate (0.1 mg/mL)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Naloxone (0.4 mg/mL)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            NS or lactated Ringer's solution (500 mL bags)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent2\">",
"            Sodium bicarbonate (0.5 mEq/mL [4.2 percent])",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     IV: intravenous; NS: normal saline.",
"     <br>",
"      * Essential supplies are recommended for all office practices that provide primary pediatric care. Strongly suggested supplies are essential if advanced emergency medical system response time to the practice is greater than 10 minutes.",
"      <br>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       Venturi and nonrebreather oxygen masks with reservoirs in infant, child, and adult sizes.",
"       <br>",
"        &Delta; Wall or portable suction with tonsil tip suction catheter and bulb syringe.",
"        <br>",
"         <span class=\"lozenge\">",
"          &loz;",
"         </span>",
"         450 and 1000 mL reservoir self-inflating resuscitation bags with infant, child, and adult masks.",
"         <br>",
"          &sect; Manual intraosseous needles (16 and 18 gauge) or 15 gauge intraosseous needles of varying lengths with driver (eg, EZ-IO&reg;).",
"          <br>",
"           &yen; Medications and fluids require regular inspection to ensure that they are properly packaged and not expired. Parenteral lorazepam requires refrigeration.",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Committee on Pediatric Emergency Medicine, Frush, K. Policy Statement: preparation for emergencies in the offices of pediatricians and pediatric primary care providers. Pediatrics 2007; 120:200.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_32_12814=[""].join("\n");
var outline_f12_32_12814=null;
var title_f12_32_12815="Giant cell arteritis fundus";
var content_f12_32_12815=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F69437&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F69437&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Giant cell arteritis fundus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 271px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pallid disc swelling in GCA.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Madhura Tamhankar, MD and Nicholas J Volpe, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_32_12815=[""].join("\n");
var outline_f12_32_12815=null;
